{"title": "PDF", "author": "PDF", "url": "https://apps.legislature.ky.gov/recorddocuments/bill/22RS/HB136/HCS1.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 1 of 141 HB013630.100 - 50 - XXXX House Committee Substitute AN ACT relating to medicinal cannabis and making an appropriation therefor. 1 Be it enacted by the General Assembly of the Commonwealth of Kentucky: 2 SECTION 1. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 3 READ AS FOLLOWS: 4 For the purposes of Sections 1 to 30 of this Act, unless the context otherwise requires: 5 (1) \"Bona fide practitioner -patient relationship\" means a treating or consulting 6 relationship, during the course of which a medicinal cannabis practitioner has: 7 (a) Completed an initial in -person examination and assessment of the patient's 8 medical history and current medical condition; 9 (b) Consulted with the patient with respect to the possible medical, therapeutic, 10 and palliative properties of medicinal cannabis; 11 (c) Advised the patient of the possible risks and side effects associated with the 12 use of medicinal cannabis, including possible interactions between 13 medicinal cannabis and any other drug or medication that the patient is 14 taking at that time; and 15 (d) Establishe d an expectation that he or she will provide follow -up care and 16 treatment to the patient; 17 (2) \"Cannabis business\" means an entity licensed under this chapter as a cultivator, 18 dispensary, processor, producer, or safety compliance facility; 19 (3) \"Cannabis bus iness agent\" means a principal officer, board member, employee, 20 volunteer, or agent of a cannabis business; 21 (4) \"Cannabis consultation agreement\" means a written agreement between a 22 dispensary and a pharmacist, who shall serve as the dispensary's pharmacy 23 director, to provide medicinal cannabis consultation services to the dispensary; 24 (5) \"Cardholder\" means: 25 (a) A registered qualified patient, designated caregiver, or visiting qualified 26 patient who has applied for, obtained, and possesses a valid registry 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 2 of 141 HB013630.100 - 50 - XXXX House Committee Substitute identification card issued by the department; or 1 (b) A visiting qualified patient who has obtained and possesses a valid out -of- 2 state registry identification card; 3 (6) \"Cultivator\" means an entity licensed as such under Sections 16, 17, and 18 of 4 this Act; 5 (7) \"Cultivator agent\" means a principal officer, board member, employee, 6 volunteer, or agent of a cultivator; 7 (8) \"Department\" means the Department for Public Health or its successor agency; 8 (9) \"Designated caregiver\" means a person who has registered as such with the 9 department as required by this chapter; 10 (10) \"Dispensary\" means an entity licensed as such under Sections 16, 17, and 18 of 11 this Act; 12 (11) \"Dispensary agent\" means a principal officer, board member, employee, 13 volunteer, or agent of a dispensa ry; 14 (12) \"Disqualifying felony offense\" means: 15 (a) A felony offense that would classify the person as a violent offender under 16 KRS 439.3401; or 17 (b) A violation of a state or federal controlled substance law that was classified 18 as a felony in the jurisdicti on where the person was convicted, except: 19 1. An offense for which the sentence, including any term of probation, 20 incarceration, or supervised release, was completed five (5) or more 21 years earlier; or 22 2. An offense that consisted of conduct for which Secti ons 1 to 30 of this 23 Act would likely have prevented a conviction, but the conduct either 24 occurred prior to the enactment of Sections 1 to 30 of this Act or was 25 prosecuted by an authority other than the Commonwealth of 26 Kentucky; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 3 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (13) \"Diversion\" or \"divert\" means the act of dispensing, selling, or otherwise 1 transferring possession of medicinal cannabis from a licensed cannabis business 2 or cardholder to any person or entity not authorized under the provisions of 3 Sections 1 to 30 of this Act to legally possess or use medicinal cannabis; 4 (14) \"Enclosed, locked facility\" means an indoor growing space such as a room, 5 greenhouse, building, or other indoor enclosed area that is maintained and 6 operated by a cultivator or producer and is equipped with locks and other security 7 devices that permit only authorized access by agents of the cultivator or producer, 8 as required by the department; 9 (15) \"Gross receipts\" means the total amount or consideration, including cash, credit, 10 property, and services, for which medicinal c annabis is sold, valued in money, 11 whether received in money or otherwise; 12 (16) \"Growth area\" means the same as an enclosed, locked facility; 13 (17) \"Marijuana\" has the same meaning as in Section 37 of this Act; 14 (18) \"Medicinal cannabis\": 15 (a) Means marijuana as defined in Section 37 of this Act when cultivated, 16 harvested, processed, produced, transported, dispensed, distributed, sold, 17 possessed, or used in accordance with Sections 1 to 30 of this Act; 18 (b) Includes medicinal cannabis products and raw plant mate rial; and 19 (c) Does not include industrial hemp or industrial hemp products as defined in 20 KRS 260.850; 21 (19) \"Medicinal cannabis accessories\" means any equipment, product, or material of 22 any kind which is used, intended for use, or designed for use in the pr eparing, 23 storing, using, or consuming medicinal cannabis in accordance with Sections 1 24 to 30 of this Act; 25 (20) \"Medicinal cannabis practitioner\" means a physician, a physician assistant, or 26 an advanced practice registered nurse who is authorized by his or her state 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 4 of 141 HB013630.100 - 50 - XXXX House Committee Substitute licensing board to provide written certifications for the use of medicinal cannabis 1 in accordance with Section 9 of this Act; 2 (21) \"Medicinal cannabis product\" means any compound, manufacture, salt, 3 derivative, mixture, or preparation of any part of the plant Cannabis sp., its seeds 4 or its resin; or any compound, mixture, or preparation which contains any 5 quantity of these substances when cultivated, harvested, processed, produced, 6 transported, dispensed, distributed, sold, possessed, or used in a ccordance with 7 Sections 1 to 30 of this Act. The term \"medicinal cannabis product\" does not 8 include industrial hemp products as defined in KRS 260.850; 9 (22) \"Minor\" means a person less than eighteen (18) years of age; 10 (23) \"Out -of-state registry identifica tion card\" means a registry identification card, or 11 an equivalent document, that was issued pursuant to the laws of another state, 12 district, territory, commonwealth, or insular possession of the United States, 13 except that the card must be issued for a dise ase or medical condition that 14 appears on the approved list of qualifying medical conditions created by the 15 department, that allows the person to use medicinal cannabis in the jurisdiction 16 of issuance; 17 (24) \"Pharmacist\" means the same as in KRS 315.010; 18 (25) \"Processor\" means an entity licensed as such under Sections 16, 17, and 18 of 19 this Act; 20 (26) \"Processor agent\" means a principal officer, board member, employee, 21 volunteer, or agent of a processor; 22 (27) \"Producer\" means an entity licensed as such under Sections 16, 17, and 18 of 23 this Act; 24 (28) \"Producer agent\" means a principal officer, board member, employee, volunteer, 25 or agent of a producer; 26 (29) \"Qualified patient\" means a person who has obtained a written certification from 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 5 of 141 HB013630.100 - 50 - XXXX House Committee Substitute a medicinal cannabis practitioner with whom he or she has a bona fide 1 practitioner -patient relationship; 2 (30) \"Qualifying medical condition\" means a disease or medical condition that 3 appears on the approved list of qualifying medical conditions for which a 4 medicinal cannabis practitioner may provide a patient with a written certification 5 for the use of medicinal cannabis established by the department pursuant Section 6 28 of this Act; 7 (31) \"Raw plant material\" means the trichome -covered part of the female plan t 8 Cannabis sp. or any mixture of shredded leaves, stems, seeds, and flowers of the 9 Cannabis sp. plant. The term \"raw plant material\" does not include plant 10 material obtained from industrial hemp as defined in KRS 260.850; 11 (32) \"Registered qualified patient \" means a qualified patient who has applied for, 12 obtained, and possesses a valid registry identification card or provisional 13 registration receipt issued by the department; 14 (33) \"Registry identification card\" means a document issued by the department that 15 identifies a person as a registered qualified patient, visiting qualified patient, or 16 designated caregiver; 17 (34) \"Safety compliance facility\" means an entity licensed as such under Sections 16, 18 17, and 18 of this Act; 19 (35) \"Safety compliance facility agent\" means a principal officer, board member, 20 employee, volunteer, or agent of a safety compliance facility; 21 (36) \"Seedling\" means a medicinal cannabis plant that has no flowers and is not 22 taller than eight (8) inches; 23 (37) \"Serious violation\" means: 24 (a) Any v iolation of Sections 1 to 30 of this Act or any administrative regulation 25 promulgated thereunder that is capable of causing death or which causes 26 serious and prolonged disfigurement, prolonged impairment of health, or 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 6 of 141 HB013630.100 - 50 - XXXX House Committee Substitute prolonged loss or impairment of the fu nction of any bodily organ; 1 (b) Diversion of medicinal cannabis; or 2 (c) Any act that would constitute a violation of Section 38 of this Act; 3 (38) \"Smoking\" means the inhalation of smoke produced from the combustion of raw 4 plant material when ignited by a f lame; 5 (39) \"State licensing board\" means, respectively: 6 (a) The Kentucky Board of Medical Licensure; or 7 (b) The Kentucky Board of Nursing; 8 (40) \"Telehealth\" has the same meaning as in KRS 211.332; 9 (41) \"Use of medicinal cannabis\" includes the acquisition, administration, 10 possession, transfer, transportation, or consumption of medicinal cannabis or 11 medicinal cannabis accessories by a cardholder in accordance with Sections 1 to 12 30 of this Act. The term \"use of medicinal cannabis\" does not include: 13 (a) Cultiva tion of marijuana by a cardholder; 14 (b) The use or consumption of marijuana by smoking; or 15 (c) The use of industrial hemp or industrial hemp products as defined in KRS 16 260.850; 17 (42) \"Visiting qualified patient\" means a person who has registered as such thro ugh 18 the department as required under Section 11 of this Act or who possesses a valid 19 out-of-state registry identification card; and 20 (43) \"Written certification\" means a document dated and signed by a medicinal 21 cannabis practitioner, that: 22 (a) States, that in the medicinal cannabis practitioner's professional medical 23 opinion, the patient may receive medical, therapeutic, or palliative benefit 24 from the use of medicinal cannabis; 25 (b) Specifies the qualifying medical condition or conditions for which the 26 medici nal cannabis practitioner believes that the patient may receive 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 7 of 141 HB013630.100 - 50 - XXXX House Committee Substitute medical, therapeutic, or palliative benefit; and 1 (c) Affirms that the medicinal cannabis practitioner has a bona fide 2 practitioner -patient relationship with the patient. 3 SECTION 2. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 4 READ AS FOLLOWS: 5 (1) Nothing in Sections 1 to 30 of this Act shall be construed as applying to industrial 6 hemp or industrial hemp products as defined in KRS 260.850. 7 (2) Notwithstanding any provision of law to the contrary, and except as provided in 8 subsections (3) and (4) of this section: 9 (a) The use of medicinal cannabis by a cardholder shall be considered lawful if 10 done in accordance with Sections 1 to 30 of this Act an d any administrative 11 regulations promulgated thereunder; 12 (b) The acquisition, blending, cultivation, delivery, distribution, 13 manufacturing, manipulation, packaging for sale, preparation, possession, 14 sale, testing, transportation, or transfer of medicinal c annabis or medicinal 15 cannabis accessories by a cannabis business or cannabis business agent 16 shall be considered lawful if done in accordance with Sections 1 to 30 of 17 this Act and any administrative regulations promulgated thereunder; 18 (c) A registered quali fied patient or visiting qualified patient shall not be 19 considered to be under the influence of medicinal cannabis solely because 20 of the presence of tetrahydrocannabinol metabolites, including but not 21 limited to the cannabinoid carboxy THC, which is also k nown as THC - 22 COOH; 23 (d) A medicinal cannabis practitioner shall not be subject to arrest, 24 prosecution, or penalty in any manner, or denied any right or privilege, 25 including but not limited to a civil penalty or disciplinary action by a state 26 licensing board or by any other occupational or professional licensing 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 8 of 141 HB013630.100 - 50 - XXXX House Committee Substitute board, solely for providing written certifications or for otherwise stating 1 that, in the medicinal cannabis practitioner's professional opinion, a patient 2 may receive medical, therapeutic, or palliativ e benefit from the use of 3 medicinal cannabis, if done in accordance with Sections 1 to 30 of this Act; 4 (e) A pharmacist shall not be subject to arrest, prosecution, or penalty in any 5 manner, or denied any right or privilege, including but not limited to a civil 6 penalty or disciplinary action by the Kentucky Board of Pharmacy or by any 7 other professional licensing board, solely for consulting with or providing 8 information with respect to the possible risks or side effects of medicinal 9 cannabis, including any potentially harmful or dangerous interactions 10 between medicinal cannabis and any other drug; 11 (f) An attorney shall not be subject to arrest, prosecution, or penalty in any 12 manner, or denied any right or privilege, including but not limited to a civil 13 pena lty or disciplinary action by the Kentucky Court of Justice, the 14 Kentucky Bar Association, or any other professional licensing board, solely 15 for providing an individual or cannabis business with legal assistance 16 related to activity that is no longer subjec t to criminal penalties under state 17 law pursuant to Sections 1 to 30 of this Act; and 18 (g) No person shall be subject to arrest, prosecution, or penalty in any manner, 19 or denied any right or privilege, including but not limited to a civil penalty 20 or discipl inary action by an occupational or professional licensing board, 21 solely for providing assistance or services, including but not limited to 22 accounting services, financial services, security services, or business 23 consulting services, to any individual or can nabis business related to 24 activity that is no longer subject to criminal penalties under state law 25 pursuant to Sections 1 to 30 of this Act. 26 (3) Nothing in subsection (2) of this section shall be construed or interpreted to: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 9 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (a) Prohibit the arrest, prosec ution, or imposition of any other penalty arising 1 from but not limited to breach of contract, breach of fiduciary duty, 2 negligence, or engaging in criminal activity that would constitute a felony 3 or misdemeanor; 4 (b) Prevent a practitioner from being subjec t to administrative penalties 5 imposed by his or her state licensing board for any violation of Section 1 to 6 30 of this Act or any administrative regulation promulgated under Section 9 7 of this Act; or 8 (c) Prevent a pharmacist from being subject to administr ative penalties 9 imposed by the Kentucky Board of Pharmacy for any violation of Section 1 10 to 30 of this Act or any administrative regulation promulgated under 11 Section 10 of this Act. 12 (4) Notwithstanding subsection (2) of this section and any other provision of law to 13 the contrary, a cardholder who is licensed under KRS Chapter 311 or KRS 14 Chapter 314 may be subject to intervention or disciplinary action by his or her 15 state licensing board if: 16 (a) There is probable cause to believe that the cardholder has beco me impaired 17 by, or otherwise abused, medicinal cannabis; or 18 (b) The cardholder has a medically diagnosable disease that is characterized by 19 chronic, habitual, or periodic use of medicinal cannabis resulting in 20 interference with the cardholder's professiona l, social, or economic 21 functions in the community or the loss of powers of self -control regarding 22 the use of medicinal cannabis. 23 SECTION 3. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 24 READ AS FOLLOWS: 25 (1) The Divisio n of Medicinal Cannabis is hereby established within the Department 26 for Public Health and is charged with the implementation, operation, oversight, 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 10 of 141 HB013630.100 - 50 - XXXX House Committee Substitute and regulation of the medicinal cannabis program established in Sections 1 to 30 1 of this Act. 2 (2) The Board of Physicians and Advisors is hereby established within the Division 3 of Medicinal Cannabis which shall consist of the following members: 4 (a) Five (5) physicians appointed by the Kentucky Board of Medical Licensure. 5 In order to be eligible to be appointed t o the board, a physician shall be 6 authorized, pursuant to Section 9 of this Act, to provide written 7 certifications for the use of medicinal cannabis and shall be certified by the 8 appropriate board in one (1) of the following specialties: 9 1. Addiction medic ine; 10 2. Anesthesiology; 11 3. Gastroenterology; 12 4. Obstetrics and gynecology; 13 5. Ophthalmology; 14 6. Optometry; 15 7. Infectious disease; 16 8. Neurology; 17 9. Oncology; 18 10. Pain management; 19 11. Pain medicine; 20 12. Pediatrics; 21 13. Physical medicine and rehabilitation; or 22 14. Psychiatry. 23 One (1) of the physicians appointed to the board pursuant to this paragraph 24 shall be designated by the commissioner to serve as chairperson; 25 (b) Three (3) advanced practice registered nurses appoint ed by the Kentucky 26 Board of Nursing. In order to be eligible to be appointed to the board, an 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 11 of 141 HB013630.100 - 50 - XXXX House Committee Substitute advanced practice registered nurse shall be authorized, pursuant to Section 1 9 of this Act, to provide written certifications for the use of medicinal 2 cannabis; 3 (c) One (1) pharmacist appointed by the Kentucky Board of Pharmacy. In 4 order to be eligible to be appointed to the board, a pharmacist shall be 5 authorized, pursuant to Section 10 of this Act, to provide medicinal 6 cannabis consultation services to cardholders and to enter into cannabis 7 consultation agreements with dispensaries; 8 (d) Six (6) patient advocates selected by the commissioner of the department; 9 (e) The commissioner of the department, who shall serve as a non -voting ex 10 officio member; and 11 (f) The dire ctor of the Division of Medicinal Cannabis, who shall serve as a 12 non-voting ex officio member. 13 (3) The members of the Board of Physicians and Advisors appointed by the 14 commissioner shall: 15 (a) Serve for a term of four (4) years and until their successors ar e appointed, 16 except that the term for members appointed to fill the initial appointments 17 after the effective date of this section shall be as follows: 18 1. Five (5) members shall be appointed for a term of two (2) years; 19 2. Five (5) members shall be appointe d for a term of three (3) years; 20 3. Five (5) members shall be appointed for a term of four (4) years; and 21 4. The respective terms of the first members shall be designated by the 22 commissioner at the time of their appointment; 23 (b) Be eligible for reappointme nt; and 24 (c) Serve without compensation, but each member of the board not otherwise 25 compensated for his or her time or expenses shall be entitled to 26 reimbursement for his or her actual and necessary expenses in carrying out 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 12 of 141 HB013630.100 - 50 - XXXX House Committee Substitute his or her duties with reimbursem ent for expenses being made in 1 accordance with administrative regulations relating to travel expenses. 2 (4) The Board of Physicians and Advisors shall not be subject to reorganization 3 under KRS Chapter 12. 4 (5) The Board of Physicians and Advisors shall: 5 (a) Review and recommend to the department an approved list of qualifying 6 medical conditions for which a medicinal cannabis practitioner may provide 7 a patient with a written certification; 8 (b) Accept and review petitions to add diseases or medical conditions to the 9 approved list of qualifying medical conditions for which a medicinal 10 cannabis practitioner may provider a patient with a written certification; 11 (c) Review and recommend to the department medicinal can nabis dosing 12 guidelines to be used by medicinal cannabis practitioners when providing 13 patients with medicinal cannabis dosing recommendations; 14 (d) Convene at least twice per year to conduct public hearings and to evaluate 15 petitions, which shall be maintain ed as confidential pursuant to subsection 16 (7) of this section, for the purpose of adding diseases or medical conditions 17 to the approved list of qualifying medical conditions for which a medicinal 18 cannabis practitioner may provide a patient with a written c ertification; 19 (e) Review and recommend to the department protocols for determining: 20 1. The amount of medicinal cannabis or delta -9 tetrahydrocannabinol 21 that constitutes: 22 a. A ten (10) day maximum allowance of medicinal cannabis and a 23 thirty (30) day maximu m allowance of medicinal cannabis for 24 registered qualified patients and visiting qualified patients who 25 are over eighteen (18) years of age; and 26 b. A ten (10) day maximum allowance of medicinal cannabis and a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 13 of 141 HB013630.100 - 50 - XXXX House Committee Substitute thirty (30) day maximum allowance of medicinal cannabis for 1 registered qualified patients who are under eighteen (18) years of 2 age; and 3 2. The amount of raw plant material that medicinal cannabis products 4 are considered to be equivalent to; 5 (f) Review and recommend to the department evolving continuous quality 6 improvement metrics and minimal performance standards for the biennial 7 accreditation process of licensed cannabis businesses; 8 (g) Review relevant scientific data related to the delta -9 tetrahydrocannabinol 9 content limits established in subsection (2)(b) of Section 19 of this Act and 10 make recommendations to the General Assembly regarding revisions to the 11 limits as the board deems appropriate; 12 (h) Review relevant scientific data related to the various methods of use and 13 consumption of medicinal canna bis and make recommendations to the 14 General Assembly to approve or restrict certain methods as the board deems 15 appropriate; and 16 (i) Perform other duties related to the use of medicinal cannabis upon request 17 by the commissioner of the department or the dire ctor of the Division of 18 Medicinal Cannabis. 19 (6) When, in accordance with paragraphs (a) to (c) of subsection 5 of this section, 20 the Board of Physicians and Advisors considers which diseases and medical 21 conditions to recommend to the department for inclusio n on the approved list of 22 qualifying medical conditions for which a medicinal cannabis practitioner may 23 provider a patient with a written certification, the board shall prioritize 24 consideration of, but not limit their consideration to, end -of-life conditio ns and 25 terminal diseases as defined in KRS 217.5401. 26 (7) The department shall promulgate administrative regulations, in accordance with 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 14 of 141 HB013630.100 - 50 - XXXX House Committee Substitute KRS Chapter 13A, to implement the provisions of this subsection, including but 1 not limited to the process by which petit ions to add diseases or medical conditions 2 to the approved list of qualifying medical conditions for which a medicinal 3 cannabis practitioner may provide a patient with a written certification shall be 4 received, reviewed, and considered. Administrative regu lations promulgated 5 pursuant to this subsection shall require that any individually identifiable health 6 information contained in a petition received by the department, the Division of 7 Medicinal Cannabis, or the Board of Physicians and Advisors shall be 8 confidential and shall not be subject to disclosure under the Open Records Act, 9 KRS 61.870 to 61.884. 10 (8) No later than December 1 of each year beginning in 2023, the department, in 11 consultation with the University of Kentucky College of Medicine shall submit an 12 annual report to the Legislative Research Commission. The report submitted by 13 the department shall, at a minimum, include: 14 (a) The number of applications and renewals received by the department for 15 registry identification cards for registered qualified patients, visiting 16 qualified patients, and designated caregivers, individually and collectively; 17 (b) The number of applications and renewals for registry identification cards 18 that were approved and denied by the department; 19 (c) The number of registry iden tification cards revoked by the department for 20 misconduct and the nature of the misconduct; 21 (d) The number of physicians, physician assistants, and advanced practice 22 registered nurses authorized pursuant to Section 9 of this Act to provide 23 written certific ations for the use of medicinal cannabis; 24 (e) The number of pharmacists authorized pursuant to Section 10 of this Act to 25 provide consultation to cardholders; 26 (f) The nature of the qualifying medical conditions for which medicinal 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 15 of 141 HB013630.100 - 50 - XXXX House Committee Substitute cannabis practitioners hav e provided written certifications; 1 (g) The number of applications and renewals received by the department for 2 cannabis business licenses; the number of cannabis business licenses issued 3 for each business type and tier; and the number of cannabis business 4 license applications and renewals that were denied by the department; 5 (h) The number of cannabis business agents associated with each type of 6 cannabis business; 7 (i) An assessment of: 8 1. The ability of cardholders in all areas of the state to obtain timely a nd 9 affordable access to medicinal cannabis; 10 2. The evolving continuous quality improvement metrics and minimal 11 performance standards for the biennial accreditation process of 12 licensed cannabis businesses developed by the department pursuant to 13 Section 28 o f this Act; 14 3. The effectiveness of the cultivators, processors, and producers licensed 15 under this chapter, individually and collectively, in serving the needs 16 of processors, dispensaries, and cardholders, and whether they are 17 generating any complaints or security proble ms; 18 4. The effectiveness of the dispensaries licensed under this chapter, 19 individually and collectively, in serving the needs of cardholders, 20 including the provision of educational and support services, and 21 whether they are generating any complaints or sec urity problems; 22 5. The effectiveness of the safety compliance facilities licensed under this 23 chapter, individually and collectively, in serving the needs of other 24 cannabis businesses, including the provision of testing and training 25 services, and whether th ey are generating any complaints or security 26 problems; and 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 16 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 6. The sufficiency of the regulatory and security safeguards contained in 1 Sections 1 to 30 of this Act and adopted by the department through 2 administrative regulations to ensure that access to medi cinal cannabis 3 cultivated and processed in this state is provided only to cardholders; 4 (j) The profits and expenditures by cannabis businesses, individually and 5 collectively; 6 (k) The amount of medicinal cannabis sold per month in the Commonwealth; 7 (l) The total amount of revenue generated from cannabis business licensure 8 and cardholder fees for each calendar year and aggregated by prior years; 9 (m) The total amount of revenue generated by the excise tax established in 10 Section 33 of this Act; 11 (n) The total co st of enforcement for the medicinal cannabis program at the 12 time of the report, by city, county, and overall; 13 (o) Any recommended additions or revisions to Sections 1 to 30 of this Act or 14 administrative regulations promulgated thereunder, including those 15 relating to security, safe handling, labeling, and nomenclature; 16 (p) Any recommendations for changes to the approved list of qualifying 17 medical conditions for which a medicinal cannabis practitioner may provide 18 a patient with a written certification and the rationale for those 19 recommendations; 20 (q) The results of any peer -reviewed, scientific research studies regarding the 21 health effects of cannabis; and 22 (r) Any other data requested by the Legislative Research Commission relating 23 to the medicinal cannabis pro gram and Sections 1 to 30 of this Act. 24 (9) The department shall provide the University of Kentucky College of Medicine 25 with all information necessary to allow collaboration with the department on the 26 preparation of this report. The University of Kentucky C ollege of Medicine may 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 17 of 141 HB013630.100 - 50 - XXXX House Committee Substitute also produce its own report regarding the medicinal cannabis program 1 established in Sections 1 to 30 of this Act which, if produced, shall be submitted 2 to the Legislative Research Commission upon completion. 3 (10) The information cont ained in the report described in subsection (8) of this section 4 shall be presented in a manner that does not disclose any identifying information 5 about cardholders or licensed cannabis businesses. 6 (11) (a) Nothing in Sections 1 to 30 of this Act shall requ ire the department to 7 assume duties in relation to the medicinal cannabis program that are more 8 than administrative in nature if federal law or a current and clear directive 9 from the federal government indicates that duties assumed by the 10 department that a re more than administrative could result in the loss of 11 federal funds, federal prosecution, or invalidation of the medicinal 12 cannabis program established in Sections 1 to 30 of this Act. 13 (b) If the department makes a determination that it is required by Se ctions 1 to 14 30 of this Act to conduct duties that are more than administrative in nature, 15 then it shall continue to conduct duties that are administrative in nature 16 and designate or enter into a contract with, in accordance with KRS 17 Chapter 45A, a qualifie d nongovernmental entity to conduct any duties 18 required by Sections 1 to 30 of this Act that are more than administrative in 19 nature. A nongovernmental entity contracted pursuant to this paragraph 20 shall not own, in whole or in part, any cannabis business in this state or any 21 other, or be owned, in whole or in part, by any cannabis business in this 22 state or any other. The department may reimburse the state for any costs 23 involved in working with outside consultants to implement the program. 24 SECTION 4. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 25 READ AS FOLLOWS: 26 (1) A registered qualified patient, except as provided in subsection (6) of this section, 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 18 of 141 HB013630.100 - 50 - XXXX House Committee Substitute shall not be subject to arrest, prosecution, or denial of any right or pr ivilege, 1 including but not limited to a civil penalty or disciplinary action by a court or 2 occupational or professional licensing board, for the use of medicinal cannabis, 3 if the registered qualified patient does not possess more than: 4 (a) The thirty (30) day maximum allowance of medicinal cannabis, as 5 established by the department pursuant to Section 28 of this Act, at his or 6 her residence; or 7 (b) The ten (10) day maximum allowance of medicinal cannabis, as established 8 by the department pursuant to Section 28 of this Act, on his or her person, 9 except that an amount greater than the ten (10) day maximum allowance 10 may be transported by a registered qualified patient from a dispensary 11 directly to his or her residence if the medicinal cannabis is contained in a 12 sealed package that requires at least a two (2) step process for initial 13 opening. 14 (2) A visiting qualified patient shall not be subject to arrest, prosecution, or denial of 15 any right or privilege, including but not limited to civil penalty or disciplinary 16 action by a court or occupational or professional licensing board, for the use of 17 medicinal cannabis, if the visiting qualified patient does not possess more than an 18 amount of medicinal cannabis determined by the department to constitute the ten 19 (10) day maximum allowance of medicinal cannabis, as established by the 20 department pursuant to Section 28 of this Act, on his or her person. 21 (3) A designated caregiver shall not be subject to arrest, prosecution, or denial of any 22 right or privilege, including but n ot limited to civil penalty or disciplinary action 23 by a court or occupational or professional licensing board, for: 24 (a) Assisting a registered qualified patient to whom the designated caregiver is 25 connected through the department's registration process wit h the use of 26 medicinal cannabis if the designated caregiver does not possess more than: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 19 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 1. The thirty (30) day maximum allowance of medicinal cannabis, as 1 established by the department pursuant to Section 28 of this Act, at his 2 or her residence for each re gistered qualified patient to whom the 3 caregiver is connected through the department's registration process; 4 or 5 2. The ten (10) day maximum allowance of medicinal cannabis, as 6 established by the department pursuant to Section 28 of this Act, on 7 his or her person for each registered qualified patient to whom the 8 caregiver is connected through the department's registrati on process, 9 except that an amount greater than he ten (10) day maximum 10 allowance may be transported by a designated caregiver from a 11 dispensary directly to his or her residence if the medicinal cannabis is 12 contained in a sealed package that requires at lea st a two (2) step 13 process for initial opening; or 14 (b) Receiving reimbursement for documented expenses associated with 15 assisting a registered qualified patient in the use of medicinal cannabis if 16 the designated caregiver is connected to the registered quali fied patient 17 through the department's registration process. 18 (4) A cardholder shall not be subject to arrest, prosecution, or denial of any right or 19 privilege, including but not limited to a civil penalty or disciplinary action by a 20 court or occupational or professional licensing board, for: 21 (a) Possession of medicinal cannabis that is incidental to the use of medicinal 22 cannabis; 23 (b) Possession of medicinal cannabis accessories; or 24 (c) Transferring medicinal cannabis to a safety facility for testing. 25 (5) No person shall be subject to arrest, prosecution, or denial of any right or 26 privilege, including but not limited to a civil penalty or disciplinary action by a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 20 of 141 HB013630.100 - 50 - XXXX House Committee Substitute court or occupational or professional licensing board, solely for: 1 (a) Selling medicinal cannabis accessories to a cardholder who is over eighteen 2 (18) years of age upon presentation of a valid registry identification card 3 issued by the department or, for a visiting qualified patient, a valid out -of- 4 state registry identification card; 5 (b) Being in the presence or vicinity of the use of medicinal cannabis; or 6 (c) Assisting a registered qualified patient or visiting qualified patient with 7 using or administering medicinal cannabis. For purposes of illustration and 8 not limitation, this includes preparing ra w plant material or brewing tea for 9 a registered qualified patient or visiting qualified patient. This does not 10 include providing medicinal cannabis to a patient that the patient did not 11 already possess. 12 (6) Notwithstanding subsection (1) of this section, a registered qualified patient who 13 is under eighteen (18) years of age shall not be permitted to possess, purchase, or 14 acquire medicinal cannabis and shall only engage in the use of medicinal 15 cannabis with the assistance of a designated caregiver. 16 (7) Notw ithstanding subsections (1), (2), and (3) of this section: 17 (a) A registered qualified patient shall not be permitted to purchase more 18 medicinal cannabis than the thirty (30) day maximum allowance of 19 medicinal cannabis, as determined by the department pursu ant to Section 20 28 of this Act, during a given twenty -five (25) day period; 21 (b) A designated caregiver shall not be permitted to purchase more medicinal 22 cannabis than the thirty (30) day maximum allowance of medicinal 23 cannabis, as determined by the departme nt pursuant to Section 28 of this 24 Act, for each registered qualified patient to whom the caregiver is connected 25 through the department's registration process during a given twenty -five 26 (25) day period; and 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 21 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (c) 1. A visiting qualified patient who has applie d for and obtained a registry 1 identification card issued by the department shall not be permitted to 2 purchase more medicinal cannabis than the ten (10) day maximum 3 allowance of medicinal cannabis, as determined by the department 4 pursuant to Section 28 of t his Act, during a given eight (8) day period. 5 2. A visiting qualified patient who has not applied for and obtained a 6 registry identification card issued by the department but possesses a 7 valid out -of-state registry identification card shall not be permitte d to 8 purchase medicinal cannabis is this state more than once per calendar 9 year and shall not be permitted to purchase more medicinal cannabis 10 than the ten (10) day maximum allowance of medicinal cannabis, as 11 determined by the department pursuant to Sectio n 28 of this Act. 12 (8) (a) All medicinal cannabis possessed by a cardholder in accordance with 13 subsections (1), (2), (3), and (7) of this section shall be kept in the original 14 container in which the cardholder received the medicinal cannabis from a 15 dispensa ry. 16 (b) An individual who violates paragraph (a) of this subsection may be fined up 17 to one hundred dollars ($100) per violation. 18 (9) Notwithstanding any other provision of law to the contrary, a registered qualified 19 patient who is injured or defrauded, inc luding by theft or deprivation of the use 20 and benefit of any money, personal property including medicinal cannabis, or 21 articles of value of any kind, by his or her designated caregiver shall have a civil 22 cause of action in Circuit Court to recover the actu al damages sustained, together 23 with the costs of the lawsuit, including a reasonable fee for the individual's 24 attorney of record. 25 SECTION 5. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 26 READ AS FOLLOWS: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 22 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (1) (a) Any me dicinal cannabis, medicinal cannabis accessories, lawful property, 1 or interest in lawful property that is possessed, owned, or used in connection 2 with the use of medicinal cannabis or acts incidental to that use shall not be 3 subject to seizure or forfeitur e under KRS 218A.405 to 218A.460. 4 (b) Sections 1 to 30 of this Act shall not prevent the seizure or forfeiture of 5 marijuana exceeding the amounts allowed under Section 4 of this Act nor 6 shall it prevent seizure or forfeiture if the basis for that action is unrelated 7 to the use of medicinal cannabis in accordance with Sections 1 to 30 of this 8 Act and any administrative regulation promulgated thereunder. 9 (2) Possession of, or application for, a registry identification card, an out -of-state 10 registry identifica tion card, or cannabis business license shall not constitute 11 probable cause or reasonable suspicion, nor shall it be used to support the search 12 of the person, property, or home of the person possessing or applying for the 13 registry identification card, an o ut-of-state registry identification card, or 14 cannabis business license. The possession of, or application for, a registry 15 identification card, an out -of-state registry identification card, or cannabis 16 business license shall not preclude the existence of pr obable cause or reasonable 17 suspicion if probable cause or reasonable suspicion exists on other grounds. 18 (3) (a) There shall be a rebuttable presumption that a cardholder is engaged in the 19 lawful use of medicinal cannabis, or in the case of a designated car egiver, 20 assisting with the lawful use of medicinal cannabis, if the cardholder: 21 1. Possesses a valid registry identification card or, in the case of a 22 visiting qualified patient, a valid out -of-state registry identification 23 card; and 24 2. Possesses an amount of medicinal cannabis that does not exceed the 25 amount the cardholder is permitted to possess under Section 4 of this 26 Act. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 23 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (b) This presumption may be rebutted by a preponderance of evidence that 1 conduct was unrelated to the use of medic inal cannabis or was otherwise in 2 violation of Sections 1 to 30 of this Act. 3 SECTION 6. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 4 READ AS FOLLOWS: 5 (1) Sections 1 to 30 of this Act do not authorize any person to eng age in, and shall 6 not prevent the imposition of any civil, criminal, or other penalties, including but 7 not limited to criminal prosecution or disciplinary action by the department or an 8 occupational or professional licensing board, for engaging in, the fol lowing 9 conduct: 10 (a) Operating, navigating, or being in actual physical control of any aircraft, 11 vehicle, vessel, or any other device known, or hereafter invented, that is 12 powered by machinery and that is or may be used to transport persons or 13 property whil e under the influence of medicinal cannabis; 14 (b) Consuming medicinal cannabis while operating, navigating, or being in 15 actual physical control of an aircraft, vehicle, vessel, or any other device 16 known, or hereafter invented, that is powered by machinery a nd that is or 17 may be used to transport persons or property; 18 (c) Possessing medicinal cannabis that is within the operator's arm's reach or 19 that is not contained in a package that requires at least a two (2) step 20 process for initial opening, in accordance w ith administrative regulations 21 promulgated pursuant to subsection (1)(c)12.a. of Section 28 of this Act, 22 while operating, navigating, or being in actual physical control of an 23 aircraft, vehicle, vessel, or any other device known, or hereafter invented, 24 that is powered by machinery and that is or may be used to transport 25 persons or property; 26 (d) Undertaking any task under the influence of medicinal cannabis, when 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 24 of 141 HB013630.100 - 50 - XXXX House Committee Substitute doing so would constitute negligence or professional malpractice; 1 (e) Possessing medicinal canna bis, or otherwise engaging in the use of 2 medicinal cannabis: 3 1. On the grounds of any preschool or primary or secondary school, 4 except as permitted in accordance with policies enacted pursuant to 5 subsection (4)(c) of Section 8 of this Act; 6 2. In any correc tional facility; or 7 3. On any property of the federal government; 8 (f) Using marijuana, if that person is not a registered qualified patient or 9 visiting qualified patient; 10 (g) Using or consuming marijuana by smoking; or 11 (h) Cultivating marijuana unless that person is licensed by the department as a 12 cannabis cultivator or cannabis producer pursuant to Sections 16, 17, and 13 18 of this Act or is a cultivator or producer agent. 14 (2) Sections 1 to 30 of this Act shall not prevent enforcement of current laws 15 pertain ing to the operation of any aircraft, vehicle, or vessel, including under 16 KRS Chapters 183, 189, 189A, and 235. 17 (3) If a cardholders violates subsection (1)(a) or (b) of this section, in addition to 18 penalties that may be imposed under KRS Chapters 183, 189 , 189A, or 235, the 19 cardholder's registry identification card shall be revoked. 20 (4) (a) An individual who violates subsection (1)(g) of this section shall not be 21 considered to be in possession of medicinal cannabis or engaged in the use 22 of medicinal cannab is and may not benefit from the legal protections 23 afforded by Sections 1 to 30 of this Act. 24 (b) The odor or smell of medicinal cannabis shall not constitute conclusive 25 evidence of use or consumption of medicinal cannabis by smoking. 26 (c) Notwithstanding par agraph (a) of this subsection: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 25 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 1. If an individual violates subsection (1)(g) of this section by using or 1 consuming marijuana by smoking while on any form of public 2 transportation, in any public place as defined in KRS 525.010, or in 3 any place of public ac commodation, resort, or amusement as defined 4 in KRS 344.130: 5 a. The department may suspend or revoke the individual's registry 6 identification card; and 7 b. The individual may be subject to prosecution under Section 39 of 8 this Act. 9 2. For any individual who violates subsection (1)(g) of this section by 10 using or consuming marijuana by smoking on residential property 11 owned or leased by that individual or with the permission of the owner 12 or lessee of the residential property on which the violation occurred, 13 the penalty shall be a fine of not more than one hundred dollars 14 ($100) per violation. 15 (5) As used in this section: 16 (a) \"Aircraft\" has the same meaning as in KRS 183.011; 17 (b) \"Vehicle\" has the same meaning as in KRS 189.010; and 18 (c) \"Vessel\" has the same meaning as in KRS 235.010. 19 SECTION 7. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 20 READ AS FOLLOWS: 21 (1) Nothing in Sections 1 to 30 of this Act shall: 22 (a) Require an employer to permit or accommo date the use, consumption, 23 possession, transfer, display, transportation, distribution, sale, or growing 24 of medicinal cannabis in the workplace; 25 (b) Prohibit an employer from implementing policies promoting workplace 26 health and safety by: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 26 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 1. Restricting th e use of medicinal cannabis by employees; or 1 2. Restricting or prohibiting the use of equipment, machinery, or power 2 tools by an employee who is a registered qualified patient, if the 3 employer believes that the use of such equipment, machinery, or 4 power to ols by an employee who is a registered qualified patient poses 5 an unreasonable safety risk; 6 (c) Prohibit an employer from including in any contract, provisions that 7 prohibit the use of medicinal cannabis by employees; 8 (d) Subject an employer to liability f or wrongful discharge or discrimination; 9 (e) Except as provided in Section 8 of this Act, prohibit a person, employer, 10 corporation, or any other entity who occupies, owns, or controls a property 11 from prohibiting or otherwise regulating the use, consumption , possession, 12 transfer, display, transportation, sale, or growing of medicinal cannabis on 13 or in that property; or 14 (f) Prohibit an employer from establishing and enforcing a drug testing policy, 15 drug -free workplace, or zero -tolerance drug policy. 16 (2) An em ployee who is discharged from employment for consuming medicinal 17 cannabis in the workplace, working while under the influence of medicinal 18 cannabis, or testing positive for a controlled substance shall not be eligible to 19 receive benefits under KRS Chapter 341 if such actions are in violation of an 20 employment contract or established personnel policy. 21 (3) An employer shall not be penalized or denied any benefit under state law for 22 employing a cardholder. 23 SECTION 8. A NEW SE CTION OF KRS CHAPTER 218A IS CREATED TO 24 READ AS FOLLOWS: 25 (1) Except as provided in Section 7 of this Act, the lawful use of medicinal cannabis 26 by a cardholder is equivalent to the authorized use of any other medication used 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 27 of 141 HB013630.100 - 50 - XXXX House Committee Substitute at the direction of a practition er, shall not constitute the use of an illicit 1 substance, and shall not constitute an acceptable basis for disqualifying a 2 cardholder from any rights or privileges that he or she may otherwise be entitled 3 to, including those guaranteed under KRS Chapter 34 4. 4 (2) A cardholder otherwise entitled to custody of or visitation time or parenting time 5 with a minor child shall not be denied that right, and there shall be no 6 presumption of dependency, neglect, or abuse, for conduct permitted under 7 Sections 1 to 30 of this Act unless the person's actions in relation to medicinal 8 cannabis create a danger that is not in the best interest of the safety of the minor 9 child as established by clear and convincing evidence. 10 (3) (a) For the purposes of medical care, including o rgan transplants, a patient's 11 authorized use of medicinal cannabis is the equivalent of the authorized use 12 of any other medication used at the direction of a practitioner, and shall not 13 constitute the use of an illicit substance or otherwise disqualify a p atient 14 from needed medical care. 15 (b) A health facility as defined in KRS 216B.015 may develop policies to allow a 16 patient who is a registered qualified patient or visiting qualified patient to 17 use medicinal cannabis on the premises of the health facility. 18 (4) (a) A school shall not refuse to enroll, or otherwise penalize, a person solely for 19 his or her status as a cardholder, unless failing to do so would violate 20 federal law or regulations and cause the school to lose a monetary or 21 licensing -related benefit under federal law or regulations. 22 (b) A school shall not be penalized or denied any benefit under state law for 23 enrolling a cardholder. 24 (c) Each local board of education and each board of directors of a public 25 charter school shall, within ninety (90) days after the effective date of this 26 section, establish policies to permit a pupil who is a registered qualified 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 28 of 141 HB013630.100 - 50 - XXXX House Committee Substitute patient to consume medicinal cannabis on school property as deemed 1 necessary by the pupil's parent or legal guardian. Policies enacted pursuant 2 to this paragraph shall require that medicinal cannabis be administered by 3 a school nurse or under the supervision of appropriate school staff. 4 (5) (a) No landlord may be penalized or denied any benefit under state law for 5 leasing to a cardholder. 6 (b) A landlord shall not include in a rental agreement terms and conditions 7 that prohibit the use of medicinal cannabis by a cardholder. 8 SECTION 9. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 9 READ AS FOLLOWS: 10 (1) Except as provided in subsection (13) of this section, a physician, a physician 11 assistant, or an advanced practice registered nurse seeking to become a medicinal 12 cannabis practitioner and provide written certifications for the use of medicinal 13 cannabis shall appl y to the same state licensing board that issued his or her 14 professional practice license, on a form prescribed by the state licensing board, 15 for authorization to provide written certifications for the use of medicinal 16 cannabis. 17 (2) (a) A state licensing bo ard shall approve an application for authorization to 18 provide written certifications for the use of medicinal cannabis if the 19 application is complete and meets the requirements established in 20 administrative regulations promulgated by the state licensing bo ard. 21 (b) A state licensing board shall deny an application for authorization to 22 provide written certifications for the use of medicinal cannabis if the 23 applicant has an ownership or investment interest in or compensation 24 agreement with a cannabis business licensed under this chapter. A state 25 licensing board may consult with the department to determine if an 26 applicant has an ownership or investment interest in or compensation 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 29 of 141 HB013630.100 - 50 - XXXX House Committee Substitute agreement with a cannabis business. 1 (3) Authorization to provide written certificat ions for the use of medicinal cannabis 2 granted under this section shall expire, and may be renewed, in accordance with 3 administrative regulations promulgated by a state licensing board. 4 (4) A medicinal cannabis practitioner may provide a patient with a wri tten 5 certification only after the practitioner has: 6 (a) Established a bona fide practitioner -patient relationship with the patient; 7 (b) Diagnosed the patient with a qualifying medical condition or confirmed a 8 diagnosis for a qualifying medical condition pr ovided by another health 9 care provider; 10 (c) Reviewed a report of information from the electronic monitoring system 11 established pursuant to Section 41 of this Act related to the patient for a 12 period of time that covers at least the twelve (12) months immed iately 13 preceding the date of the report; 14 (d) Consulted with the patient, or the patient's custodial parent or legal 15 guardian responsible for providing consent to treatment if the patient is a 16 minor child, with respect to the possible risks and side effects associated 17 with medicinal cannabis, including possible interactions between medicinal 18 cannabis and any other drug or medication that the patient is taking at that 19 time; and 20 (e) Obtained the consent of the patient's custodial parent or legal guardian 21 respo nsible for providing consent to treatment, if the patient is a minor 22 child. 23 (5) A bona fide practitioner -patient relationship may be established following a 24 referral from the patient's primary care provider and may be maintained via 25 telehealth. However, a bona fide practitioner -patient relationship shall not be 26 established via telehealth. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 30 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (6) (a) When issuing a written certification for the use of medicinal cannabis to a 1 patient, the medicinal cannabis practitioner shall, to the best of his or her 2 professio nal medical knowledge, provide the patient with recommendations 3 for: 4 1. The strains of medicinal cannabis and types of medicinal cannabis 5 products that may be most effective in providing medical, therapeutic, 6 or palliative relief to the patient; and 7 2. Medicinal cannabis dosing including the quantity and frequency of 8 doses. 9 (b) Recommendations provided pursuant to paragraph (a) of this subsection 10 shall comply with medicinal cannabis dosing guidelines and the ten (10) 11 day and thirty (30) day maximum allowanc e of medicinal cannabis 12 developed by the department pursuant to Section 28 of this Act. 13 (7) (a) A written certification for the use of medicinal cannabis shall be provided to 14 a patient on a form prescribed by the department. 15 (b) An initial written certific ation for the use of medicinal cannabis shall be 16 provided during the course of an in -person examination of the patient by 17 the medicinal cannabis practitioner. Subsequent written certifications, 18 including for the purpose of renewing a registry identificatio n card, may be 19 provided electronically or during the course of a telehealth consultation. 20 (c) For the purpose of applying for a registry identification card, a written 21 certification provided under this section shall be valid for ninety (90) days 22 after the date of issuance by a medicinal cannabis practitioner. The 23 medicinal cannabis practitioner may renew a written certification for not 24 more than three (3) additional periods of not more than ninety (90) days 25 each. Thereafter, the medicinal cannabis practitio ner may issue another 26 certification to the patient only after conducting an additional examination 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 31 of 141 HB013630.100 - 50 - XXXX House Committee Substitute of the patient in person or via telehealth. 1 (d) Within twenty -four (24) hours of providing a patient with a written 2 certification for the use of medicinal ca nnabis, a medicinal cannabis 3 practitioner shall record the issuance of the written certification in the 4 electronic monitoring system established pursuant to Section 41 of this Act. 5 (8) A medicinal cannabis practitioner shall not: 6 (a) Dispense medicinal can nabis; or 7 (b) Provide a written certification for the use of medicinal cannabis to a family 8 member or to himself or herself. 9 (9) Nothing in Sections 1 to 30 of this Act shall prevent a practitioner from being 10 sanctioned for: 11 (a) Issuing a written certification without first obtaining authorization to 12 provide written certifications from a state licensing board; 13 (b) Issuing a written certification to a patient with whom the practitioner does 14 not have a bona fide practitioner -patient relationship; 15 (c) Failing to properly evaluate a patient's medical history and current medical 16 condition prior to issuing a written certification; 17 (d) Otherwise failing to use good faith in his or her treatment of the patient; or 18 (e) Any other violation o f this section or any administrative regulation 19 promulgated thereunder. 20 (10) A state licensing board may suspend or revoke a medicinal cannabis 21 practitioner's authorization to provide written certification for the use of 22 medicinal cannabis and practice lic ense for multiple violations or a serious 23 violation of this section or any administrative regulation promulgated 24 thereunder. 25 (11) The state licensing boards shall: 26 (a) No later than January 1, 2023, promulgate, in accordance with KRS 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 32 of 141 HB013630.100 - 50 - XXXX House Committee Substitute Chapter 13A, administr ative regulations to establish at least the following: 1 1. The application and renewal process for authorization to provide 2 written certifications for the use of medicinal cannabis. Any 3 administrative regulation promulgated pursuant to this subparagraph 4 shall include an application and renewal fee which shall be sufficient 5 to generate the funds necessary to enable the state licensing board to 6 process applications and enforce administrative regulations 7 promulgated under this section; 8 2. The conditions that mu st be met to be eligible for authorization to 9 provide written certifications. Eligibility criteria established by 10 administrative regulations promulgated pursuant to this paragraph 11 shall require that: 12 a. An advanced practice registered nurse be authorized t o prescribe 13 controlled substances under KRS 314.042; and 14 b. A physician assistant: 15 i. Be authorized to prescribe controlled substances under 16 KRS 311.858; and 17 ii. Have and maintain a supervision agreement, established in 18 accordance with KRS Chapter 311, wit h a physician who is 19 authorized to provide written certifications; 20 3. Continuing education requirements for medicinal cannabis 21 practitioners related to the use of medicinal cannabis and the 22 recommending of cannabis for medicinal use. The continuing 23 educati on requirements established pursuant to this subparagraph 24 shall include continuing education requirements related to medicinal 25 cannabis dosing and dosing guidelines established by the department 26 pursuant to Section 28 of this Act; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 33 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 4. The reasons for which authorization to provide written certifications 1 for the use of medicinal cannabis may be suspended or revoked; and 2 5. The minimal standards of care when providing written certifications; 3 (b) On a regular basis, provide the department with the names of all medicinal 4 cannabis practitioners; and 5 (c) Immediately provide the department with the name of any medicinal 6 cannabis practitioner whose authorization to provide written certifications 7 is suspended or revoked. 8 (12) Nothing in Sections 1 to 30 of this Act sh all be construed or interpreted to limit or 9 restrict a state licensing board's authority or ability to enforce administrative 10 regulations promulgated pursuant to subsection (11) of this section. 11 (13) This section does not apply to a practitioner who recomm ends treatment with 12 cannabis or a drug derived from cannabis under any of the following that are 13 approved by an investigational review board or equivalent entity, the United 14 States Food and Drug Administration, or the National Institutes for Health or 15 any of its cooperative groups or centers under the United States Department of 16 Health and Human Services: 17 (a) A research protocol; 18 (b) A clinical trial; 19 (c) An investigational new drug application; or 20 (d) An expanded access submission. 21 SECTION 10. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 22 TO READ AS FOLLOWS: 23 (1) Except as provided in subsection (2) of this section, prio r to making an initial 24 purchase of medicinal cannabis in this state and at least annually thereafter, a 25 registered qualified patient shall be required to complete a consultation with a 26 pharmacist who is authorized by the Kentucky Board of Pharmacy to provi de 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 34 of 141 HB013630.100 - 50 - XXXX House Committee Substitute medicinal cannabis consultation services to cardholders. The consultation shall, 1 at a minimum, cover the possible risks and side effects of medicinal cannabis and 2 any potential drug interactions between medicinal cannabis and any other drug 3 that the reg istered qualified patient or visiting qualified patient is taking. The 4 consultation required by this subsection may be completed via telehealth. 5 (2) (a) A designated caregiver shall be permitted to complete the consultation 6 required by subsection (1) of th is section on behalf of any registered 7 qualified patient to whom the designated caregiver is connected through the 8 department's registration process. 9 (b) If the registered qualified patient is under eighteen (18) years of age, the 10 registered qualified pati ent's parent or legal guardian who is responsible for 11 providing consent for medical treatment shall be present for the 12 consultation required by subsection (1) of this section and may complete the 13 consultation on behalf of the registered qualified patient. 14 (c) A visiting qualified patient who has not applied for and obtained a registry 15 identification card issued by the department but presents a valid out -of-state 16 registry identification card to purchase medicinal cannabis in this state not 17 more than once per calendar year shall not be required to complete the 18 consultation required by subsection (1) of this section. 19 (3) A pharmacist who wishes to be authorized by the Kentucky Board of Pharmacy to 20 provide medicinal cannabis consultation services to cardholders or to enter into a 21 cannabis consultation agreement with dispensaries, as required by Section 22 of 22 this Act, shall apply to the board on a form prescribed by the board. 23 (4) No later than January 1, 2023, the Kentucky Board of Pharmacy shall, in 24 accordance with KRS Chapter 13A, promulgate administrative regulations to: 25 (a) Establish the application and renewal process for authorization to provide 26 medicinal cannabis consultation services to cardholders and to enter into a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 35 of 141 HB013630.100 - 50 - XXXX House Committee Substitute cannabis consultation agreement with dispensaries. Any administrative 1 regulation promulgated pursuant to this paragraph shall include an 2 application and renewal fee which shall be sufficient to generate the funds 3 necessary to enable the Board of Pharmacy to process applications and 4 enforce ad ministrative regulations promulgated under this section; 5 (b) Establish continuing education and training requirements for pharmacists 6 who are authorized to provide medicinal cannabis consultation services to 7 cardholders and to enter into cannabis consultat ion agreements with 8 dispensaries; 9 (c) Define the standards of care for medicinal cannabis consultation services 10 provided by a pharmacist to a cardholder; 11 (d) Define the nature and scope of a cannabis consultation agreement between 12 a pharmacist and a dispen sary, including the process by which a 13 pharmacist and dispensary may establish a cannabis consultation 14 agreement. Administrative regulations promulgated pursuant to this 15 paragraph: 16 1. Shall not require a pharmacist to be present at a dispensary; and 17 2. May limit the number of cannabis consultation agreements a 18 pharmacist is permitted to maintain at any given time; 19 (e) Establish the fee that a pharmacist may charge a cardholder for medicinal 20 cannabis consultation services. The fee established pursuant to thi s 21 paragraph shall not exceed forty dollar ($40) per consultation; and 22 (f) Establish a cannabis consultation agreement fee to be paid by a dispensary 23 to a pharmacist. 24 (5) Nothing in Sections 1 to 30 of this Act shall be construed or interpreted to limit or 25 restrict the Kentucky Board of Pharmacy's authority or ability to enforce 26 administrative regulations promulgated pursuant to subsection (4) of this section. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 36 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (6) Members of the Kentucky Board of Pharmacy, its agents, its employees, and any 1 pharmacist author ized by the board to provide medicinal cannabis consultation 2 services to cardholders or to enter into cannabis consultation agreements with 3 dispensaries shall be immune from suit in any action, civil or criminal, which is 4 based upon any act that is conduct ed in accordance with this section and 5 administrative regulations promulgated thereunder. 6 SECTION 11. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 7 TO READ AS FOLLOWS: 8 (1) Except as provided in subsection (9) of this sect ion, no person shall possess, 9 purchase, acquire, or otherwise engage or assist in the use of medicinal cannabis 10 in Kentucky without first applying for and receiving a registry identification card 11 for registered qualified patients, designated caregivers, or visiting qualified 12 patients issued by the department. 13 (2) A person shall be eligible to apply for a registry identification card as a registered 14 qualified patient if he or she is a resident of Kentucky, has obtained a written 15 certification issued by a med icinal cannabis practitioner in accordance with 16 Section 9 of this Act and administrative regulations promulgated thereunder, and 17 has not been convicted of a disqualifying felony offense. 18 (3) A person shall be eligible to apply for a registry identification card as a 19 designated caregiver if he or she is a resident of Kentucky, is at least twenty -one 20 (21) years of age, has been identified as a designated caregiver on qualified 21 patient's or registered qualified patient's registry identification card applicatio n 22 or renewal form, has not been convicted of a disqualifying felony offense, and 23 has agreed to assist no more than three (3) registered qualified patients with the 24 use of medicinal cannabis. 25 (4) A person shall be eligible to apply for a registry identifica tion card as a visiting 26 qualified patient if he or she is not a resident of Kentucky or has been a resident 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 37 of 141 HB013630.100 - 50 - XXXX House Committee Substitute of Kentucky for less than thirty (30) days, possess a valid out -of-state registry 1 identification card, is at least twenty -one (21) years of age, has obtained a written 2 certification issued by a medicinal cannabis practitioner in accordance with 3 Section 9 of this Act and administrative regulations promulgated thereunder, and 4 has not been convicted of a disqualifying felony offense. 5 (5) To apply for or renew a registry identification card, a qualified patient who is 6 eighteen (18) years of age or older shall submit the following, in accordance with 7 administrative regulations promulgated by the department: 8 (a) The name, address, and date of birth of the qu alified patient, except that if 9 the applicant is homeless an address where the applicant may be reached 10 shall be provided to the department; 11 (b) A valid written certification issued to the qualified patient; 12 (c) The name, address, and telephone number of t he qualified patient's 13 medicinal cannabis practitioner; 14 (d) A sta tement, signed by the qualified patient, pledging not to divert medicinal 15 cannabis to anyone who is not permitted to possess medicinal cannabis 16 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 17 listing of potential penalties, includin g criminal prosecution, for diverting 18 medicinal cannabis; 19 (e) If the qualified patient determines that he or she needs a designated 20 caregiver: 21 1. A statement, signed by the qualified patient, attesting to such need; 22 2. The name, address, and date of birth of not more than two (2) 23 individuals chosen by the qualified patient to be designated as a 24 caregiver; and 25 3. A statement, signed by the individuals chosen by the qualified patient 26 to be designated as a caregiver agreeing to be designated as the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 38 of 141 HB013630.100 - 50 - XXXX House Committee Substitute patient's d esignated caregiver and pledging not to divert medicinal 1 cannabis to anyone other than the registered qualified patient to 2 whom the caregiver is connected through the department's 3 registration process. The statement shall contain a listing of potential 4 penalties, including criminal prosecution, for diverting medicinal 5 cannabis; and 6 (f) The application or renewal fee for a registry identification card for a 7 qualified patient and the application or renewal fee for a registry 8 identification card for any design ated caregiver chosen by the qualified 9 patient. 10 (6) To apply for or renew a registry identification card for a qualified patient who is 11 under eighteen (18) years of age, the qualified patient's custodial parent or legal 12 guardian with responsibility for hea lth care decisions shall submit the following, 13 in accordance with administrative regulations promulgated by the department: 14 (a) The name, address, and date of birth of the qualified patient, except that if 15 the applicant is homeless an address where the app licant may be reached 16 shall be provided to the department; 17 (b) A valid written certification issued to the qualified patient; 18 (c) The name, address, and telephone number of the qualified patient's 19 medicinal cannabis practitioner; 20 (d) A statement, signed by the qualified patient's custodial parent or legal 21 guardian with responsibility for health care decisions, attesting to the fact 22 that the custodial parent or legal guardian agrees to: 23 1. Allow the qualified patient to use medicinal cannabis; 24 2. Serve as th e qualified patient's designated caregiver; and 25 3. Control the acquisition, dosage, and frequency of use of medicinal 26 cannabis by the qualified patient; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 39 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (e) A statement, signed by the qualified patient's custodial parent or legal 1 guardian with responsibili ty for health care decisions, pledging not to 2 divert, or to knowingly allow the qualified patient to divert, medicinal 3 cannabis to anyone who is not permitted to possess medicinal cannabis 4 pursuant to Sections 1 to 30 of this Act. The statement shall conta in a 5 listing of potential penalties, including criminal prosecution, for diverting 6 medicinal cannabis; 7 (f) If the qualified patient's custodial parent or legal guardian with 8 responsibility for health care decisions determines that the qualified patient 9 needs an additional designated caregiver: 10 1. A statement, signed by the qualified patient's custodial parent or legal 11 guardian with responsibility for health care decisions, attesting to 12 such need; 13 2. The name, address, and date of birth of not more than one (1) 14 individual chosen by the qualified patient's custodial parent or legal 15 guardian with responsibility for health care decisions to be designated 16 as a second designated caregiver; and 17 3. A statement, signed by the individual chosen by the qualified patien t's 18 custodial parent or legal guardian with responsibility for health care 19 decisions to be designated as a caregiver, agreeing to be designated as 20 the patient's designated caregiver and pledging not to divert medicinal 21 cannabis to anyone other than the reg istered qualified patient to 22 whom the caregiver is connected through the department's 23 registration process. The statement shall contain a listing of potential 24 penalties, including criminal prosecution, for diverting medicinal 25 cannabis; and 26 (g) The applicat ion or renewal fee for a registry identification card for a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 40 of 141 HB013630.100 - 50 - XXXX House Committee Substitute qualified patient and the application or renewal fee for a registry 1 identification card for any designated caregiver chosen by the qualified 2 patient. 3 (7) To apply for or renew a registry identific ation card, a visiting qualified patient 4 shall submit the following, in accordance with administrative regulations 5 promulgated by the department: 6 (a) The name, address, and date of birth of the visiting qualified patient, except 7 that if the applicant is ho meless an address where the applicant may be 8 reached shall be provided to the department; 9 (b) A copy of his or her valid out -of-state registry identification card; 10 (c) A valid written certification issued to the qualified patient; 11 (d) The name, address, an d telephone number of the qualified patient's 12 medicinal cannabis practitioner; 13 (e) A statement, signed by the qualified patient, pledging not to divert medicinal 14 cannabis to anyone who is not permitted to possess medicinal cannabis 15 pursuant to Sections 1 t o 30 of this Act. The statement shall contain a 16 listing of potential penalties, including criminal prosecution, for diverting 17 medicinal cannabis; and 18 (f) The application or renewal fee for a registry identification card for a 19 visiting qualified patient; 20 (8) The application for qualified patients' registry identification cards shall ask 21 whether the patient would like the department to notify him or her of any clinical 22 studies needing human subjects for research on the use of medicinal cannabis. 23 The departm ent shall notify interested patients if it is aware of studies that will be 24 conducted in the United States. 25 (9) A visiting qualified patient who possess a valid out -of-state registry identification 26 card shall not be required to apply for or obtain a visiti ng qualified patient 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 41 of 141 HB013630.100 - 50 - XXXX House Committee Substitute registry identification card issued by the department and may use his or her valid 1 out-of-state registry identification card for all purposes established in Sections 1 2 to 30 of this Act, except that a visiting qualified patient who has not applied for 3 and obtained a registry identification card issued by the department shall only be 4 permitted to purchase medicinal cannabis in this state once per calendar year. 5 SECTION 12. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 6 TO READ AS FOLLOWS: 7 (1) The department shall establish, implement, and operate a registry identification 8 card program for registered qualified patients, visiting qualified patients, and 9 designated caregivers. 10 (2) The following shall be clea rly and visibly printed on registry identification cards: 11 (a) The name of the cardholder; 12 (b) A designation of whether the cardholder is a registered qualified patient, 13 visiting qualified patient, or designated caregiver; 14 (c) The date of issuance and expir ation date of the registry identification card; 15 (d) A random alphanumeric identification number of at least ten (10) 16 characters, containing at least four (4) numbers and at least four (4) letters, 17 that is unique to the cardholder; 18 (e) A photograph of the c ardholder, if the department's administrative 19 regulations require one; 20 (f) The telephone number and Web site address for the electronic monitoring 21 system established pursuant to Section 41 of this Act; 22 (g) If the cardholder is a designated caregiver, the r andom alphanumeric 23 identification number of the registered qualified patient the designated 24 caregiver is receiving the registry identification card to assist; 25 (h) If the cardholder is under eighteen (18) years of age, a clear and obvious 26 designation or ide ntifier indicating that the cardholder is under eighteen 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 42 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (18) years of age; and 1 (i) A bar code or other marking that can be scanned electronically to provide 2 access to the information described in subsection (4) of this section. 3 (3) (a) Except as provided in this subsection, the expiration date for registry 4 identification cards shall be one (1) year after the date of issuance. 5 (b) If a medicinal cannabis practitioner states in the written certification that 6 the qualified patient would benefit from the use o f medicinal cannabis until 7 a specified earlier date, then the registry identification card shall expire on 8 that date. 9 (4) The department shall electronically store in the card at least all of the 10 information listed in subsection (2) of this section, the ca rdholder's the address, 11 and the cardholder's date of birth, so that it may be read electronically by law 12 enforcement agents and licensed cannabis businesses. 13 (5) The registry identification card application and renewal fees shall be as follows: 14 (a) A regis try identification card for a qualified patient who is a Kentucky 15 resident shall be sixty dollars ($60); 16 (b) A registry identification card for a visiting qualified patient shall be sixty 17 dollars ($60); and 18 (c) A registry identification card for a designat ed caregiver shall be twenty 19 dollars ($20) per registered qualified patient to whom the designated 20 caregiver is connected unless the designated caregiver is the parent, legal 21 guardian, spouse, or adult child of the qualified patient, in which case there 22 shall be no fee for a registry identification card. 23 (6) (a) The department shall operate a provisional registration receipt system for 24 registered qualified patients, designated caregivers, and visiting qualified 25 patients that shall be valid for forty -five (4 5) days, or until a permanent card 26 can be issued, as if it is a registry identification card issued pursuant to this 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 43 of 141 HB013630.100 - 50 - XXXX House Committee Substitute section and Sections 11 and 13 of this Act. This program shall be 1 implemented and operational simultaneously with the department's 2 implemen tation of the registry identification card program established in 3 this section. A provisional registration receipt shall contain the following: 4 1. A temporary identification number; 5 2. A barcode or other marking that can be scanned electronically; 6 3. The n ame of the applicant; 7 4. A designation of whether the cardholder is a registered qualified 8 patient, visiting qualified patient, or designated caregiver; 9 5. If the cardholder is under eighteen (18) years of age, a clear and 10 obvious designation or identifier indicating that the cardholder is 11 under eighteen (18) years of age; 12 6. The effective date of the receipt; 13 7. The expiration date of the receipt; 14 8. An indi cation that the cardholder fee has been paid; 15 9. An indication that the application has been submitted and is 16 apparently complete; and 17 10. The name of the qualified patient's medicinal cannabis practitioner. 18 (b) The registration receipt system shall be des igned so that this provisional 19 registration receipt shall be produced by the application Web site upon 20 completion of an application that includes a valid written certification for 21 the use of medicinal cannabis issued by medicinal cannabis practitioner 22 and payment of the cardholder fee. To reduce application errors and 23 processing time, medicinal cannabis practitioners and licensed dispensaries 24 may offer a service that allows an applicant to use a computer and printer 25 on the premises of the practitioner's off ice or dispensary to complete an 26 application and receive a provisional registration receipt pursuant to this 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 44 of 141 HB013630.100 - 50 - XXXX House Committee Substitute subsection. 1 (c) Notwithstanding any other provision of Sections 1 to 30 of this Act, a valid 2 provisional registration receipt issued pursuant to th is subsection shall 3 convey to the individual whose name appears on the provisional registration 4 receipt all of the same rights and privileges as a registry identification card 5 issued pursuant to this section and Sections 11 and 13 of this Act and shall 6 be accepted by a cannabis business in place of a registry identification card. 7 (7) All registry identification card fees collected by the department pursuant to 8 subsection (5) of this section shall be forwarded to the medicinal cannabis trust 9 fund established in Section 31 of this Act. 10 SECTION 13. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 11 TO READ AS FOLLOWS: 12 (1) Except as provided in subsections (2) to (5) of this section, the department shall: 13 (a) Acknowledge receipt of an application or renewal within fifteen (15) days of 14 receipt, and approve or deny an application or renewal within thirty (30) 15 days of receiving a completed application or renewal application; and 16 (b) Issue registry identification cards to a qualified pat ient and any individual 17 designated by the qualified patient as a designated caregiver, or a visiting 18 qualified patient within five (5) days of approving the application or 19 renewal. An individual designated as a caregiver shall be issued a 20 designated caregi ver registry identification card for each registered 21 qualified patient to whom he or she is connected through the department's 22 registration process. 23 (2) The department shall not issue a registry identification card to a qualified patient 24 who is younger tha n eighteen (18) years of age unless: 25 (a) The custodial parent or legal guardian with responsibility for health care 26 decisions for the qualified patient consents in writing to: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 45 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 1. Allow the qualified patient's use of medicinal cannabis; 1 2. Serve as the qual ified patient's designated caregiver; and 2 3. Control the acquisition of the medicinal cannabis, the dosage, and the 3 frequency of the use by the qualified patient; and 4 (b) The designated caregiver application for the custodial parent or legal 5 guardian with responsibility for health care decisions for the qualified 6 patient is approved. 7 (3) (a) The department shall deny an application or renewal for a qualified 8 patient's or visiting qualified patient's registry identification card if the 9 applicant: 10 1. Did not provide the information or materials required by Section 11 of 11 this Act; 12 2. Previously had a registry identification card revoked; 13 3. Provided false or falsified information; or 14 4. Does not meet the eligibility requirements established in Section 11 of 15 this Act. 16 (b) The department may deny an application or renewal for a qualified 17 patient's or visiting qualified patient's registry identification card for any 18 reason that the department, in the exercise of sound discretion, deems 19 sufficient. 20 (4) (a) The department shall deny an application or renewal for a designated 21 caregiver's registration card if the applicant: 22 1. Is already registered as a designated caregiver for three (3) registered 23 qualified patients; 24 2. Does not meet the eligibility requiremen ts established in Section 11 of 25 this Act; 26 3. Did not provide the information or materials required by Section 11 of 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 46 of 141 HB013630.100 - 50 - XXXX House Committee Substitute this Act; 1 4. Previously had a registry identification card revoked; 2 5. Provided false or falsified information; or 3 6. Has applied as a desig nated caregiver for a qualified patient whose 4 application or renewal for a registry identification card was denied. 5 (b) The department may deny application or renewal for a designated 6 caregiver's registration card for any reason that the department, in the 7 exercise of sound discretion, deems sufficient. 8 (5) The department may conduct a criminal background check of any applicant if the 9 criminal background check is conducted solely to determine whether the 10 applicant was previously convicted of a disqualifying felony offense. 11 (6) The department shall notify the registered qualified patient who has designated 12 someone to serve as his or her designated caregiver if the individual designated as 13 a caregiver is denied a registry identification card. 14 (7) The departmen t shall notify the applicant in writing of the denial and reasons for 15 the denial by registered or certified mail at the address given in the application or 16 supplement. The applicant may, within thirty (30) days after the date of the 17 mailing of the departme nt's notice, file a written request for an administrative 18 hearing on the application. The hearing shall be conducted on the application in 19 compliance with the requirements of KRS Chapter 13B. 20 (8) Final orders of the department after administrative hearings shall be subject to 21 judicial review. Jurisdiction and venue for judicial review are vested in the 22 Circuit Court of the county in which the appealing party resides. 23 SECTION 14. A NEW SECTION OF KRS CHAPTER 218A IS CREATE D 24 TO READ AS FOLLOWS: 25 (1) Cardholders shall be required to make the following notifications to the 26 department: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 47 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (a) A cardholder shall notify the department of any change in his or her name 1 or address; 2 (b) If a cardholder loses his or her registry identific ation card, he or she shall 3 notify the department within ten (10) days of becoming aware that the card 4 has been lost; 5 (c) A cardholder shall immediately notify the department if he or she is 6 convicted of a disqualifying felony offense; 7 (d) A registered q ualified patient shall notify the department within thirty (30) 8 days if he or she ceases to suffer from the qualifying medical condition for 9 which a medicinal cannabis practitioner provided a written certification; 10 (e) A registered qualified patient shall immediately notify the department if he 11 or she wishes to terminate a designated caregiver relationship with an 12 individual who has been designated as his or her caregiver; and 13 (f) A designated caregiver shall notify the department within ten (10) days if he 14 or she becomes aware that a registered qualified patient to whom the 15 caregiver is connected through the department's registration process has 16 died or has ceased to suffer from the qualifying medical condition for which 17 a medicinal cannabis practitioner pr ovided a written certification. 18 (2) When a cardholder notifies the department of items listed in subsection (1)(a) or 19 (b) of this section, but remains eligible under Sections 1 to 30 of this Act, the 20 department shall issue the cardholder a new registry ide ntification card with a 21 new random ten (10) character alphanumeric identification number. If the 22 department issues a new registry identification card to a registered qualified 23 patient, the department shall also issue a new registry identification card with a 24 new ten (10) character alphanumeric number to the registered qualified patient's 25 designated caregiver. New registry identification cards issued under this 26 subsection shall be issued by the department within ten (10) days of receiving the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 48 of 141 HB013630.100 - 50 - XXXX House Committee Substitute updated informa tion and a twenty dollar ($20) fee for each new registry 1 identification card to be issued. 2 (3) When a cardholder notifies the department of items listed in subsection (1)(c) to 3 (e) of this section, the cardholder shall, within ten (10) days of notification , 4 return any unused medicinal cannabis products to a licensed dispensary for 5 destruction. 6 (4) If a registered qualified patient ceases to be a registered qualified patient or 7 changes his or her designated caregiver, the department shall promptly notify the 8 designated caregiver in writing. The designated caregiver's protections under 9 Sections 1 to 30 of this Act as to that registered qualified patient shall expire 10 fifteen (15) days after notification by the department. 11 (5) A cardholder who fails to make a no tification to the department that is required 12 by this section is subject to a violation, punishable by a penalty of no more than 13 one hundred fifty dollars ($150). 14 (6) All fees and penalties collected pursuant to this secti on shall be forwarded to the 15 medicinal cannabis trust fund established in Section 31 of this Act. 16 SECTION 15. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 17 TO READ AS FOLLOWS: 18 (1) Any cardholder who sells, distributes, di spenses, or otherwise diverts medicinal 19 cannabis to a person who is not permitted to possess or use medicinal cannabis 20 under Sections 1 to 30 of this Act shall have his or her registry identification card 21 revoked, shall be permanently ineligible for a regi stry identification card in the 22 future, and shall be subject to other penalties, including but not limited to 23 criminal prosecution, under any relevant chapter of the Kentucky Revised 24 Statutes. 25 (2) The department may revoke the registry identification card of any cardholder 26 who knowingly commits multiple violations or a serious violation of Sections 1 to 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 49 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 30 of this Act. 1 (3) The department shall provide notice of revocation, fine, or any other 2 administrative penalty by mailing, via certified mail, the same in writing to the 3 cardholder. The cardholder may, within thirty (30) days after the date of the 4 mailing of the department's notice, file a written request for an administrative 5 hearing regarding the revocation, fine, or other penalty. The hearing shall be 6 conducted in compliance with the requirements of KRS Chapter 13B. 7 (4) Final orders of the department after administrative hearings shall be subject to 8 judicial review. Jurisdiction and venue for judicial review are vested in the 9 Circuit Court of the county i n which the appealing party resides. 10 SECTION 16. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 11 TO READ AS FOLLOWS: 12 (1) No person shall cultivate, process, produce, possess, test, transfer, transport, or 13 sell medicinal can nabis or otherwise operate a cannabis business in this state 14 without first obtaining a cannabis business licenses issued by the department. 15 (2) The department shall create separate licenses allowing persons to operate a 16 cannabis business, pursuant to Secti ons 1 to 30 of this Act and any administrative 17 regulations promulgated thereunder, as: 18 (a) A cannabis cultivator, for which the license shall be tiered as follows: 19 1. Tier I, for which the initial licensing fee shall be five thousand dollars 20 ($5,000); 21 2. Tier II, for which the initial licensing fee shall be ten thousand dollars 22 ($10,000); 23 3. Tier III, for which the initial licensing fee shall be twenty -five 24 thousand dollars ($25,000); and 25 4. Tier IV, for which the initial licensing fee shall be fifty thousa nd 26 dollars ($50,000); 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 50 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (b) A cannabis dispensary, for which the initial licensing fee shall be ten 1 thousand dollars ($10,000); 2 (c) A cannabis processor, for which the initial licensing fee shall be twenty 3 thousand dollars ($20,000); 4 (d) A cannabis producer, for which the initial licensing fee shall be seventy -five 5 thousand dollars ($75,000); or 6 (e) A cannabis safety compliance facility, for which the initial licensing fee 7 shall be two thousand five hundred dollars ($2,500). 8 (3) (a) Except as provided in para graph (b) of this subsection, a cannabis business 9 shall be required to apply for and obtain from the department a separate 10 license for each location it intends to operate. 11 (b) A cannabis business licensed as a producer may operate cultivation and 12 processin g activities at separate locations, but shall not operate more than 13 one (1) cultivation and one (1) processing facility per license. 14 (4) (a) A cannabis business license issued under this section and Sections 17 and 15 18 of this Act shall be valid for one (1) year from the date of issuance. The 16 department shall notify each licensee ninety (90) days prior to the date on 17 which the license expires to allow the licensee to begin the renewal process 18 established by the department through the promulgation of administ rative 19 regulations pursuant to Section 28 of this Act. 20 (b) The renewal of a cannabis business license shall be contingent upon 21 successful achievement of minimal performance standards established by 22 the department as part of the biennial accreditation proce ss established 23 pursuant to Section 28 of this Act. 24 (c) Cannabis business licensure renewal fees shall be: 25 1. Five hundred dollars ($500) plus one percent (1%) of all gross receipts 26 during the previous calendar year for a cannabis business that, upon 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 51 of 141 HB013630.100 - 50 - XXXX House Committee Substitute applyi ng for renewal of a cannabis business license, had no more than 1 two million dollars ($2,000,000) of gross receipts during the previous 2 calendar year; 3 2. Two thousand dollars ($2,000) plus one and one -half percent (1.5%) 4 of all gross receipts during the pre vious calendar year for a cannabis 5 business that, upon applying for renewal of a cannabis business 6 license, had more than two million dollars ($2,000,000) but not more 7 than eight million dollars ($8,000,000) of gross receipts during the 8 previous calendar y ear; and 9 3. Four thousand dollars ($4,000) plus two percent (2%) of all gross 10 receipts during the previous calendar year for a cannabis business 11 that, upon applying for renewal of a cannabis business license, had 12 over eight million dollars ($8,000,000) of gross receip ts during the 13 previous calendar year. 14 (5) All licensure fees collected pursuant to this section shall be forwarded to the 15 medicinal cannabis trust fund established in Section 31 of this Act. 16 (6) The department shall approve a license holder's sale of a lic ense issued pursuant 17 to this section and Sections 17 and 18 of this Act if the purchaser and any new 18 facilities meet the requirements of Sections 1 to 30 of this Act and any 19 administrative regulations promulgated thereunder. 20 SECTION 17. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 21 TO READ AS FOLLOWS: 22 (1) The department shall create a uniform application form for the cannabis 23 business licenses established in Section 16 of this Act. 24 (2) When applying for a cannabis business license, the applicant shall submit the 25 following in accordance with the department's administrative regulations: 26 (a) The proposed legal name of the cannabis business; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 52 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (b) The proposed physical address of the cannabis business and the global 1 positioning s ystem coordinates for any proposed cultivation activities; 2 (c) The name, address, and date of birth of each principal officer and board 3 member of the cannabis business; 4 (d) Any instances in which a business or not -for-profit entity that any of the 5 prospect ive board members managed or served on the board of was 6 convicted, fined, censured, or had a registration or license suspended or 7 revoked in any administrative or judicial proceeding; 8 (e) Any other information required by the department pursuant to 9 adminis trative regulations; and 10 (f) A nonrefundable licensure application fee of one hundred dollars ($100). 11 (3) The application fee required under subsection (2) of this section shall be applied 12 to the initial licensing fee if the license is approved; otherwise it shall be retained 13 by the department for administrative purposes. 14 (4) If a cannabis business license application is approved: 15 (a) The cannabis business shall, before it begins operations: 16 1. Submit the initial license fee established in Section 16 of thi s Act, 17 minus the one hundred dollars ($100) application fee, to the 18 department; and 19 2. If a physical address or the global positioning system coordinates for 20 any cultivation activities had not been finalized when it applied, 21 submit its complete physical ad dress and the global positioning system 22 coordinates for any cultivation activities; and 23 (b) The department shall issue a copy of the license that includes the business's 24 identification number. The department shall also provide each licensed 25 dispensary with contact and access information for the electronic 26 monitoring system established pursuant to Section 41 of this Act. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 53 of 141 HB013630.100 - 50 - XXXX House Committee Substitute SECTION 18. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 1 TO READ AS FOLLOWS: 2 (1) The department shall: 3 (a) Acknowledge receipt of an application for a cannabis business license 4 within fifteen (15) days of receipt; and 5 (b) Provide notification to the cannabis business license applicant as to whether 6 the application for a cannabis business license has been ap proved or denied 7 within forty -five (45) days of receiving a completed application. 8 (2) (a) The department shall deny an application for a cannabis business license if: 9 1. The applicant failed to submit the materials required by Section 17 of 10 this Act, incl uding if the applicant's plans do not satisfy the security, 11 oversight, or recordkeeping administrative regulations promulgated by 12 the department pursuant to Section 28 of this Act; 13 2. The applicant provided false or falsified information on the licensure 14 application; 15 3. The applicant would not be in compliance with local cannabis 16 business prohibitions enacted pursuant to Section 26 of this Act; 17 4. The applicant does not meet, or in the opinion of the department is 18 unlikely to meet, the requirements for cannabis businesses established 19 in Section 19 of this Act; 20 5. One (1) or more of the prospective principal officers or board 21 members: 22 a. Has been con victed of a disqualifying felony offense, the 23 provisions of KRS 335B.020 and 335B.030 notwithstanding; 24 b. Has served as a principal officer or board member for a 25 cannabis business that has had its license revoked; 26 c. Is younger than twenty -one (21) years o f age; or 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 54 of 141 HB013630.100 - 50 - XXXX House Committee Substitute d. Is a medicinal cannabis practitioner authorized by a state 1 licensing board to provide patients with written certifications; or 2 6. a. For a safety compliance facility, one (1) or more of the 3 prospective principal officers or board members is a principal 4 officer or board member of a cultivator, processor, producer, or 5 dispensary licensed to operate in Kentucky; or 6 b. For a cultivator, processor, producer, or dispensary, one (1) or 7 more of the prospective principal officers or board members is a 8 principal officer or board member of a safety compliance facility 9 licensed to operate in Kentucky. 10 (b) The department may deny an application for a cannabis business license for 11 any reason that the department, in the exercise of sound discretion, deems 12 sufficient. 13 (3) The department shall notify the applicant in writing of a license denial and 14 reasons by registered or certified mail at the address given in the application or 15 supplement. Except for license denials based upon subsection (2)(a) of this 16 section, the applicant may, within thirty (30) days after the mailing of the 17 department's notice, file a written request for an administrative hearing on the 18 application. The hearing shall be conducted on the application in compliance 19 with the requirements of KRS Chapter 13B. 20 (4) Final orders of the department after administrative hearings shall be subject to 21 judicial review as provided in KRS 13B.140. Jurisdiction and venue for judicial 22 review are vested in the Circuit Court of the county in which the applicant's 23 business would be located. 24 SECTION 19. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 25 TO READ AS FOLLOWS: 26 (1) A cannabis business licensed under this chapter shall: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 55 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (a) Comply with Sections 1 to 30 of this Act and any administrative regulations 1 promulgated thereunder by the department; 2 (b) Conduct a criminal background check into the criminal history of each 3 person seeking to become a principal officer, board member, agent, 4 volunteer, or employee befor e that person begins work. A cannabis business 5 shall not employ, accept as a volunteer, or have as a board member, 6 principal officer, or agent any person who: 7 1. Was convicted of a disqualifying felony offense; or 8 2. Is under twenty -one (21) years of age; 9 (c) Implement appropriate security measures required pursuant to 10 administrative regulations promulgated by the department in accordance 11 with Section 28 of this Act to deter and prevent the theft or diversion of 12 medicinal cannabis and unauthorized entrance into areas containing 13 medicinal cannabis; 14 (d) Display its license on the premises in a conspicuous place and manner at all 15 times; and 16 (e) Only acquire, possess, cultivate, process, manufacture, deliver, transfer, 17 transport, supply, sell, or dispense medici nal cannabis: 18 1. For the purposes of distributing medicinal cannabis to cardholders 19 who possess a valid registry identification card issued by the 20 department, or for visiting qualified patients, a valid out -of-state 21 registry identification card; and 22 2. Cultivated and processed by a cannabis business licensed under 23 Sections 16, 17, and 18 of this Act. 24 (2) A cannabis business licensed under Sections 16, 17, and 18 of this Act this 25 chapter shall not: 26 (a) Be located within one thousand (1,000) feet of an elemen tary or secondary 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 56 of 141 HB013630.100 - 50 - XXXX House Committee Substitute school or a day -care center; 1 (b) Acquire, possess, cultivate, process, manufacture, deliver, transfer, 2 transport, supply, dispense, or sell: 3 1. Raw plant material with a delta -9 tetrahydrocannabinol content of 4 more than thirty -five percent (35%); 5 2. Medicinal cannabis products intended for oral consumption as an 6 edible, oil, or tincture with more than ten (10) milligrams of delta -9 7 tetrahydrocanna binol per serving; 8 3. Any medicinal cannabis product not described in subparagraph 1. or 9 2. of this paragraph with a delta -9 tetrahydrocannabinol content of 10 more than seventy percent (70%); 11 4. Any medicinal cannabis product that contains vitamin E acetate; or 12 5. Medicinal cannabis cultivated, processed, or manufactured in another 13 state; 14 (c) Permit a person under eighteen (18) years of age to enter or remain on the 15 premises of a cannabis business; 16 (d) Permit a person who is not a cardholder to enter or remai n on the premises 17 of a cannabis business, except in accordance with subsection (6) of this 18 section; 19 (e) Employ, have as a board member, or be owned by, in part or in whole, a 20 medicinal cannabis practitioner authorized by a state licensing board to 21 provide patients with written certifications; or 22 (f) Advertise medicinal cannabis sales in print, broadcast, online, by paid in - 23 person solicitation of customers, or by any other advertising device as 24 defined in KRS 177.830, except that this paragraph shall not pre vent 25 appropriate signs on the property of a licensed cannabis business, listings in 26 business directories including phone books, listings in trade or medical 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 57 of 141 HB013630.100 - 50 - XXXX House Committee Substitute publications, or sponsorship of health or not -for-profit charity or advocacy 1 events. 2 (3) The operat ing documents of a cannabis business shall include procedures for its 3 oversight and procedures to ensure accurate recordkeeping and inventory control 4 in accordance with administrative regulations promulgated by the department 5 pursuant to Section 28 of this Act. 6 (4) When transporting medicinal cannabis on behalf of a licensed cannabis business, 7 a cannabis business agent shall have: 8 (a) A copy of the cannabis business license for the business that employs the 9 agent; 10 (b) Documentation that specifies the amount of medicinal cannabis being 11 transported and the date on which it is being transported; and 12 (c) The cannabis business license number and a working telephone number for 13 any other cannabis business receiving or otherwise involved in the 14 transportation of the medicinal cannabis. 15 (5) The cultivation of medicinal cannabis for cannabis businesses licensed in this 16 state shall only be done by cultivators and producers licensed under this chapter 17 and shall take place in an enclosed, locked facility which can be acce ssed by only 18 cannabis business agents working on behalf of the cultivator or producer at the 19 physical address or global positioning system coordinates provided to the 20 department during the license application process. 21 (6) A person who is at least eighteen (18) years of age but not a cardholder may be 22 allowed to enter and remain on the premises of a cannabis business if: 23 (a) The person is present at the cannabis business to perform contract work, 24 including but not limited to electrical, plumbing, or security maintenance, 25 that does not involve handling medicinal cannabis; or 26 (b) The person is a government employee and is at the cannabis business in the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 58 of 141 HB013630.100 - 50 - XXXX House Committee Substitute course of his or her official duties. 1 SECTION 20. A NEW SECTION OF KRS CH APTER 218A IS CREATED 2 TO READ AS FOLLOWS: 3 (1) Cannabis businesses shall be subject to reasonable inspection by the department 4 pursuant to the department's procedures and administrative regulations. The 5 department may inspect any licensed cannabis business premises without having 6 to first obtain a search warrant. 7 (2) (a) Except as provided in Section 22 of this Act, the department may issue a 8 civil fine of up to three thousand dollars ($3,000) to a cannabis business for 9 a violation of Sections 1 to 30 of thi s Act or any administrative regulation 10 promulgated thereunder. All fines collected pursuant to this subsection 11 shall be forwarded to the medicinal cannabis trust fund established in 12 Section 31 of this Act. 13 (b) The department may, on its own motion or on co mplaint and after 14 investigation, suspend or revoke a cannabis business license for multiple 15 violations or a serious violation of Sections 1 to 30 of this Act or any 16 administrative regulations promulgated thereunder by the licensee or any of 17 its agents. A s uspension shall not be for a period of time longer than six (6) 18 months. 19 (c) The department shall, via certified mail, provide a written notice of license 20 suspension, revocation, fine to the cannabis business at the address on the 21 license. 22 (3) Subsection (2 ) of this section notwithstanding, the department shall not suspend 23 or revoke a cannabis business's license or impose a civil fine without first 24 providing the cannabis business with the opportunity for an administrative 25 hearing at which the cannabis busine ss is afforded an opportunity to appear and 26 be heard pursuant to KRS Chapter 13B. A cannabis business may, within thirty 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 59 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (30) days after the mailing of a written notice required by subsection (2)(c) of this 1 section, file a written request for an administra tive hearing regarding the 2 suspension, revocation, or fine. If a cannabis business requests an administrative 3 hearing, prior to the disposition of the administrative hearing, the cannabis 4 business shall be allowed to operate as normally permitted by Sectio ns 1 to 30 of 5 this Act. 6 (4) Final orders of the department after administrative hearings shall be subject to 7 judicial review. Jurisdiction and venue for judicial review are vested in the 8 Circuit Court of the county in which the cannabis business is physically located. 9 (5) Under a sus pended license: 10 (a) A cultivator may continue to cultivate and possess cannabis plants, but it 11 shall not transfer or sell medicinal cannabis during a suspension; 12 (b) A dispensary may continue to possess its existing medicinal cannabis 13 inventory, but it sh all not acquire additional medicinal cannabis, or 14 dispense, transfer, or sell medicinal cannabis to any cardholder or any 15 other cannabis business; 16 (c) A processor may continue to process and possess its existing medicinal 17 cannabis inventory, but it shall n ot acquire additional medicinal cannabis, 18 or dispense, transfer, or sell medicinal cannabis products to any other 19 cannabis business; 20 (d) A producer may continue to cultivate, process, and possess cannabis plants 21 and its existing medicinal cannabis inventor y, but it shall not acquire 22 additional medicinal cannabis, or dispense, transfer, or sell medicinal 23 cannabis to any other cannabis business; and 24 (e) A safety compliance facility may continue to possess medicinal cannabis, 25 but it shall not receive any new m edicinal cannabis, test or otherwise 26 analyze medicinal cannabis, or transfer or transport medicinal cannabis. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 60 of 141 HB013630.100 - 50 - XXXX House Committee Substitute SECTION 21. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 1 TO READ AS FOLLOWS: 2 (1) A cultivator or cultivator ag ent acting on behalf of a cultivator shall not be 3 subject to prosecution under state or local law, to search or inspection except by 4 the department pursuant to Section 20 of this Act, to seizure or penalty in any 5 manner, or be denied any right or privilege , including but not limited to civil 6 penalty or disciplinary action by a court or business licensing board, for acting 7 pursuant to Sections 1 to 30 of this Act and the department's administrative 8 regulations promulgated thereunder for: 9 (a) Acquiring, posse ssing, planting, cultivating, raising, harvesting, trimming, 10 or storing cannabis seeds, seedlings, plants, or raw plant material; 11 (b) Delivering, transporting, transferring, supplying, or selling raw plant 12 material or related supplies to other licensed can nabis businesses in this 13 state; or 14 (c) Selling cannabis seeds or seedlings to similar entities that are licensed to 15 cultivate cannabis in this state or in any other jurisdiction. 16 (2) Cultivators and cultivator agents acting on behalf of a cultivator shall: 17 (a) Only deliver raw plant material to a licensed processor, licensed producer, 18 licensed safety compliance facility, or licensed dispensary for fair market 19 value; 20 (b) Only deliver raw plant material to a licensed dispensary, processor, or 21 producer after i t has been checked by a safety compliance facility agent for 22 cannabinoid contents and contaminants in accordance with administrative 23 regulations promulgated by the department; 24 (c) Not supply a dispensary with more than the amount of raw plant material 25 reasonably required by a dispensary; and 26 (d) Not deliver, transfer, or sell raw plant material with a delta -9 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 61 of 141 HB013630.100 - 50 - XXXX House Committee Substitute tetrahydrocannabinol content of more than thirty -five percent (35%) to a 1 licensed dispensary, processor, or producer. 2 (3) (a) A Tier I cultivator shal l not exceed an indoor growth area of two thousand 3 five hundred (2,500) square feet. 4 (b) A Tier II cultivator shall not exceed an indoor growth area of ten thousand 5 (10,000) square feet. 6 (c) A Tier III cultivator shall not exceed an indoor growth area of t wenty -five 7 thousand (25,000) square feet. 8 (d) A Tier IV cultivator shall not exceed an indoor growth area of fifty 9 thousand (50,000) square feet. 10 SECTION 22. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 11 TO READ AS FOLLOW S: 12 (1) A dispensary or dispensary agent acting on behalf of a dispensary shall not be 13 subject to prosecution under state or local law, to search or inspection except by 14 the department pursuant to Section 20 of this Act, to seizure or penalty in any 15 manner, or be denied any right or privilege, including but not limited to a civil 16 penalty or disciplinary action by a court or business licensing board, for acting 17 pursuant to Sections 1 to 30 of this Act and the department's administrative 18 regulations promulgate d thereunder for: 19 (a) Acquiring or possessing medicinal cannabis from a cultivator, processor, or 20 producer in this state; 21 (b) Acquiring or possessing medicinal cannabis accessories or educational 22 material; 23 (c) Supplying, selling, dispensing, distributing, or delivering medicinal 24 cannabis, medicinal cannabis accessories, and educational material to 25 cardholders or other licensed dispensaries; 26 (d) Selling cannabis seeds to an entity that are licensed to cultivate cannabis in 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 62 of 141 HB013630.100 - 50 - XXXX House Committee Substitute this state or in any other jurisdiction; or 1 (e) Acquiring, accepting, or receiving medicinal cannabis products from a 2 cardholder, except that a dispensary may not offer anything of monetary 3 value in return for medicinal cannabis received from a cardholder. Any 4 medicinal cannabis received by a dispensary under this paragraph or 5 pursuant to Section 14 of this Act shall be destroyed by the dispensary or its 6 agents and shall not be s old, dispensed, or distributed to another 7 cardholder. 8 (2) A dispensary or dispensary agent acting on behalf of a dispensary shall: 9 (a) Maintain records that include specific notations of the type and quantity of 10 medicinal cannabis products being dispensed to a cardholder and whether it 11 was dispensed directly to a registered qualified patient, a visiting qualified 12 patient, or a registered qualified patient's designated caregiver. Each entry 13 shall include sufficient information to identify the product or prod ucts 14 dispensed, the quantity dispensed, and the date and time of the dispensing. 15 The data required to be recorded by this paragraph shall be entered into the 16 electronic monitoring system established pursuant to Section 41 of this Act 17 in accordance with adm inistrative regulations promulgated by the 18 department for the recording of medicinal cannabis dispensing; 19 (b) Only dispense or sell medicinal cannabis after it has been checked by a 20 safety compliance facility agent for cannabinoid contents and contaminants 21 in accordance with administrative regulations promulgated by the 22 department; 23 (c) Only dispense or sell medicinal cannabis to a cardholder after making a 24 good faith, reasonable effort to verify: 25 1. That the registry identification card or, for visiting qua lified patients, 26 the out -of-state registry identification card presented to the dispensary 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 63 of 141 HB013630.100 - 50 - XXXX House Committee Substitute is valid, including by checking the verification system, if it is 1 operational, or other department -designated databases; 2 2. That the person presenting the registry i dentification card or, for 3 visiting qualified patients, the out -of-state registry identification card 4 is at least eighteen (18) years of age and is the person identified on the 5 card by examining at least one (1) other form of government -issued 6 photo identi fication; 7 3. That the person presenting the registry identification card has 8 consulted with a pharmacist as required by Section 10 of this Act; 9 4. The amount of medicinal cannabis the person is legally permitted to 10 purchase pursuant to subsection (4) of Se ction 4 of this Act at the time 11 of verification by checking the electronic monitoring system 12 established pursuant to Section 41 of this Act; and 13 5. For a visiting qualified patient who presents an out -of-state registry 14 identification card, that the visitin g qualified patient has not 15 purchased medicinal cannabis in this state during the current 16 calendar year by checking the electronic monitoring system 17 established pursuant to Section 41 of this Act; 18 (d) Require a visiting qualified patient who presents a val id out -of-state registry 19 identification card to sign a statement attesting to the fact that the visiting 20 qualified patient has been diagnosed with a disease or medical condition 21 included on the list of qualifying medical conditions established by the 22 depar tment; 23 (e) Not acquire, possess, dispense, sell, offer for sale, transfer, or transport: 24 1. Raw plant material with a delta -9 tetrahydrocannabinol content of 25 more than thirty -five percent (35%); 26 2. Medicinal cannabis products intended for oral consumption as an 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 64 of 141 HB013630.100 - 50 - XXXX House Committee Substitute edible, oil, or tincture with more than ten (10) milligrams of delta -9 1 tetrahydrocannabinol per serving; 2 3. Any medicinal cannabis product not described in subparagraph 1. or 3 2. of this paragraph with a delta -9 tetrahydrocannabinol content of 4 more th an seventy percent (70%); or 5 4. Any medicinal cannabis product that contains vitamin E acetate; 6 (f) Not acquire medicinal cannabis from any person other than a cannabis 7 business licensed under Sections 16, 17, and 18 of this Act or an agent 8 thereof, or a r egistered qualified patient or a designated caregiver as 9 provided for in Section 14 of this Act; 10 (g) Not sell or dispense medicinal cannabis products intended for consumption 11 by vaporizing to a cardholder who is less than twenty -one (21) years of age; 12 (h) Not dispense or sell medicinal cannabis to a minor; 13 (i) Not dispense or sell more medicinal cannabis to a cardholder than he or she 14 is legally permitted to purchase at the time of the transaction; and 15 (j) Not rent office space to a medicinal cannabis pract itioner. 16 (3) A dispensary shall be required to establish and maintain a cannabis consultation 17 agreement, as described in Section 10 of this Act and any administrative 18 regulation promulgated thereunder, with a pharmacist authorized by the 19 Kentucky Board of Pharmacy to enter into a cannabis consultation agreement 20 with a dispensary. 21 (4) (a) A dispensary may operate a delivery service for cardholders and may deliver 22 medicinal cannabis, medicinal cannabis accessories, and educational 23 material to cardholders at t he address identified on the cardholder's registry 24 identification. 25 (b) All delivery services operated or offered by a dispensary shall comply with 26 administrative regulations promulgated by the department pursuant to this 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 65 of 141 HB013630.100 - 50 - XXXX House Committee Substitute section and Section 28 of this Act. 1 (5) If a dispensary fails to comply with subsection (2)(c) of this section, the 2 department may issue the dispensary a civil fine of up to fifty thousand dollars 3 ($50,000), except that the fine shall be one hundred thousand dollars ($100,000) 4 if the person purchasing or attempting to purchase medicinal cannabis is a 5 minor. All fines collected pursuant to this subsection shall be forwarded to the 6 medicinal cannabis trust fund established in Section 31 of this Act. 7 (6) If a dispensary or dispensary agent fails to comply with subsection (2)(c), (d), (e), 8 (f), or (g) of this section, the dispensary and dispensary agent are liable in a civil 9 action for compensatory and punitive damages and reasonable attorney's fees to 10 any person or the representative of the estate of any person who sustains injury, 11 death, or loss to person or property as a result of the failure to comply. In any 12 action under this subsection, the court may also award any injunctive or 13 equitable relief that t he court considers appropriate. 14 SECTION 23. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 15 TO READ AS FOLLOWS: 16 (1) A processor or processor agent acting on behalf of a processor shall not be 17 subject to prosecution under st ate or local law, to search or inspection except by 18 the department pursuant to Section 20 of this Act, to seizure or penalty in any 19 manner, or be denied any right or privilege, including but not limited to civil 20 penalty or disciplinary action by a court or business licensing board, for acting 21 pursuant to Sections 1 to 30 of this Act and the department's administrative 22 regulations promulgated thereunder for: 23 (a) Acquiring or purchasing raw plant material from a cultivator, processor, or 24 producer in this stat e; 25 (b) Possessing, processing, preparing, manufacturing, manipulating, blending, 26 preparing, or packaging medicinal cannabis; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 66 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (c) Transferring, transporting, supplying, or selling medicinal cannabis and 1 related supplies to other cannabis businesses in this state; or 2 (d) Selling cannabis seeds or seedlings to similar entities that are licensed to 3 cultivate cannabis in this state or in any other jurisdiction. 4 (2) A processor licensed under this section shall not possess, process, produce, or 5 manufacture: 6 (a) Raw plant material with a delta -9 tetrahydrocannabinol content of more 7 than thirty -five percent (35%); 8 (b) Medicinal cannabis products intended for oral consumption as an edible, 9 oil, or tincture with more than ten (10) milligrams of delta -9 10 tetrahydrocanna binol per serving; 11 (c) Any medicinal cannabis product not described in paragraph (a) or (b) of 12 this subsection with a delta -9 tetrahydrocannabinol content of more than 13 seventy percent (70%); or 14 (d) Any medicinal cannabis product that contains vitamin E ace tate. 15 SECTION 24. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 16 TO READ AS FOLLOWS: 17 (1) A producer or producer agent acting on behalf of a producer shall not be subject 18 to prosecution under state or local law, to search o r inspection except by the 19 department pursuant to Section 20 of this Act, to seizure or penalty in any 20 manner, or be denied any right or privilege, including but not limited to civil 21 penalty or disciplinary action by a court or business licensing board, fo r acting 22 pursuant to Sections 1 to 30 of this Act and the department's administrative 23 regulations promulgated thereunder for: 24 (a) Acquiring, possessing, planting, cultivating, raising, harvesting, trimming, 25 or storing cannabis seeds, seedlings, plants, or raw plant material; 26 (b) Delivering, transporting, transferring, supplying, or selling raw plant 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 67 of 141 HB013630.100 - 50 - XXXX House Committee Substitute material, medicinal cannabis products, or related supplies to other licensed 1 cannabis businesses in this state; 2 (c) Selling cannabis seeds or seedlings to simil ar entities that are licensed to 3 cultivate cannabis in this state or in any other jurisdiction; 4 (d) Acquiring or purchasing raw plant material from a cultivator in this state; 5 or 6 (e) Possessing, processing, preparing, manufacturing, manipulating, blending , 7 preparing, or packaging medicinal cannabis; 8 (2) Producers and producer agents acting on behalf of a producer shall: 9 (a) Only deliver raw plant material to a licensed processor, licensed producer, 10 licensed safety compliance facility, or licensed dispensar y for fair market 11 value; 12 (b) Only deliver raw plant material to a licensed dispensary, processor, or 13 producer after it has been checked by a safety compliance facility agent for 14 cannabinoid contents and contaminants in accordance with administrative 15 regula tions promulgated by the department; 16 (c) Not supply a dispensary with more than the amount of raw plant material 17 reasonably required by a dispensary; and 18 (d) Be limited to an indoor cannabis growth area of fifty thousand (50,000) 19 square feet. 20 (3) A produce r licensed under this section shall not possess, process, produce, or 21 manufacture: 22 (a) Raw plant material with a delta -9 tetrahydrocannabinol content of more 23 than thirty -five percent (35%); 24 (b) Medicinal cannabis products intended for oral consumption as a n edible, 25 oil, or tincture with more than ten (10) milligrams of delta -9 26 tetrahydrocannabinol per serving; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 68 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (c) Any medicinal cannabis product not described in paragraph (a) or (b) of 1 this subsection with a delta -9 tetrahydrocannabinol content of more than 2 seventy percent (70%); or 3 (d) Any medicinal cannabis product that contains vitamin E acetate. 4 SECTION 25. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 5 TO READ AS FOLLOWS: 6 A safety compliance facility or safety compl iance facility agent acting on behalf of a 7 safety compliance facility shall not be subject to prosecution, search except by the 8 department pursuant to Section 20 of this Act, seizure, or penalty in any manner, or be 9 denied any right or privilege, including but not limited to civil penalty or disciplinary 10 action by a court or business licensing board, for acting in accordance with Sections 1 11 to 30 of this Act and the department's administrative regulations promulgated 12 thereunder to provide the following serv ices: 13 (1) Acquiring or possessing medicinal cannabis obtained from cardholders or 14 cannabis businesses in this state; 15 (2) Returning the medicinal cannabis to cardholders or cannabis businesses in this 16 state; 17 (3) Transporting medicinal cannabis that was prod uced by cannabis businesses in 18 this state; 19 (4) The production or sale of approved educational materials related to the use of 20 medicinal cannabis; 21 (5) The production, sale, or transportation of equipment or materials other than 22 medicinal cannabis, including but not limited to lab equipment and packaging 23 materials that are used by cannabis businesses and cardholders, to cardholders or 24 cannabis businesses licensed under this chapter; 25 (6) Testing of medicinal cannabis produced in this state, including testing f or 26 cannabinoid content, pesticides, mold, contamination, vitamin E acetate, and 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 69 of 141 HB013630.100 - 50 - XXXX House Committee Substitute other prohibited additives; 1 (7) Training cardholders and cannabis business agents. Training may include but 2 need not be limited to: 3 (a) The safe and efficient cultivation, harv esting, packaging, labeling, and 4 distribution of medicinal cannabis; 5 (b) Security and inventory accountability procedures; and 6 (c) Up-to-date scientific and medical research findings related to use of 7 medicinal cannabis; 8 (8) Receiving compensation for acti ons allowed under this section; and 9 (9) Engaging in any non -cannabis -related business activities that are not otherwise 10 prohibited or restricted by state law. 11 SECTION 26. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 12 TO R EAD AS FOLLOWS: 13 (1) For the purposes of this section, \"local government\" means a city, county, 14 urban -county government, consolidated local government, charter county 15 government, or unified local government. 16 (2) A local government may: 17 (a) 1. Enact ordinanc es, not in conflict with Sections 1 to 30 of this Act or 18 with the department's administrative regulations, regulating the time, 19 place, and manner of cannabis business operations, except that a local 20 government shall not enact ordinances that impose an undu e burden 21 or make cannabis business operations unreasonable or impractical; 22 and 23 2. Enact an ordinance to assess a local fee on cannabis businesses 24 operating within the jurisdiction of the local government to 25 compensate the local government for any additiona l public safety 26 impact caused by the operation of cannabis businesses within the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 70 of 141 HB013630.100 - 50 - XXXX House Committee Substitute jurisdiction of the local government. Any fee established pursuant to 1 this paragraph shall not exceed the additional public safety impact 2 caused by the operation of cannabis b usinesses within the jurisdiction 3 of the local government; 4 (b) Prohibit all cannabis business operations within its territory through the 5 passage of an ordinance; or 6 (c) Enact resolutions directing that the question of prohibiting cannabis 7 businesses from operating within its territory be submitted to the voters of 8 its territory at the next regular election pursuant to subsection (4) of this 9 section. 10 (3) If a county, consolidated local government, charter county government, or 11 unified local government prohi bits all cannabis business operations, the 12 legislative body of a city located within the county, consolidated local 13 government, charter county government, or unified local government may: 14 (a) Approve cannabis business operations within the limits of the ci ty through 15 the passage of an ordinance; or 16 (b) Enact resolutions directing that the question of allowing cannabis 17 businesses to operate within the limits of the city be submitted to the voters 18 who are eligible to vote in that city's elections at the next r egular election 19 pursuant to subsection (4) of this section. 20 (4) If, not later than the second Tuesday in August preceding the day established for 21 a regular election, the county clerk has received a local government resolution 22 pursuant to subsection (2) or (3) of this section, the county clerk shall have 23 prepared to place before the voters of the affected territory at the next reg ular 24 election the question, which shall be \"Are you in favor of the sale of medicinal 25 cannabis at a licensed dispensary and the operation of other cannabis businesses 26 in (affected territory)? Yes....No....\". The county clerk shall cause to be published 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 71 of 141 HB013630.100 - 50 - XXXX House Committee Substitute in accordance with KRS Chapter 424, at the same time as the remaining voter 1 information, the full text of the proposal. The county clerk shall cause to be 2 posted in each polling place one (1) copy of the full text of the proposal. 3 (5) (a) If the question subm itted to the voters fails to pass, three (3) years shall 4 elapse before the question of medicinal cannabis sales and cannabis 5 business operations may be included on a regular election ballot for the 6 affected territory. 7 (b) If the question submitted to the v oters passes, medicinal cannabis sales and 8 cannabis business operations may be conducted in the affected territory, 9 notwithstanding any local government ordinances which prohibit all 10 cannabis business operations within its territory. 11 (6) In circumstances w here a county, consolidated local government, charter county 12 government, or unified local government prohibits cannabis business operations 13 but a city within that county, consolidated local government, charter county 14 government, or unified local government approves cannabis business operations 15 either through the adoption of an ordinance or following the affirmative vote of a 16 public question allowing cannabis business operations, then: 17 (a) The cannabis business operations may proceed within the limits of the city; 18 and 19 (b) The county, consolidated local government, charter county government, or 20 unified local government may assess an additional reasonable fee to 21 compensate for any additional public safety impact caused by the approval 22 of cannabis business opera tions. Any additional fees collected pursuant to 23 this subsection shall not exceed the additional public safety impact caused 24 by the approval of cannabis business operations. 25 (7) In circumstances where both a city and the county, consolidated local 26 governme nt, charter county government, or unified local government in which 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 72 of 141 HB013630.100 - 50 - XXXX House Committee Substitute the city is located have assessed a local fee on cannabis businesses pursuant to 1 subsection (2) of this section, a cannabis business shall be allowed to credit any 2 fee paid to the city aga inst fees owed to the county, consolidated local 3 government, charter county government, or unified local government. 4 (8) The provisions of general election law shall apply to public questions submitted to 5 voters under this section. 6 SECTION 27. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 7 TO READ AS FOLLOWS: 8 (1) The department shall maintain a confidential list of the persons to whom the 9 department has issued registry identification cards and their addresses, telephone 10 numbers, and registry identification numbers. 11 (2) The department shall, only at a cardholder's r equest, confirm his or her status as 12 a registered qualified patient, visiting qualified patient, or designated caregiver to 13 a third party, such as a landlord, employer, school, medical professional, or 14 court. 15 (3) The following information received and reco rds kept pursuant Sections 1 to 30 of 16 this Act and any administrative regulations promulgated thereunder shall be 17 confidential and exempt from the Open Records Act, KRS 61.870 to 61.884, and 18 shall not be subject to disclosure to any individual or public or private entity, 19 except as necessary for authorized employees of the department to perform 20 official duties pursuant to Sections 1 to 30 of this Act: 21 (a) Applications and renewals, their contents, and supporting information 22 submitted by qualified patients, visiting qualified patients, and designated 23 caregivers in compliance with Section 11 of this Act, including information 24 regarding their designated caregivers and medicinal cannabis practitioners; 25 (b) The individual names and other information identifying p ersons to whom 26 the department has issued registry identification cards; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 73 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (c) Any dispensing information required to be kept under Section 22 of this Act 1 or the department's administrative regulations which shall only identify 2 cardholders by their registry i dentification numbers and shall not contain 3 names or other personal identifying information; and 4 (d) Any department hard drives or other data -recording media that are no 5 longer in use and that contain cardholder information. These hard drives 6 and other med ia shall be destroyed after a reasonable time or after the data 7 is otherwise stored. 8 Data subject to this section shall not be combined or linked in any manner with 9 any other list or database maintained by the department or the Cabinet for Health 10 and Fami ly Services and shall not be used for any purpose not provided for in 11 Sections 1 to 30 of this Act. 12 (4) Nothing in this section shall preclude: 13 (a) Notification by the department's employees to state or local law enforcement 14 about suspected falsified or fr audulent information submitted to the 15 department or of other apparently criminal violations of Sections 1 to 30 of 16 this Act; 17 (b) Notification by the department's employees to a state licensing board if the 18 department has reasonable suspicion to believe a m edicinal cannabis 19 practitioner did not have a bona fide practitioner -patient relationship with a 20 patient for whom he or she signed a written certification, that the medicinal 21 cannabis practitioner violated the standard of care, or that the medicinal 22 cannab is practitioner has violated any provision of Sections 1 to 30 of this 23 Act; 24 (c) Notification by dispensary agents to the department of a suspected violation 25 or attempted violation of Sections 1 to 30 of this Act or the administrative 26 regulations promulgate d thereunder; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 74 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (d) Verification by the department of registry identification cards issued 1 pursuant to Sections 11, 12, and 13 of this Act; and 2 (e) The submission of the report required by Section 3 of this Act to the 3 General Assembly. 4 (5) It shall be a Clas s B misdemeanor for any person, including an employee or 5 official of the department or another state agency or local government, to 6 knowingly breach the confidentiality of information obtained pursuant to 7 Sections 1 to 30 of this Act. 8 SECTION 28. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 9 TO READ AS FOLLOWS: 10 (1) No later than January 1, 2023, the department shall: 11 (a) Ensure that the electronic monitoring system established pursuant to 12 Section 41 of this Act is designed to enable: 13 1. Medicinal cannabis practitioners to record the issuance of written 14 certifications to qualified patients, as required by Section 9 of this Act; 15 2. Pharmacists to perform and record the completion of consultations 16 with cardholders as required under Section 10 of this Act; 17 3. The department and state licensing boards to monitor the issuance of 18 written certifications by medicinal cannabis practi tioners; 19 4. Department personnel, law enforcement personnel, and dispensary 20 agents to verify the validity of registry identification cards issued by 21 the department by entering a registry identification number to 22 determine whether or not the identification number corresponds with 23 a current, valid registry identification card. The system shall only 24 disclose whether the identification card is valid and whether the 25 cardholder is a registered qualified patient, visiting qualified patient, 26 or designated caregiver ; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 75 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 5. Law enforcement personnel and dispensary agents to access medicinal 1 cannabis sales data record by dispensary agents pursuant to Section 2 22 of this Act; 3 6. Dispensary agents to record the amount of medicinal cannabis that is 4 dispensed to a cardholder d uring each transaction as required by 5 Section 22 of this Act; and 6 7. The sharing of dispensing data recorded by dispensary agents 7 pursuant to Section 22 of this Act with all dispensaries in real time; 8 (b) Ensure that the electronic monitoring system establ ished pursuant to 9 Section 41 of this Act is designed to facilitate the tracking of medicinal 10 cannabis from the point of cultivation to the point of sale to cardholders; 11 (c) Promulgate administrative regulations, in accordance with KRS Chapter 12 13A, to estab lish: 13 1. A list of qualifying medical conditions for which medicinal cannabis 14 practitioners may provide a patient with a written certification for the 15 use of medicinal cannabis. The list shall, at a minimum, include the 16 following: 17 a. Any type or form of ca ncer regardless of stage; 18 b. Chronic, severe, intractable, or debilitating pain; 19 c. Epilepsy or any other intractable seizure disorder; 20 d. Multiple sclerosis, muscle spasms, or spasticity; and 21 e. Nausea or vomiting; 22 2. Procedures for the issuance, renewal, suspension, and revocation of 23 registry identification cards, including the creation of a uniform 24 written certification form and a uniform application form; 25 3. Procedures for the issuance, renewal, suspension, and revocation of 26 cannabis business licenses, including the creation of a uniform 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 76 of 141 HB013630.100 - 50 - XXXX House Committee Substitute licensure application form; 1 4. A convenience fee to be assessed and collected by dispensaries for 2 visiting qualified patients who do not possess a valid registry 3 identification card issued by the department and who purch ase 4 medicinal cannabis with a valid out -of-state registry identification 5 card. The convenience fee established pursuant to this subparagraph 6 shall not exceed fifteen dollars ($15) per transaction; 7 5. In collaboration with the Board of Physicians and Adviso rs, as 8 required by Section 3 of this Act: 9 a. A definition of the amount of medicinal cannabis or delta -9 10 tetrahydrocannabinol that constitutes a ten (10) day maximum 11 allowance and a thirty (30) day maximum allowance of 12 medicinal cannabis for registered qua lified patients who are over 13 eighteen (18) years of age; 14 b. A definition of the amount of medicinal cannabis or delta -9 15 tetrahydrocannabinol that constitutes a ten (10) day maximum 16 allowance and a thirty (30) day maximum allowance of 17 medicinal cannabis for registered qualified patients who are 18 under eighteen (18) years of age; and 19 c. The amount of raw plant material that medicinal cannabis 20 products are considered to be equivalent to; 21 6. Provisions governing the following matters related to cannabis 22 business es with the goal of protecting against diversion and theft, 23 without imposing any undue burden that would make cannabis 24 business operations unreasonable or impractical or compromising the 25 confidentiality of cardholders: 26 a. Recordkeeping and inventory contro l requirements that facilitate 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 77 of 141 HB013630.100 - 50 - XXXX House Committee Substitute the tracking of medicinal cannabis from the point of cultivation 1 to the point of sale to cardholders, including the use of the 2 electronic monitoring system established pursuant to Section 41 3 of this Act; 4 b. Procedures for the verification and validation of registry 5 identification cards issued by the department and out -of-state 6 registry identification cards; 7 c. Security requirements fo r safety compliance facilities, 8 processors, producers, dispensaries, and cultivators, which shall 9 include at a minimum lighting, video security, alarm 10 requirements, on -site parking, and measures to prevent loitering; 11 d. Procedures for the secure transporta tion, including delivery 12 services provided by dispensaries, and storage of medicinal 13 cannabis by cannabis business licensees and their employees or 14 agents; 15 e. Employment and training requirements for licensees and their 16 agents, including requiring each lic ensee to create an 17 identification badge for each of the licensee's agents or 18 employees; and 19 f. Restrictions on visits to licensed cultivation and processing 20 facilities, including requiring the use of visitor logs; 21 7. Procedures to establish, publish, and a nnually update a list of varieties 22 of cannabis that consist of less than five percent (5%) 23 tetrahydrocannabinol; 24 8. A rating system that tracks the terpene content of at least the twelve 25 (12) major terpenoids within each strain of cannabis available for 26 medicinal use within the Commonwealth; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 78 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 9. Requirements for random sample testing of medicinal cannabis to 1 ensure quality control, including testing for cannabinoids, terpenoids, 2 residual solvents, pesticides, poisons, toxins, mold, mildew, insects, 3 bacteria, and any other dangerous adulterant; 4 10. Requirements for licensed cultivators, producers, and processors to 5 contract with an independent safety compliance facility to test the 6 medicinal cannabis before it is sold at a dispensary. The department 7 may approv e the safety compliance facility chosen by a cultivator, 8 producer, or processor and require that the safety compliance facility 9 report test results for a designated quantity of medicinal cannabis to 10 the cultivator, producer, or processor and department; 11 11. Standards for the operation of safety compliance facilities which may 12 include: 13 a. Requirements for equipment; 14 b. Personnel qualifications; and 15 c. Requiring facilities to be accredited by a relevant certifying 16 entity; 17 12. Standards for the packaging and l abeling of medicinal cannabis sold 18 or distributed by cannabis businesses which shall comply with 15 19 U.S.C. sec. 1471 to 1476 and shall include: 20 a. Packaging that requires at least a two (2) step process of initial 21 opening; 22 b. A warning label which may incl ude the length of time it typically 23 takes for the product to take effect, how long the effects of the 24 product typically last, and any other information deemed 25 appropriate or necessary by the department; 26 c. The amount of medicinal cannabis the product is co nsidered the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 79 of 141 HB013630.100 - 50 - XXXX House Committee Substitute equivalent to; 1 d. Disclosing ingredients, possible allergens, and certain bioactive 2 components, including cannabinoids and terpenoids, as 3 determined by the department; 4 e. A nutritional fact panel; 5 f. Opaque, child -resistant packaging; 6 g. A req uirement that all raw plant material packaged or sold in 7 this state be marked or labeled as \"NOT INTENDED FOR 8 CONSUMPTION BY SMOKING\"; 9 h. A requirement that medicinal cannabis products be clearly 10 marked with an identifiable and standardized symbol indicati ng 11 that the product contains cannabis; 12 i. A requirement that all medicinal cannabis product packaging 13 include an expiration date; and 14 j. A requirement that medicinal cannabis products and their 15 packaging not be visually reminiscent of major brands of edib le 16 noncannabis products or otherwise present an attractive 17 nuisance to minors; 18 13. Health and safety requirements for the processing of medicinal 19 cannabis and the indoor cultivation of medicinal cannabis by 20 licensees; 21 14. Restrictions on: 22 a. Additives to m edicinal cannabis that are toxic, including vitamin 23 E acetate, or increase the likelihood of addiction; and 24 b. Pesticides, fertilizers, and herbicides used during medicinal 25 cannabis cultivation which pose a threat to human health and 26 safety; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 80 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 15. Standards for the safe processing of medicinal cannabis products 1 created by extracting or concentrating compounds from raw plant 2 material; 3 16. Standards for determining the amount of unprocessed raw plant 4 material that medicinal cannabis products are considered the 5 equivalent to; 6 17. Restrictions on advertising, marketing, and signage in regard to 7 operations or establishments owned by licensees n ecessary to prevent 8 the targeting of minors; 9 18. The requirement that evidence -based educational materials regarding 10 dosage and impairment be disseminated to cardholders who purchase 11 medicinal cannabis products; 12 19. Policies governing insurance requirement s for cultivators, 13 dispensaries, processors, producers, and safety compliance facilities; 14 20. The process by which the Board of Physicians and Advisors will 15 recommend to the department the inclusion of additional diseases and 16 medical conditions on the appr oved list of qualifying medical 17 conditions for which a medicinal cannabis practitioner may provide a 18 patient with a written certification for the use of medicinal cannabis, 19 including the process by which an individual may petition the board to 20 recommend th e inclusion of a disease or medical condition; and 21 21. A form to be signed by visiting qualified patients who use a valid out - 22 of-state registry identification card to purchase medicinal cannabis in 23 this state that indicates that the visiting qualified pati ent has been 24 diagnosed with a disease or medical condition that is included on the 25 list of qualifying medical conditions established by the department; 26 and 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 81 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 22. Standards, procedures, or restrictions that the department deems 1 necessary to ensure the efficie nt, transparent, and safe operation of 2 the medicinal cannabis program, including procedures for the 3 submission of complaints from individual citizens of the 4 Commonwealth regarding potential or suspected violations of Sections 5 1 to 30 of this Act or any adm inistrative regulation promulgated 6 thereunder by a licensed cannabis business. 7 (2) When promulgating administrative regulations under Sections 1 to 30 of this Act, 8 the department: 9 (a) Shall consider standards, procedures, and restrictions that have been fo und 10 to be best practices relative to the use and regulation of medicinal cannabis; 11 and 12 (b) Shall not promulgate any administrative regulation that would impose an 13 undue burden or make cannabis business operations unreasonable or 14 impractical. 15 (3) No later t han July 1, 2023, the department shall: 16 (a) In collaboration with the Board of Physicians and Advisors established in 17 Section 3 of this Act, develop medicinal cannabis dosing guidelines to be 18 used by medicinal cannabis practitioners when providing patients with 19 medicinal cannabis dosing recommendations. Guidelines developed 20 pursuant to this paragraph shall be: 21 1. Regularly updated as additional scientific information on the use of 22 medicinal cannabis become available; 23 2. Made publicly available on the depart ment's Web site; and 24 3. Distributed to all medicinal cannabis practitioners who are authorized 25 to provide written certifications for the use of medicinal cannabis; and 26 (b) Develop and implement a biennial accreditation process, including minimal 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 82 of 141 HB013630.100 - 50 - XXXX House Committee Substitute performanc e standards, based on evolving continuous quality improvement 1 metrics to ensure best -practice standards. Pursuant to Section 16 of this 2 Act, the renewal of cannabis business licenses shall be contingent upon 3 successfully achievement of minimal performance standards established by 4 the department. 5 (4) If a need for additional cannabis cultivation in this state is demonstrated by 6 cannabis businesses or the department's own analysis, the department may, 7 through the promulgation of administrative regulations, in crease the cultivation 8 area square footage limits for either cultivators or producers, or both by up to 9 three (3) times the limits established in Sections 21 and 24 of this Act. Any 10 increase in the cultivation square footage limits adopted by the departmen t 11 pursuant to this section shall not result in an increase in the licensure application 12 or renewal fees established in Section 16 of this Act. 13 (5) The department shall not restrict or limit methods of delivery, use, or 14 consumption of medicinal cannabis or the types of products that may be 15 acquired, produced, processed, possessed, sold, or distributed by a cannabis 16 business except as provided in: 17 (a) Subsection (1)(g) of Section 6 of this Act; 18 (b) Subsection (2)(b) of Section 19 of this Act; 19 (c) Subsection (2)(e) of Section 22 of this Act; 20 (d) Subsection (2) of Section 23 of this Act; 21 (e) Subsection (3) of Section 24 of this Act; and 22 (f) Subsection (1)(c)9., 12.,14., and 15. of this section. 23 SECTION 29. A NEW SECTION OF KR S CHAPTER 218A IS CREATED 24 TO READ AS FOLLOWS: 25 Nothing in Sections 1 to 30 of this Act shall require a government medical assistance 26 program, private health insurer or workers' compensation carrier, or self -funded 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 83 of 141 HB013630.100 - 50 - XXXX House Committee Substitute employer providing workers' compensation be nefits to reimburse a person for costs 1 associated with the use of medicinal cannabis. 2 SECTION 30. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 3 TO READ AS FOLLOWS: 4 The provisions of KRS 138.870 to 138.889 shall not apply to any individual or entity 5 for: 6 (1) Any amount of medicinal cannabis that is necessary or reasonably necessary for 7 use of a license or registry identification card issued pursuant to Sections 1 to 3 0 8 of this Act; or 9 (2) Any use of medicinal cannabis that complies with Sections 1 to 30 of this Act and 10 any administrative regulations promulgated thereunder. 11 SECTION 31. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 12 TO R EAD AS FOLLOWS: 13 (1) The medicinal cannabis trust fund is hereby created within the State Treasury. 14 The fund shall consist of funds collected from registration fees, licensing fees, 15 fines, and penalties established pursuant to Sections 1 to 30 of this Act, excluding 16 Section 27 of this Act, and any administrative regulations promulgated 17 thereunder, a portion of the excise taxes imposed under Section 33 of this Act, 18 and any proceeds from grants, contributions, appropriations, or other moneys 19 made available for purposes of this fund. 20 (2) The medicinal cannabis trust fund shall be administered by the Finance and 21 Administration Cabinet. 22 (3) The Finance and Administration Cabinet shall, no later than the fifteenth 23 calendar day of each calendar quarter, distribute t he funds deposited into the 24 medicinal cannabis trust fund during the immediately preceding calendar 25 quarter. Trust fund moneys shall be distributed as follows: 26 (a) Sixty percent (60%) shall be transferred to the Department for Public 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 84 of 141 HB013630.100 - 50 - XXXX House Committee Substitute Health to offset the d epartment's actual cost and expenses for operating the 1 medicinal cannabis program and enforcement activities established in 2 Sections 1 to 30 of this Act; 3 (b) Two and one -half percent (2.5%) shall be transferred to the Department 4 For Public Health for the p urpose of developing, implementing, and 5 administering a grant program to further education and scientific and 6 clinical research on the use of medicinal cannabis; 7 (c) Thirteen and three -quarters percent (13.75%) shall be transferred to the 8 Office of Drug Co ntrol Policy, as established in KRS 15A.020, for the 9 purpose of developing, implementing, and administering a grant program 10 for city and county law enforcement agencies to enforce medicinal cannabis 11 laws, hire and train additional drug recognition experts (DRE), and provide 12 advanced roadside impaired driving enforcement (ARIDE) training; 13 (d) Thirteen and three -quarters percent (13.75%) shall be returned equally to 14 dispensaries for the use of indigent persons who are registered qualified 15 patients enrolled in Medicaid, receiving Supplemental Security Income or 16 Social Security disability insurance, or veterans of the United States Armed 17 Forces; and 18 (e) The remaining ten percent (10%) shall be retained by the Finance and 19 Administration Cabinet in the fund to cov er any additional administrative 20 costs that the Department for Public Health may incur related to its 21 operational and enforcement responsibilities as established in Sections 1 to 22 30 of this Act. If the department is able to demonstrate to the Finance and 23 Administration Cabinet a need for any portion of the retained funds, the 24 Finance and Administration Cabinet shall distribute the additional funds 25 for which the department has demonstrated need no later than the fifteenth 26 calendar day of the next calendar qu arter. If the department cannot 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 85 of 141 HB013630.100 - 50 - XXXX House Committee Substitute demonstrate a need for the additional funding described in this paragraph, 1 the retained funds shall be equally divided between the grant programs and 2 the indigent patient program described in paragraphs (b), (c), and (d) of this 3 subsection at the close of each fiscal year. 4 (4) Notwithstanding KRS 45.229, moneys in the fund not expended at the close of the 5 fiscal year shall not lapse but shall be equally divided between the grant 6 programs and the indigent patient program descr ibed in subsection (3)(b), (c), 7 and (d) of this section. 8 (5) Any interest earnings of the trust fund shall become part of the fund and shall 9 not lapse. 10 (6) Moneys transferred to the fund are hereby appropriated for the purposes set forth 11 in this section. 12 SECTION 32. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 13 TO READ AS FOLLOWS: 14 (1) The local medicinal cannabis trust fund is hereby created within the State 15 Treasury. The fund shall consist of funds collected from a portio n of the excise 16 taxes imposed under Section 33 of this Act. 17 (2) The local medicinal cannabis trust fund shall be administered by the Finance 18 and Administration Cabinet. 19 (3) The Finance and Administration Cabinet shall, no later than the fifteenth 20 calendar day of each calendar quarter, distribute the funds deposited into the 21 local medicinal cannabis trust fund during the calendar quarter immediately 22 preceding the most recent calendar quarter. Funds shall be distributed among 23 those cities and counties in whic h at least one (1) cannabis business licensed as a 24 cultivator, dispensary, processor, or producer operated during the calendar 25 quarter immediately preceding the most recent calendar quarter as follows: 26 (a) The funds deposited into the local medicinal canna bis trust fund during the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 86 of 141 HB013630.100 - 50 - XXXX House Committee Substitute calendar quarter immediately preceding the most recent calendar quarter 1 shall be divided into two (2) equal parts; 2 (b) One-half (1/2) of the funds deposited into the local medicinal cannabis trust 3 fund during the calendar quarter immediately preceding the most recent 4 calendar quarter shall be distributed to cities and counties in which at least 5 one (1) cannabis business licensed as a cultivator, processor, or producer 6 operated during the calendar quarter immediately preceding the m ost recent 7 calendar quarter as follows: 8 1. a. A city in which at least one (1) cannabis business licensed as a 9 cultivator, processor, or producer operated during the calendar 10 quarter immediately preceding the most recent calendar quarter 11 shall receive an a mount equal to seven and one -half percent 12 (7.5%) of the total excise tax revenue collected from all cannabis 13 businesses licensed to operate inside the territory of the city 14 during the calendar quarter immediately preceding the most 15 recent calendar quarter; or 16 b. If the county in which the city is located has prohibited the 17 operation of cannabis businesses, then the city shall receive an 18 amount equal to ten percent (10%) of the total excise tax revenue 19 collected from all cannabis businesses licensed to oper ate inside 20 the territory of the city during the calendar quarter immediately 21 preceding the most recent calendar quarter; and 22 2. A county that has not prohibited the operation of cannabis businesses, 23 pursuant to Section 26 of this Act, and in which at least one (1) 24 cannabis business licensed as a cultivator, processor, or producer 25 operated during the calendar quarter immediately preceding the most 26 recent calendar quarter shall receive an amount equal to: 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 87 of 141 HB013630.100 - 50 - XXXX House Committee Substitute a. Ten percent (10%) of the total excise tax revenue collected from 1 all cannabis businesses licensed to operate within the territory of 2 the county, but outside the territory of any city in that county, 3 during the calendar quarter immediately preceding the mos t 4 recent calendar quarter; and 5 b. Two and one -half percent (2.5%) of the total excise tax revenue 6 collected from all cannabis businesses licensed to operate inside 7 the territory of an incorporated municipality inside the territory 8 of the county during the calendar quarter immediately preceding 9 the most recent calendar quarter; and 10 (c) The other one -half (1/2) of the funds deposited into the local medicinal 11 cannabis trust fund during the calendar quarter immediately preceding the 12 most recent calendar quarter shall be distributed to cities and counties in 13 which at least one (1) cannabis business licensed as a dispensary was 14 operated during the calendar quarter immediately preceding the most recent 15 calendar quarter as follows: 16 1. a. A city in which at least one (1) cannabis business licensed as a 17 dispensary operated during the calendar quarter immediately 18 preceding the most recent calendar quarter shall receive a 19 percentage of the funds described in this subparagraph equal to 20 seventy -five percent (75%) of the ci ty's proportionate share of 21 gross receipts derived from the retail sales of medicinal cannabis 22 products by licensed dispensaries in the territory of that city 23 divided by the total statewide retail sales of medicinal cannabis 24 products by all licensed dispen saries in the state during the 25 calendar quarter immediately preceding the most recent 26 calendar quarter; or 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 88 of 141 HB013630.100 - 50 - XXXX House Committee Substitute b. If the county in which the city is located has prohibited the 1 operation of cannabis businesses, then the city shall receive a 2 percentage of the fu nds described in this subparagraph equal to 3 one hundred percent (100%) of the city's proportionate share of 4 gross receipts derived from the retail sales of medicinal cannabis 5 products by licensed dispensaries in the territory of that city 6 divided by the to tal statewide retail sales of medicinal cannabis 7 products by all licensed dispensaries in the state during the 8 calendar quarter immediately preceding the most recent 9 calendar quarter; and 10 2. A county that has not prohibited the operation of cannabis busine sses, 11 pursuant to Section 26 of this Act, and in which at least one (1) 12 cannabis business licensed as a dispensary operated during the 13 calendar quarter immediately preceding the most recent calendar 14 quarter shall receive a percentage of the funds described in this 15 subparagraph equal to: 16 a. One hundred percent (100%) of the county's proportionate share 17 of gross receipts derived from the retail sales of medicinal 18 cannabis products by licensed dispensaries within the territory of 19 that county, but outside the t erritory of any city in that county, 20 divided by the total statewide retail sales of medicinal cannabis 21 products by all licensed dispensaries in the state during the 22 calendar quarter immediately preceding the most recent 23 calendar quarter; and 24 b. A percentag e of the funds described in this subparagraph equal 25 to twenty -five percent (25%) of the proportionate share of gross 26 receipts derived from the retail sales of medicinal cannabis 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 89 of 141 HB013630.100 - 50 - XXXX House Committee Substitute products by licensed dispensaries within the territory of all cities 1 in the co unty divided by the total statewide retail sales of 2 medicinal cannabis products by all licensed dispensaries in the 3 state during the calendar quarter immediately preceding the 4 most recent calendar quarter. 5 (4) Trust fund moneys may be used for the purposes of local enforcement of 6 medicinal cannabis laws by local law enforcement agencies, local medicinal 7 cannabis licensing, the hiring or training of additional drug recognition experts 8 (DRE), advanced roadside impaired driving enforcement (ARIDE) training, lo cal 9 evidence -based drug addiction rehabilitation projects, or educational activities 10 within local jails. 11 (5) Notwithstanding KRS 45.229, moneys in the fund not expended at the close of the 12 fiscal year shall not lapse but shall be carried forward to the nex t fiscal year. 13 (6) Any interest earnings of the trust fund shall become part of the fund and shall 14 not lapse. 15 (7) Moneys transferred to the fund are hereby appropriated for the purposes set forth 16 in this section. 17 (8) As used in this section, \"county\" has t he same meaning as in KRS 65A.010. 18 SECTION 33. A NEW SECTION OF KRS CHAPTER 138 IS CREATED TO 19 READ AS FOLLOWS: 20 (1) As used in this section: 21 (a) \"Cultivator\" has the same meaning as in Section 1 of this Act; 22 (b) \"Departme nt\" means the Department of Revenue; 23 (c) \"Dispensary\" has the same meaning as in Section 1 of this Act; 24 (d) \"Medicinal cannabis\" has the same meaning as in Section 1 of this Act; 25 (e) \"Processor\" has the same meaning as in Section 1 of this Act; and 26 (f) \"Producer\" has the same meaning as in Section 1 of this Act. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 90 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (2) Effective January 1, 2023: 1 (a) An excise tax is hereby imposed on the gross receipts of a cultivator, 2 processor, or producer received from the sale of medicinal cannabis by a 3 cultivator, process or, or producer to a dispensary, to be paid by the 4 cultivator, processor, or producer at a rate of twelve percent (12%) of the 5 actual price for which a cultivator, processor, or producer sells medicinal 6 cannabis to a dispensary in this state; and 7 (b) The t ax shall be charged against and be paid by the cultivator, processor, or 8 producer and shall not be added as a separate charge or line item on any 9 sales slip, invoice, receipt, or other statement or memorandum of the price 10 paid by the dispensary. 11 (3) (a) Eighty percent (80%) of the revenue from the excise tax established in this 12 section shall be deposited in the medicinal cannabis trust fund established 13 in Section 31 of this Act for the purpose of administration of the medicinal 14 cannabis program and for the purposes established in that section. 15 (b) Twenty percent (20%) of the revenue from the excise tax established in this 16 section shall be deposited in the local medicinal cannabis trust fund 17 established in Section 32 of this Act for the purposes of distributing tax 18 proceeds among participating local governments and for the purposes 19 established in that section. 20 (4) Cultivators, processors, and producers licensed under KRS Chapter 218A shall: 21 (a) Register with the department; 22 (b) Report and pay the tax levied under this section on or before the twentiet h 23 day of the calendar month immediately following the month in which the 24 medicinal cannabis was sold. A tax return shall be filed for each reporting 25 period whether or not tax is due; and 26 (c) Identify the county and city, if any, in which the medicinal cann abis 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 91 of 141 HB013630.100 - 50 - XXXX House Committee Substitute business is located. 1 (5) Any person who violates any provision of this section shall be subject to the 2 uniform civil penalties imposed pursuant to KRS 131.180 and interest at the tax 3 interest rate as defined in KRS 131.010 from the date due until the date of 4 payment. 5 (6) (a) Notwithstanding any other provision of this section, the president, vice 6 president, secretary, treasurer, or any other person holding any equivalent 7 corporate office of any corporation subject to this section shall be 8 personally an d individually liable, both jointly and severally, for the taxes 9 imposed under this section. 10 (b) Corporate dissolution, withdrawal of the corporation from the state, or the 11 cessation of holding any corporate office shall not discharge the liability of 12 any person. The personal and individual liability shall apply to every person 13 holding a corporate office at the time the tax becomes or became due. 14 (c) Notwithstanding any other provision of this chapter, KRS 275.150, 362.1 - 15 306(3) or predecessor law, or 362.2 -404(3) to the contrary, the managers of 16 a limited liability company, the partners of a limited liability partnership, 17 and the general partners of a limited liability limited partnership, or any 18 other person holding any equivalent office of a limited liabil ity company, 19 limited liability partnership, or limited liability limited partnership subject to 20 the provisions of this section shall be personally and individually liable, 21 both jointly and severally, for the tax imposed under this section. 22 (d) Dissolution, withdrawal of the limited liability company, limited liability 23 partnership, or limited liability limited partnership from the state, or the 24 cessation of holding any office shall not discharge the liability of any 25 person. The personal and individual liabil ity shall apply to every manager 26 of a limited liability company, partner of a limited liability partnership, or 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 92 of 141 HB013630.100 - 50 - XXXX House Committee Substitute general partner of a limited liability limited partnership at the time the tax 1 becomes or became due. 2 (e) No person shall be personally and indi vidually liable under this section who 3 had no authority to truthfully account for, or pay over, any tax imposed by 4 this section at the time the tax imposed becomes or became due. 5 (f) \"Taxes\" as used in this section includes interest accrued at the rate 6 provided by KRS 131.183, all applicable penalties imposed under the 7 provisions of this chapter, and all applicable penalties imposed under KRS 8 131.180, 131.410 to 131.445, and 131.990. 9 (7) The department shall administer the provisions of this section and sha ll have all 10 of the powers, rights, duties, and authority with respect to the assessment, 11 collection, refunding, and administration of the taxes levied by this section, 12 conferred generally upon the department by the Kentucky Revised Statutes, 13 including KRS Chapters 131, 134, and 135. 14 (8) Every cultivator, processor, and producer shall keep records, receipts, invoices, 15 and other pertinent papers in such form as the department may require for not 16 less than four (4) years from the making of such records, receip ts, invoices, and 17 other pertinent papers. 18 Section 34. KRS 139.470 is amended to read as follows: 19 There are excluded from the computation of the amount of taxes imposed by this chapter: 20 (1) Gross receipts from the sale of , and the storage, use, or other consumption in this 21 state of, tangible personal property or digital property which this state is prohibited 22 from taxing under the Constitution or laws of the United States, or under the 23 Constitution of this state; 24 (2) Gross receipts from sales of, and the storage, use, or other consumption in this state 25 of: 26 (a) Nonreturnable and returnable containers when sold without the contents to 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 93 of 141 HB013630.100 - 50 - XXXX House Committee Substitute persons who place the contents in the container and sell the contents together 1 with the cont ainer; and 2 (b) Returnable containers when sold with the contents in connection with a retail 3 sale of the contents or when resold for refilling; 4 As used in this section the term \"returnable containers\" means containers of a kind 5 customarily returned by the buyer of the contents for reuse. All other containers are 6 \"nonreturnable containers\"; 7 (3) Gross receipts from occasional sales of tangible personal property or digital 8 property and the storage, use, or other consumption in this state of tangible personal 9 property or digital property, the transfer of which to the purchaser is an occasional 10 sale; 11 (4) Gross receipts from sales of tangible personal property to a common carrier, 12 shipped by the retailer via the purchasing carrier under a bill of lading, whether the 13 freight is paid in advance or the shipment is made freight charges collect, to a point 14 outside this state and the property is actually transported to the out -of-state 15 destination for use by the carrier in the conduct of its business as a common carrier ; 16 (5) Gross receipts from sales of tangible personal property sold through coin -operated 17 bulk vending machines, if the sale amounts to fifty cents ($0.50) or less, if the 18 retailer is primarily engaged in making the sales and maintains records satisfactory 19 to the department. As used in this subsection, \"bulk vending machine\" means a 20 vending machine containing unsorted merchandise which, upon insertion of a coin, 21 dispenses the same in approximately equal portions, at random and without 22 selection by the custom er; 23 (6) Gross receipts from sales to any cabinet, department, bureau, commission, board, or 24 other statutory or constitutional agency of the state and gross receipts from sales to 25 counties, cities, or special districts as defined in KRS 65.005. This exempti on shall 26 apply only to purchases of tangible personal property, digital property, or services 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 94 of 141 HB013630.100 - 50 - XXXX House Committee Substitute for use solely in the government function. A purchaser not qualifying as a 1 governmental agency or unit shall not be entitled to the exemption even though the 2 purchaser may be the recipient of public funds or grants; 3 (7) (a) Gross receipts from the sale of sewer services, water, and fuel to Kentucky 4 residents for use in heating, water heating, cooking, lighting, and other 5 residential uses. As used in this subsection , \"fuel\" shall include but not be 6 limited to natural gas, electricity, fuel oil, bottled gas, coal, coke, and wood. 7 Determinations of eligibility for the exemption shall be made by the 8 department; 9 (b) In making the determinations of eligibility, the department shall exempt from 10 taxation all gross receipts derived from sales: 11 1. Classified as \"residential\" by a utility company as defined by applicable 12 tariffs filed with and accepted by the Public Service Commission; 13 2. Classified as \"residential\" by a municipally owned electric distributor 14 which purchases its power at wholesale from the Tennessee Valley 15 Authority; 16 3. Classified as \"residential\" by the governing body of a municipally owned 17 electric distrib utor which does not purchase its power from the 18 Tennessee Valley Authority, if the \"residential\" classification is 19 reasonably consistent with the definitions of \"residential\" contained in 20 tariff filings accepted and approved by the Public Service Commissio n 21 with respect to utilities which are subject to Public Service Commission 22 regulation. 23 If the service is classified as residential, use other than for \"residential\" 24 purposes by the customer shall not negate the exemption; 25 (c) The exemption shall not apply if charges for sewer service, water, and fuel are 26 billed to an owner or operator of a multi -unit residential rental facility or 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 95 of 141 HB013630.100 - 50 - XXXX House Committee Substitute mobile home and recreational vehicle park other than residential 1 classification; and 2 (d) The exemption shall apply also to resi dential property which may be held by 3 legal or equitable title, by the entireties, jointly, in common, as a 4 condominium, or indirectly by the stock ownership or membership 5 representing the owner's or member's proprietary interest in a corporation 6 owning a fee or a leasehold initially in excess of ninety -eight (98) years; 7 (8) Gross receipts from sales to an out -of-state agency, organization, or institution 8 exempt from sales and use tax in its state of residence when that agency, 9 organization, or institution gives proof of its tax -exempt status to the retailer and the 10 retailer maintains a file of the proof; 11 (9) (a) Gross receipts derived from the sale of tangible personal property, as provided 12 in paragraph (b) of this subsection, to a manufacturer or industria l processor if 13 the property is to be directly used in the manufacturing or industrial 14 processing process of: 15 1. Tangible personal property at a plant facility; 16 2. Distilled spirits or wine at a plant facility or on the premises of a 17 distiller, rectifier, w inery, or small farm winery licensed under KRS 18 243.030 that includes a retail establishment on the premises; or 19 3. Malt beverages at a plant facility or on the premises of a brewer or 20 microbrewery licensed under KRS 243.040 that includes a retail 21 establish ment; 22 and which will be for sale. 23 (b) The following tangible personal property shall qualify for exemption under 24 this subsection: 25 1. Materials which enter into and become an ingredient or component part 26 of the manufactured product; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 96 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 2. Other tangible perso nal property which is directly used in the 1 manufacturing or industrial processing process, if the property has a 2 useful life of less than one (1) year. Specifically these items are 3 categorized as follows: 4 a. Materials. This refers to the raw materials whic h become an 5 ingredient or component part of supplies or industrial tools exempt 6 under subdivisions b. and c. below; 7 b. Supplies. This category includes supplies such as lubricating and 8 compounding oils, grease, machine waste, abrasives, chemicals, 9 solvents , fluxes, anodes, filtering materials, fire brick, catalysts, 10 dyes, refrigerants, and explosives. The supplies indicated above 11 need not come in direct contact with a manufactured product to be 12 exempt. \"Supplies\" does not include repair, replacement, or spa re 13 parts of any kind; and 14 c. Industrial tools. This group is limited to hand tools such as jigs, 15 dies, drills, cutters, rolls, reamers, chucks, saws, and spray guns 16 and to tools attached to a machine such as molds, grinding balls, 17 grinding wheels, dies, bi ts, and cutting blades. Normally, for 18 industrial tools to be considered directly used in the manufacturing 19 or industrial processing process, they shall come into direct contact 20 with the product being manufactured or processed; and 21 3. Materials and supplies that are not reusable in the same manufacturing 22 or industrial processing process at the completion of a single 23 manufacturing or processing cycle. A single manufacturing cycle shall 24 be considered to be the period elapsing from the time the raw materials 25 enter into the manufacturing process until the finished product emerges 26 at the end of the manufacturing process. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 97 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (c) The property described in paragraph (b) of this subsection shall be regarded as 1 having been purchased for resale. 2 (d) For purposes of this su bsection, a manufacturer or industrial processor 3 includes an individual or business entity that performs only part of the 4 manufacturing or industrial processing activity, and the person or business 5 entity need not take title to tangible personal property t hat is incorporated into, 6 or becomes the product of, the activity. 7 (e) The exemption provided in this subsection does not include repair, 8 replacement, or spare parts; 9 (10) Any water use fee paid or passed through to the Kentucky River Authority by 10 faciliti es using water from the Kentucky River basin to the Kentucky River 11 Authority in accordance with KRS 151.700 to 151.730 and administrative 12 regulations promulgated by the authority; 13 (11) Gross receipts from the sale of newspaper inserts or catalogs purchased for storage, 14 use, or other consumption outside this state and delivered by the retailer's own 15 vehicle to a location outside this state, or delivered to the United States Postal 16 Service, a common carrier, or a contract carrier for delivery outside this sta te, 17 regardless of whether the carrier is selected by the purchaser or retailer or an agent 18 or representative of the purchaser or retailer, or whether the F.O.B. is retailer's 19 shipping point or purchaser's destination. 20 (a) As used in this subsection: 21 1. \"Catalogs\" means tangible personal property that is printed to the special 22 order of the purchaser and composed substantially of information 23 regarding goods and services offered for sale; and 24 2. \"Newspaper inserts\" means printed materials that are placed in or 25 distributed with a newspaper of general circulation. 26 (b) The retailer shall be responsible for establishing that delivery was made to a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 98 of 141 HB013630.100 - 50 - XXXX House Committee Substitute non-Kentucky location through shipping documents or other credible evidence 1 as determined by the department; 2 (12) Gross receipts from the sale of water used in the raising of equine as a business; 3 (13) Gross receipts from the sale of metal retail fixtures manufactured in this state and 4 purchased for storage, use, or other consumption outside this state and delivered by 5 the retailer's own vehicle to a location outside this state, or delivered to the United 6 States Postal Service, a common carrier, or a contract carrier for delivery outside 7 this state, regardless of whether the carrier is selected by the purchaser or retail er or 8 an agent or representative of the purchaser or retailer, or whether the F.O.B. is the 9 retailer's shipping point or the purchaser's destination. 10 (a) As used in this subsection, \"metal retail fixtures\" means check stands and 11 belted and nonbelted checko ut counters, whether made in bulk or pursuant to 12 specific purchaser specifications, that are to be used directly by the purchaser 13 or to be distributed by the purchaser. 14 (b) The retailer shall be responsible for establishing that delivery was made to a 15 non-Kentucky location through shipping documents or other credible evidence 16 as determined by the department; 17 (14) Gross receipts from the sale of unenriched or enriched uranium purchased for 18 ultimate storage, use, or other consumption outside this state and de livered to a 19 common carrier in this state for delivery outside this state, regardless of whether the 20 carrier is selected by the purchaser or retailer, or is an agent or representative of the 21 purchaser or retailer, or whether the F.O.B. is the retailer's sh ipping point or 22 purchaser's destination; 23 (15) Amounts received from a tobacco buydown. As used in this subsection, \"buydown\" 24 means an agreement whereby an amount, whether paid in money, credit, or 25 otherwise, is received by a retailer from a manufacturer or wholesaler based upon 26 the quantity and unit price of tobacco products sold at retail that requires the retailer 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 99 of 141 HB013630.100 - 50 - XXXX House Committee Substitute to reduce the selling price of the product to the purchaser without the use of a 1 manufacturer's or wholesaler's coupon or redemption certificat e; 2 (16) Gross receipts from the sale of tangible personal property or digital property 3 returned by a purchaser when the full sales price is refunded either in cash or credit. 4 This exclusion shall not apply if the purchaser, in order to obtain the refund, i s 5 required to purchase other tangible personal property or digital property at a price 6 greater than the amount charged for the property that is returned; 7 (17) Gross receipts from the sales of gasoline and special fuels subject to tax under KRS 8 Chapter 138; 9 (18) The amount of any tax imposed by the United States upon or with respect to retail 10 sales, whether imposed on the retailer or the consumer, not including any 11 manufacturer's excise or import duty; 12 (19) Gross receipts from the sale of any motor vehicle a s defined in KRS 138.450 which 13 is: 14 (a) Sold to a Kentucky resident, registered for use on the public highways, and 15 upon which any applicable tax levied by KRS 138.460 has been paid; or 16 (b) Sold to a nonresident of Kentucky if the nonresident registers the motor 17 vehicle in a state that: 18 1. Allows residents of Kentucky to purchase motor vehicles without 19 payment of that state's sales tax at the time of sale; or 20 2. Allows residents of Kentucky to remove the vehicle from that state 21 within a specific period for s ubsequent registration and use in Kentucky 22 without payment of that state's sales tax; 23 (20) Gross receipts from the sale of a semi -trailer as defined in KRS 189.010(12) and 24 trailer as defined in KRS 189.010(17); 25 (21) Gross receipts from the collection of: 26 (a) Any fee or charge levied by a local government pursuant to KRS 65.760; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 100 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (b) The charge imposed by KRS 65.7629(3); 1 (c) The fee imposed by KRS 65.7634; and 2 (d) The service charge imposed by KRS 65.7636; 3 (22) Gross receipts derived from charges for labor or services to apply, install, repair, or 4 maintain tangible personal property directly used in manufacturing or industrial 5 processing process of: 6 (a) Tangible personal property at a plant facility; 7 (b) Distilled spirits or wine at a plant facility or on the premises of a distiller, 8 rectifier, winery, or small farm winery licensed under KRS 243.030; or 9 (c) Malt beverages at a plant facility or on the premises of a brewer or 10 microbrewery licensed under KRS 243.040 11 that is not otherwise exempt under subsection (9) of this section or KRS 12 139.480(10), if the charges for labor or services are separately stated on the invoice, 13 bill of sale, or similar document given to purchaser; 14 (23) (a) For persons selling services inc luded in KRS 139.200(2)(g) to (q) prior to 15 January 1, 2019, gross receipts derived from the sale of those services if the 16 gross receipts were less than six thousand dollars ($6,000) during calendar 17 year 2018. When gross receipts from these services exceed six thousand 18 dollars ($6,000) in a calendar year: 19 1. All gross receipts over six thousand dollars ($6,000) are taxable in that 20 calendar year; and 21 2. All gross receipts are subject to tax in subsequent calendar years. 22 (b) The exemption provided in this subs ection shall not apply to a person also 23 engaged in the business of selling tangible personal property, digital property, 24 or services included in KRS 139.200(2)(a) to (f); [ and] 25 (24) (a) For persons that first begin making sales of services included in KRS 26 139.200(2)(g) to (q) on or after January 1, 2019, gross receipts derived from 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 101 of 141 HB013630.100 - 50 - XXXX House Committee Substitute the sale of those services if the gross receipts are less than six thousand dollars 1 ($6,000) within the first calendar year of operation. When gross receipts from 2 these services exceed six thousand dollars ($6,000) in a calendar year: 3 1. All gross receipts over six thousand dollars ($6,000) are taxable in that 4 calendar year; and 5 2. All gross receipts are subject to tax in subsequent calendar years. 6 (b) The exemption provided in th is subsection shall not apply to a person that is 7 also engaged in the business of selling tangible personal property, digital 8 property, or services included in KRS 139.200(2)(a) to (f) ; and 9 (25) Gross receipts from the sale of medicinal cannabis as defined in Section 1 of this 10 Act and subject to tax under Section 33 of this Act . 11 Section 35. KRS 138.870 is amended to read as follows: 12 As used in KRS 138.870 to 138.889, unless the context requires otherwise: 13 (1) \"Marijuana\" means marijuana, whether real or counterfeit, as defined in KRS 14 218A.010 and does not include medicinal cannabis as defined in Section 1 of this 15 Act. 16 (2) \"Controlled substance\" means any controlled substance, whether real or counterfeit, 17 as defined in KRS 218A.010 or any regulation promulgated thereunder, except that 18 it shall not include marijuana. 19 (3) \"Offender\" means a person who engages in this state in a taxable activity as defined 20 in subsection (4) of this section. 21 (4) \"Taxable activity\" means producin g, cultivating, manufacturing, importing, 22 transporting, distributing, acquiring, purchasing, storing, selling, using, or otherwise 23 possessing, in violation of KRS Chapter 218A, more than five (5) marijuana plants 24 with foliation, 42.5 grams of marijuana whi ch has been detached from the plant on 25 which it grew, seven (7) grams of any controlled substance, or fifty (50) or more 26 dosage units of any controlled substance which is not sold by weight. The weight or 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 102 of 141 HB013630.100 - 50 - XXXX House Committee Substitute dosage units in this subsection shall include the w eight of marijuana or the weight 1 or dosage units of the controlled substance, whether pure, impure, or diluted. A 2 quantity of a controlled substance is diluted if it consists of a detectable quantity of 3 a pure controlled substance and any excipients or fil lers. 4 (5) \"Dosage unit\" means a tablet, capsule, vial, or ampule of a controlled substance or, 5 in cases of mass volume or diluted quantities, the proper dose or quantity of a 6 controlled substance to be taken all at one (1) time or in fractional amounts wit hin a 7 given period, as defined and adopted by the United States Pharmacopeia. 8 (6) \"Possessing\" includes either actual possession or constructive possession, or a 9 combination of both actual and constructive possession. Mere possession or 10 ownership of real e state or an interest therein does not establish constructive 11 possession. 12 Section 36. KRS 216B.402 is amended to read as follows: 13 (1) When a person is admitted to a hospital emergency department or hospital 14 emergency room for treatment of a drug overdose: 15 (a)[(1)] The person shall be informed of available substance use disorder 16 treatment services known to the hospital that are provided b y that hospital, 17 other local hospitals, the local community mental health center, and any other 18 local treatment programs licensed pursuant to KRS 222.231; 19 (b)[(2)] The hospital may obtain permission from the person when stabilized, or 20 the person's legal re presentative, to contact any available substance use 21 disorder treatment programs offered by that hospital, other local hospitals, the 22 local community mental health center, or any other local treatment programs 23 licensed pursuant to KRS 222.231, on behalf of the person to connect him or 24 her to treatment; and 25 (c)[(3)] The local community mental health center may provide an on -call 26 service in the hospital emergency department or hospital emergency room for 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 103 of 141 HB013630.100 - 50 - XXXX House Committee Substitute the person who was treated for a drug overdose to provi de information about 1 services and connect the person to substance use disorder treatment, as funds 2 are available. These services, when provided on the grounds of a hospital, 3 shall be coordinated with appropriate hospital staff. 4 (2) When a person who is a r egistered qualified patient or a visiting qualified patient 5 as defined in Section 1 of this Act is admitted to a hospital emergency department 6 or a hospital emergency room for treatment of cannabinoid hyperemesis 7 syndrome, the hospital shall notify the Dep artment for Public Health within 8 forty -eight (48) hours. Notification shall include the registered qualified patient's 9 or a visiting qualified patient's name and registry identification card number, if 10 available. The department shall record all cases of ca nnabinoid hyperemesis 11 syndrome in the electronic monitoring system established pursuant to Section 41 12 of this Act. 13 Section 37. KRS 218A.010 is amended to read as follows: 14 As used in this chapter: 15 (1) \"Administer\" means the direct application of a controlled substance, whether by 16 injection, inhalation, ingestion, or any other means, to the body of a patient or 17 research subject by: 18 (a) A practitioner or by his or her authorized agent under his or her imm ediate 19 supervision and pursuant to his or her order; or 20 (b) The patient or research subject at the direction and in the presence of the 21 practitioner; 22 (2) \"Anabolic steroid\" means any drug or hormonal substance chemically and 23 pharmacologically related to te stosterone that promotes muscle growth and includes 24 those substances classified as Schedule III controlled substances pursuant to KRS 25 218A.020 but does not include estrogens, progestins, and anticosteroids; 26 (3) \"Cabinet\" means the Cabinet for Health and Fa mily Services; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 104 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (4) \"Carfentanil\" means any substance containing any quantity of carfentanil, or any of 1 its salts, isomers, or salts of isomers; 2 (5) \"Certified community based palliative care program\" means a palliative care 3 program which has received certi fication from the Joint Commission; 4 (6) \"Child\" means any person under the age of majority as specified in KRS 2.015; 5 (7) \"Cocaine\" means a substance containing any quantity of cocaine, its salts, optical 6 and geometric isomers, and salts of isomers; 7 (8) \"Controlled substance\" means methamphetamine, or a drug, substance, or 8 immediate precursor in Schedules I through V and includes a controlled substance 9 analogue; 10 (9) (a) \"Controlled substance analogue,\" except as provided in paragraph (b) of this 11 subsection, means a substance: 12 1. The chemical structure of which is substantially similar to the structure 13 of a controlled substance in Schedule I or II; and 14 2. Which has a stimulant, depressant, or hallucinogenic effect on the 15 central nervous system that is substan tially similar to or greater than the 16 stimulant, depressant, or hallucinogenic effect on the central nervous 17 system of a controlled substance in Schedule I or II; or 18 3. With respect to a particular person, which such person represents or 19 intends to have a stimulant, depressant, or hallucinogenic effect on the 20 central nervous system that is substantially similar to or greater than the 21 stimulant, depressant, or hallucinogenic effect on the central nervous 22 system of a controlled substance in Schedule I or II. 23 (b) Such term does not include: 24 1. Any substance for which there is an approved new drug application; 25 2. With respect to a particular person, any substance if an exemption is in 26 effect for investigational use for that person pursuant to federal law to 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 105 of 141 HB013630.100 - 50 - XXXX House Committee Substitute the extent conduct with respect to such substance is pursuant to such 1 exemption; or 2 3. Any substance to the extent not intended for human consumption before 3 the exemption described in subparagraph 2. of this paragraph takes 4 effect with respect to that substanc e; 5 (10) \"Counterfeit substance\" means a controlled substance which, or the container or 6 labeling of which, without authorization, bears the trademark, trade name, or other 7 identifying mark, imprint, number, or device, or any likeness thereof, of a 8 manufact urer, distributor, or dispenser other than the person who in fact 9 manufactured, distributed, or dispensed the substance; 10 (11) \"Dispense\" means to deliver a controlled substance to an ultimate user or research 11 subject by or pursuant to the lawful order of a practitioner, including the packaging, 12 labeling, or compounding necessary to prepare the substance for that delivery; 13 (12) \"Dispenser\" means a person who lawfully dispenses a Schedule II, III, IV, or V 14 controlled substance to or for the use of an ultimate user; 15 (13) \"Distribute\" means to deliver other than by administering or dispensing a controlled 16 substance; 17 (14) \"Dosage unit\" means a single pill, capsule, ampule, liquid, or other form of 18 administration available as a single unit; 19 (15) \"Drug\" means: 20 (a) Substances recognized as drugs in the official United States Pharmacopoeia, 21 official Homeopathic Pharmacopoeia of the United States, or official National 22 Formulary, or any supplement to any of them; 23 (b) Substances intended for use in the diagnosis, care, m itigation, treatment, or 24 prevention of disease in man or animals; 25 (c) Substances (other than food) intended to affect the structure or any function of 26 the body of man or animals; and 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 106 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (d) Substances intended for use as a component of any article specified i n this 1 subsection. 2 It does not include devices or their components, parts, or accessories; 3 (16) \"Fentanyl\" means a substance containing any quantity of fentanyl, or any of its salts, 4 isomers, or salts isomers; 5 (17) \"Fentanyl derivative\" means a substan ce containing any quantity of any chemical 6 compound, except compounds specifically scheduled as controlled substances by 7 statute or by administrative regulation pursuant to this chapter, which is structurally 8 derived from 1 -ethyl -4-(N-phenylamido) piperadi ne: 9 (a) By substitution: 10 1. At the 2 -position of the 1 -ethyl group with a phenyl, furan, thiophene, or 11 ethyloxotetrazole ring system; and 12 2. Of the terminal amido hydrogen atom with an alkyl, alkoxy, cycloalkyl, 13 or furanyl group; and 14 (b) Which may be furth er modified in one (1) or more of the following ways: 15 1. By substitution on the N -phenyl ring to any extent with alkyl, alkoxy, 16 haloalkyl, hydroxyl, or halide substituents; 17 2. By substitution on the piperadine ring to any extent with alkyl, allyl, 18 alkoxy, hydroxy, or halide substituents at the 2 -, 3-, 5-, and/or 6 - 19 positions; 20 3. By substitution on the piperadine ring to any extent with a phenyl, 21 alkoxy, or carboxylate ester substituent at the 4 - position; or 22 4. By substitution on the 1 -ethyl group to any ex tent with alkyl, alkoxy, or 23 hydroxy substituents; 24 (18) \"Good faith prior examination,\" as used in KRS Chapter 218A and for criminal 25 prosecution only, means an in -person medical examination of the patient conducted 26 by the prescribing practitioner or other h ealth -care professional routinely relied 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 107 of 141 HB013630.100 - 50 - XXXX House Committee Substitute upon in the ordinary course of his or her practice, at which time the patient is 1 physically examined and a medical history of the patient is obtained. \"In -person\" 2 includes telehealth examinations. This subsection sh all not be applicable to hospice 3 providers licensed pursuant to KRS Chapter 216B; 4 (19) \"Hazardous chemical substance\" includes any chemical substance used or intended 5 for use in the illegal manufacture of a controlled substance as defined in this section 6 or the illegal manufacture of methamphetamine as defined in KRS 218A.1431, 7 which: 8 (a) Poses an explosion hazard; 9 (b) Poses a fire hazard; or 10 (c) Is poisonous or injurious if handled, swallowed, or inhaled; 11 (20) \"Heroin\" means a substance containing any quan tity of heroin, or any of its salts, 12 isomers, or salts of isomers; 13 (21) \"Hydrocodone combination product\" means a drug with: 14 (a) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of 15 its salts, per one hundred (100) milliliters or not more than fifteen (15) 16 milligrams per dosage unit, with a fourfold or greater quantity of an 17 isoquinoline alkaloid of opium; or 18 (b) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of 19 its salts, per one hundred (100) milliliters or not more than fifteen (15) 20 milligrams per dosage unit, with one (1) or more active, nonnarcotic 21 ingredients in recognized therapeutic amounts; 22 (22) \"Immediate precursor\" means a substance which is the principal compound 23 commonly used or produced primarily for use, and which is an immediate chemical 24 intermediary used or likely to be used in the manufacture of a controlled substance 25 or methamphetamine, the control of which is necessary to prevent, curtail, or limit 26 manufacture; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 108 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (23) \"Industrial hemp\" has the same meaning as in KRS 260.850; 1 (24) \"Industrial hemp products\" has the same as in KRS 260.850; 2 (25) \"Intent to manufacture\" means any evidence which demonstrates a person's 3 conscious objective to manufacture a controlled substance or methamphetamine. 4 Such evidence includes but is not limited to statements and a chemical substance's 5 usage, quantity, manne r of storage, or proximity to other chemical substances or 6 equipment used to manufacture a controlled substance or methamphetamine; 7 (26) \"Isomer\" means the optical isomer, except the Cabinet for Health and Family 8 Services may include the optical, positiona l, or geometric isomer to classify any 9 substance pursuant to KRS 218A.020; 10 (27) \"Manufacture,\" except as provided in KRS 218A.1431, means the production, 11 preparation, propagation, compounding, conversion, or processing of a controlled 12 substance, either dir ectly or indirectly by extraction from substances of natural 13 origin or independently by means of chemical synthesis, or by a combination of 14 extraction and chemical synthesis, and includes any packaging or repackaging of the 15 substance or labeling or relabel ing of its container except that this term does not 16 include activities: 17 (a) By a practitioner as an incident to his or her administering or dispensing of a 18 controlled substance in the course of his or her professional practice; 19 (b) By a practitioner, or by his or her authorized agent under his supervision, for 20 the purpose of, or as an incident to, research, teaching, or chemical analysis 21 and not for sale; or 22 (c) By a pharmacist as an incident to his or her dispensing of a controlled 23 substance in the course of his or her professional practice; 24 (28) \"Marijuana\" means all parts of the plant Cannabis sp., whether growing or not; the 25 seeds thereof; the resin extracted from any part of the plant; and every compound, 26 manufacture, salt, derivative, mixture, or prepa ration of the plant, its seeds or resin 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 109 of 141 HB013630.100 - 50 - XXXX House Committee Substitute or any compound, mixture, or preparation which contains any quantity of these 1 substances. The term \"marijuana\" does not include: 2 (a) Industrial hemp that is in the possession, custody, or control of a person who 3 holds a license issued by the Department of Agriculture permitting that person 4 to cultivate, handle, or process industrial hemp; 5 (b) Industrial hemp products that do not include any living plants, viable seeds, 6 leaf materials, or floral materials; 7 (c) The subs tance cannabidiol, when transferred, dispensed, or administered 8 pursuant to the written order of a physician practicing at a hospital or 9 associated clinic affiliated with a Kentucky public university having a college 10 or school of medicine; 11 (d) For persons participating in a clinical trial or in an expanded access program, 12 a drug or substance approved for the use of those participants by the United 13 States Food and Drug Administration; 14 (e) A cannabidiol product derived from industrial hemp, as defined in KRS 15 260.850; 16 (f) For the purpose of conducting scientific research, a cannabinoid product 17 derived from industrial hemp, as defined in KRS 260.850; [ or] 18 (g) A cannabinoid product approved as a prescription medication by the United 19 States Food and Drug Administr ation; or 20 (h) Medicinal cannabis as defined in Section 1 of this Act; 21 (29) \"Medical history,\" as used in KRS Chapter 218A and for criminal prosecution only, 22 means an accounting of a patient's medical background, including but not limited to 23 prior medical c onditions, prescriptions, and family background; 24 (30) \"Medical order,\" as used in KRS Chapter 218A and for criminal prosecution only, 25 means a lawful order of a specifically identified practitioner for a specifically 26 identified patient for the patient's hea lth-care needs. \"Medical order\" may or may 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 110 of 141 HB013630.100 - 50 - XXXX House Committee Substitute not include a prescription drug order; 1 (31) \"Medical record,\" as used in KRS Chapter 218A and for criminal prosecution only, 2 means a record, other than for financial or billing purposes, relating to a patient, 3 kept by a practitioner as a result of the practitioner -patient relationship; 4 (32) \"Methamphetamine\" means any substance that contains any quantity of 5 methamphetamine, or any of its salts, isomers, or salts of isomers; 6 (33) \"Narcotic drug\" means any of the fol lowing, whether produced directly or indirectly 7 by extraction from substances of vegetable origin, or independently by means of 8 chemical synthesis, or by a combination of extraction and chemical synthesis: 9 (a) Opium and opiate, and any salt, compound, deri vative, or preparation of 10 opium or opiate; 11 (b) Any salt, compound, isomer, derivative, or preparation thereof which is 12 chemically equivalent or identical with any of the substances referred to in 13 paragraph (a) of this subsection, but not including the isoq uinoline alkaloids 14 of opium; 15 (c) Opium poppy and poppy straw; 16 (d) Coca leaves, except coca leaves and extracts of coca leaves from which 17 cocaine, ecgonine, and derivatives of ecgonine or their salts have been 18 removed; 19 (e) Cocaine, its salts, optical and ge ometric isomers, and salts of isomers; (f) their salts, isomers, and salts of isomers; and 21 (g) Any compound, mixture, or preparation which contains any quantity of any of 22 the substances referred to in paragraphs (a) to (f) of thi s subsection; 23 (34) \"Opiate\" means any substance having an addiction -forming or addiction -sustaining 24 liability similar to morphine or being capable of conversion into a drug having 25 addiction -forming or addiction -sustaining liability. It does not include, unless 26 specifically designated as controlled unde r KRS 218A.020, the dextrorotatory 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 111 of 141 HB013630.100 - 50 - XXXX House Committee Substitute isomer of 3 -methoxy -n-methylmorphinan and its salts (dextromethorphan). It does 1 racemic and levorotatory forms; 2 (35) \"Opium poppy\" means the plant of the species papaver somniferum L., except its 3 seeds; 4 (36) \"Person\" means individual, corporation, government or governmental subdivision 5 or agency, business trust, estate, trust, partnership or association, or any other legal 6 entity; 7 (37) \"Physical injury\" has the same meaning it has in KRS 500.080; 8 (38) \"Poppy st raw\" means all parts, except the seeds, of the opium poppy, after mowing; 9 (39) \"Pharmacist\" means a natural person licensed by this state to engage in the practice 10 of the profession of pharmacy; 11 (40) \"Practitioner\" means a physician, dentist, podiatrist, v eterinarian, scientific 12 investigator, optometrist as authorized in KRS 320.240, advanced practice 13 registered nurse as authorized under KRS 314.011, physician assistant as authorized 14 under KRS 311.858, or other person licensed, registered, or otherwise perm itted by 15 state or federal law to acquire, distribute, dispense, conduct research with respect to, 16 or to administer a controlled substance in the course of professional practice or 17 research in this state. \"Practitioner\" also includes a physician, dentist, p odiatrist, 18 veterinarian, or advanced practice registered nurse authorized under KRS 314.011 19 who is a resident of and actively practicing in a state other than Kentucky and who 20 is licensed and has prescriptive authority for controlled substances under the 21 professional licensing laws of another state, unless the person's Kentucky license 22 has been revoked, suspended, restricted, or probated, in which case the terms of the 23 Kentucky license shall prevail; 24 (41) \"Practitioner -patient relationship,\" as used in KRS Chapter 218A and for criminal 25 prosecution only, means a medical relationship that exists between a patient and a 26 practitioner or the practitioner's designee, after the practitioner or his or her 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 112 of 141 HB013630.100 - 50 - XXXX House Committee Substitute designee has conducted at least one (1) good faith prior exam ination; 1 (42) \"Prescription\" means a written, electronic, or oral order for a drug or medicine, or 2 combination or mixture of drugs or medicines, or proprietary preparation, signed or 3 given or authorized by a medical, dental, chiropody, veterinarian, optome tric 4 practitioner, or advanced practice registered nurse, and intended for use in the 5 diagnosis, cure, mitigation, treatment, or prevention of disease in man or other 6 animals; 7 (43) \"Prescription blank,\" with reference to a controlled substance, means a doc ument 8 that meets the requirements of KRS 218A.204 and 217.216; 9 (44) \"Presumptive probation\" means a sentence of probation not to exceed the maximum 10 term specified for the offense, subject to conditions otherwise authorized by law, 11 that is presumed to be th e appropriate sentence for certain offenses designated in 12 this chapter, notwithstanding contrary provisions of KRS Chapter 533. That 13 presumption shall only be overcome by a finding on the record by the sentencing 14 court of substantial and compelling reasons why the defendant cannot be safely and 15 effectively supervised in the community, is not amenable to community -based 16 treatment, or poses a significant risk to public safety; 17 (45) \"Production\" includes the manufacture, planting, cultivation, growing, or harv esting 18 of a controlled substance; 19 (46) \"Recovery program\" means an evidence -based, nonclinical service that assists 20 individuals and families working toward sustained recovery from substance use and 21 other criminal risk factors. This can be done through an a rray of support programs 22 and services that are delivered through residential and nonresidential means; 23 (47) \"Salvia\" means Salvia divinorum or Salvinorin A and includes all parts of the plant 24 presently classified botanically as Salvia divinorum, whether gr owing or not, the 25 seeds thereof, any extract from any part of that plant, and every compound, 26 manufacture, derivative, mixture, or preparation of that plant, its seeds, or its 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 113 of 141 HB013630.100 - 50 - XXXX House Committee Substitute extracts, including salts, isomers, and salts of isomers whenever the existence of 1 such salts, isomers, and salts of isomers is possible within the specific chemical 2 designation of that plant, its seeds, or extracts. The term shall not include any other 3 species in the genus salvia; 4 (48) \"Second or subsequent offense\" means that for th e purposes of this chapter an 5 offense is considered as a second or subsequent offense, if, prior to his or her 6 conviction of the offense, the offender has at any time been convicted under this 7 chapter, or under any statute of the United States, or of any s tate relating to 8 substances classified as controlled substances or counterfeit substances, except that 9 a prior conviction for a nontrafficking offense shall be treated as a prior offense 10 only when the subsequent offense is a nontrafficking offense. For the purposes of 11 this section, a conviction voided under KRS 218A.275 or 218A.276 shall not 12 constitute a conviction under this chapter; 13 (49) \"Sell\" means to dispose of a controlled substance to another person for 14 consideration or in furtherance of commercial d istribution; 15 (50) \"Serious physical injury\" has the same meaning it has in KRS 500.080; 16 (51) \"Synthetic cannabinoids or piperazines\" means any chemical compound which is 17 not approved by the United States Food and Drug Administration or, if approved, 18 which is not dispensed or possessed in accordance with state and federal law, that 19 contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine dexanabinol (HU -211); or any 22 compound in the following structural classes: 23 (a) Naphthoylindoles: Any compound containing a 3 -(1-naphthoyl)indole 24 structure with substitution at the nitrogen atom of the indole ring by an alkyl, 25 piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group, whether or not further 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 114 of 141 HB013630.100 - 50 - XXXX House Committee Substitute substituted in the indole ring to any extent and whether or not substituted in 1 the naphthyl ring to any extent. Examples of this structural class include but 2 are not limited (b) Phenylacetylindoles: Any compound containing a 3 -phenylacetylindole 5 structure with substitution at the nitrogen atom of th e indole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group whether or not further 8 substituted in the indole ring to any extent and whether or not substituted in 9 the ph enyl ring to any extent. Examples of this structural class include but are 10 not limited to JWH -167, JWH -250, JWH -251, and RCS Benzoylindoles: Any compound containing a 3 -(benzoyl)indole structure with 12 substitution at the nitrogen atom of the indole r ing by an alkyl, haloalkyl, 1 -(N-methyl -2-piperidinyl)methyl, 14 or 2-(4-morpholinyl)ethyl group whether or not further substituted in the 15 indole ring to any extent and whether or not substituted in the phenyl ring to 16 any extent. Examples of this structural class include but are not limited to 17 AM-630, AM -2233, AM -694, Pravadoline (WIN 48,098), and RCS -4; 18 (d) Cyclohexylphenols: Any compound containing a 2 -(3- 19 hydroxycyclohexyl)phenol structure with substitution at the 5-position of the 20 phenolic ring by -(N-methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl 22 group whether or not substituted in the cyclohexyl ring to any extent. 23 Examples of this structur al class include but are not limited to CP 47,497 and 24 its C8 homologue (cannabicyclohexanol); compound containing a 1H -indol -3-yl-(1- 26 naphthyl)methane structure with substitution at the nitrogen atom of the indole 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 115 of 141 HB013630.100 - 50 - XXXX House Committee Substitute ring by an a lkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1 -(N- 1 methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group whether or not 2 further substituted in the indole ring to any extent and whether or not 3 substituted in the naphthyl ring to any ex tent. Examples of this structural class 4 include but are not limited to JWH -175, JWH -184, and JWH -185; 5 (f) Naphthoylpyrroles: Any compound containing a 3 -(1-naphthoyl)pyrrole 6 structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group whether or not further 9 substituted in the pyrrole ring to any extent and whether or not substituted in 10 the naphthyl ring to any extent. Examples of this structural class include but 11 are not limited to compound containing a 1 -(1- 13 naphthylmethyl)indene structure with substitution at the 3 -position of the 14 indene r ing 1-(N-methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group whether 16 or not further substituted in the indene ring to any extent and whether or not 17 substituted in the naphthyl rin g to any extent. Examples of this structural class 18 include but are not limited to JWH -176; 19 (h) Tetramethylcyclopropanoylindoles: Any compound containing a 3 -(1- 20 tetramethylcyclopropoyl)indole structure with substitution at the nitrogen 21 atom of the indole ri ng -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl 23 group, whether or not further substituted in the indole ring to any extent and 24 whether or not further substituted in the tetramethylcy clopropyl ring to any 25 extent. Examples of this structural class include but are not limited to UR -144 26 and XLR -11; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 116 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (i) Adamantoylindoles: Any compound containing a 3 -(1-adamantoyl)indole 1 structure with substitution at the nitrogen atom of the indole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group, whether or not further 4 substituted in the indole ring to any extent and whether or not substituted in 5 the adamantyl ring sy stem to any extent. Examples of this structural class 6 include but are not limited to AB -001 and AM -1248; or 7 (j) Any other synthetic cannabinoid or piperazine which is not approved by the 8 United States Food and Drug Administration or, if approved, which is not 9 dispensed or possessed in accordance with state and federal law; 10 (52) \"Synthetic cathinones\" means any chemical compound which is not approved by the 11 United States Food and Drug Administration or, if approved, which is not dispensed 12 or possessed in accordance with state and federal law (not including bupropion or 13 compounds listed under a different schedule) structurally derived from 2 - 14 aminopropan -1-one by substitution at the 1 -position with either phenyl, naphthyl, or 15 thiophene ring systems, wheth er or not the compound is further modified in one (1) 16 or more of the following ways: 17 (a) By substitution in the ring system to any extent with alkyl, alkylenedioxy, 18 alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further 19 substituted in the ring system by one (1) or more other univalent substituents. 20 Examples of this class include but are not limited to 3,4 - 21 Methylenedioxycathinone (bk -MDA); 22 (b) By substitution at the 3 -position with an acyclic alkyl substituent. Examples of 23 this class inc lude but are not limited to 2 -methylamino -1-phenylbutan -1-one 24 (buphedrone); 25 (c) By substitution at the 2 -amino nitrogen atom with alkyl, dialkyl, benzyl, or 26 methoxybenzyl groups, or by inclusion of the 2 -amino nitrogen atom in a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 117 of 141 HB013630.100 - 50 - XXXX House Committee Substitute cyclic structure. Examples of this class include but are not limited to 1 Dimethylcathinone, Ethcathinone, and -Pyrrolidinopropiophenone ( -PPP); 2 or 3 (d) Any other synthetic cathinone which is not approved by the United States 4 Food and Drug Administration or, if approved, is not dispensed or possessed 5 in accordance with state or federal law; 6 (53) \"Synthetic drugs\" means any synthetic cannabinoids or piperazines or any synthetic 7 cathinones; 8 (54) \"Telehealth\" has the same meaning it has in KRS 311.550; 9 (55) \"Tetrahydrocannabinols\" means synthetic equivalents of the substances contained in 10 the plant, or in the resinous extractives of the plant Cannabis, sp. or synthetic 11 substances, derivatives, and their isomers with similar chemica l structure and 12 pharmacological activity such as the following: 13 (a) Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; 14 (b) Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and 15 (c) Delta 3, 4 cis or trans tetrahydroca nnabinol, and its optical isomers; 16 (56) \"Traffic,\" except as provided in KRS 218A.1431, means to manufacture, distribute, 17 dispense, sell, transfer, or possess with intent to manufacture, distribute, dispense, 18 or sell a controlled substance; 19 (57) \"Transfer\" means to dispose of a controlled substance to another person without 20 consideration and not in furtherance of commercial distribution; and 21 (58) \"Ultimate user\" means a person who lawfully possesses a controlled substance for 22 his or her own use or for the u se of a member of his or her household or for 23 administering to an animal owned by him or her or by a member of his or her 24 household. 25 Section 38. KRS 218A.1421 is amended to read as follows: 26 (1) A person is guilty of traf ficking in marijuana when he or she knowingly and 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 118 of 141 HB013630.100 - 50 - XXXX House Committee Substitute unlawfully traffics in marijuana , and the trafficking is not in compliance with, or 1 otherwise authorized by, Sections 1 to 30 of this Act . 2 (2) Unless authorized by Sections 1 to 30 of this Act, trafficking in less than eight (8) 3 ounces of marijuana is: 4 (a) For a first offense a Class A misdemeanor. 5 (b) For a second or subsequent offense a Class D felony. 6 (3) Unless authorized by Sections 1 to 30 of this Act, trafficking in eight (8) or more 7 ounces but less t han five (5) pounds of marijuana is: 8 (a) For a first offense a Class D felony. 9 (b) For a second or subsequent offense a Class C felony. 10 (4) Unless authorized by Sections 1 to 30 of this Act, trafficking in five (5) or more 11 pounds of marijuana is: 12 (a) For a first offense a Class C felony. 13 (b) For a second or subsequent offense a Class B felony. 14 (5) Unless authorized by Sections 1 to 30 of this Act, the unlawful possession by any 15 person of eight (8) or more ounces of marijuana shall be prima facie evidence th at 16 the person possessed the marijuana with the intent to sell or transfer it. 17 (6) This section does not apply to: 18 (a) A cannabis business or a cannabis business agent, as defined in Section 1 19 of this Act, when acting in compliance with Sections 1 to 30 of this Act; or 20 (b) A cardholder, as defined in Section 1 of this Act, whose use of medicinal 21 cannabis is in compliance with Sections 1 to 30 of this Act. 22 Section 39. KRS 218A.1422 is amended to read as follows: 23 (1) A person is guilty of possession of marijuana when he or she knowingly and 24 unlawfully possesses marijuana , and the possession is not in compliance with, or 25 otherwise authorized by, Sections 1 to 30 of this Act . 26 (2) Possession of marijuana is a Class B misd emeanor, except that, KRS Chapter 532 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 119 of 141 HB013630.100 - 50 - XXXX House Committee Substitute to the contrary notwithstanding, the maximum term of incarceration shall be no 1 greater than forty -five (45) days. 2 (3) This section does not apply to: 3 (a) A cannabis business or a cannabis business agent, as defined in Section 1 4 of this Act, when acting in compliance with Sections 1 to 30 of this Act; or 5 (b) A cardholder, as defined in Section 1 of this Act, whose use of medicinal 6 cannabis is in compliance with Sections 1 to 30 of this Act. 7 Section 40. KRS 218A.1423 is amended to read as follows: 8 (1) A person is guilty of marijuana cultivation when he or she knowingly and 9 unlawfully plants, cultivates, or harvests marijuana with the intent to sell or transfer 10 it, and the cultivation is not in compliance with, or otherwise authorized by, 11 Sections 1 to 30 of this Act . 12 (2) Unless authorized by Sections 1 to 30 of this Act, marijuana cultivation of five (5) 13 or more plants of marijuana is: 14 (a) For a first offense a Class D felony. 15 (b) For a s econd or subsequent offense a Class C felony. 16 (3) Unless authorized by Sections 1 to 30 of this Act, marijuana cultivation of fewer 17 than five (5) plants is: 18 (a) For a first offense a Class A misdemeanor. 19 (b) For a second or subsequent offense a Class D fel ony. 20 (4) Unless authorized by Sections 1 to 30 of this Act, the planting, cultivating, or 21 harvesting of five (5) or more marijuana plants shall be prima facie evidence that 22 the marijuana plants were planted, cultivated, or harvested for the purpose of sale or 23 transfer. 24 (5) This section does not apply to a cannabis business or a cannabis business agent, 25 as defined in Section 1 of this Act, when acting in compliance with Sections 1 to 26 30 of this Act. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 120 of 141 HB013630.100 - 50 - XXXX House Committee Substitute Section 41. KRS 218A.20 2 is amended to read as follows: 1 (1) As used in this section: 2 (a) \"Cabinet\" means the cabinet for Health and Family Services; 3 (b) \"Cannabis business\" has the same meaning as in Section 1 of this Act; 4 (c) \"Controlled substance\" means Schedules II, III, IV, and V controlled 5 substances and does not include medicinal cannabis; 6 (d) \"Dispensary\" has the same meaning as in Section 1 of this Act; 7 (e) \"Dispensary agent\" has the same meaning as in Section 1 of this Act; 8 (f) \"Disqualifying felony offense\" has the same meaning as in Section 1 of this 9 Act; 10 (g) \"Medicinal cannabis\" has the same meaning as in Section 1 of this Act; 11 (h) \"Medical cannabis practitioner\" has the same meaning as in Section 1 of 12 this Act; 13 (i) \"Registry identification card\" has the same meaning a s in Section 1 of this 14 Act; 15 (j) \"State licensing board\" has the same meaning as in Section 1 of this Act; 16 (k) \"Use of medicinal cannabis\" has the same meaning as in Section 1 of this 17 Act; and 18 (l) \"Written certification\" has the same meaning as in Section 1 of this Act. 19 (2) The cabinet [ for Health and Family Services] shall establish and maintain an 20 electronic system for monitoring Schedules II, III, IV, and V controlled substances 21 and medicinal can nabis as defined in Section 1 of this Act . The cabinet may 22 contract for the design, upgrade, or operation of this system if the contract preserves 23 all of the rights, privileges, and protections guaranteed to Kentucky citizens under 24 this chapter and the con tract requires that all other aspects of the system be operated 25 in conformity with the requirements of this or any other applicable state or federal 26 law. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 121 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (3)[(2)] For the purpose of monitoring the prescribing and dispensing of Schedules 1 II, III, IV, and V controlled substances: 2 (a) A practitioner or a pharmacist authorized to prescribe or dispense controlled 3 substances to humans shall register with the cabinet to use the system 4 provided for in this section and shall maintain such registration continuously 5 during the practitioner's or pharmacist's term of licensure and shall not have to 6 pay a fee or tax specifically dedicated to the operation of the system ;[.] 7 (b)[(3)] Every practitioner or pharmacy which dispenses a controlled substance 8 to a person in Kentuc ky, or to a person at an address in Kentucky, shall report 9 to the cabinet [ for Health and Family Services] the data required by this 10 section, which includes the reporting of any Schedule II controlled substance 11 dispensed at a facility licensed by the cabin et and a Schedule II through 12 Schedule V controlled substance regardless of dosage when dispensed by the 13 emergency department of a hospital to an emergency department patient. 14 Reporting shall not be required for: 15 1.[(a)] A drug administered directly to a pa tient in a hospital, a resident of 16 a health care facility licensed under KRS Chapter 216B, a resident of a 17 child -caring facility as defined by KRS 199.011, or an individual in a 18 jail, correctional facility, or juvenile detention facility; 19 2.[(b)] A Schedu le III through Schedule V controlled substance dispensed 20 by a facility licensed by the cabinet provided that the quantity dispensed 21 is limited to an amount adequate to treat the patient for a maximum of 22 forty -eight (48) hours and is not dispensed by the em ergency department 23 of a hospital; or 24 3.[(c)] A drug administered or dispensed to a research subject enrolled in 25 a research protocol approved by an institutional review board that has an 26 active federalwide assurance number from the United States Department 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 122 of 141 HB013630.100 - 50 - XXXX House Committee Substitute of Health and Human Services, Office for Human Research Protections, 1 where the research involves single, double, or triple blind drug 2 administration or is additionally covered by a certificate of 3 confidentiality from the National Institutes of Health ;[.] 4 (c)[(4)] In addition to the data required by paragraph (d) of this subsection [(5) 5 of this section] , a Kentucky -licensed acute care hospital or critical access 6 hospital shall report to the cabinet all positive toxicology screens that were 7 performed by the hospital's emergency department to evaluate the patient's 8 suspected drug overdose ;[.] 9 (d)[(5)] Data for each controlled substance that is reported shall include but not 10 be limited to the following: 11 1.[(a)] Patient identifier; 12 2.[(b)] National drug code of the drug dispensed; 13 3.[(c)] Date of dispensing; 14 Dispenser ;[.] 17 (e)[(6)] The data shall be provided in the electronic format specified by the 18 cabinet [ for Health and Family Services] unless a waiver has been granted by 19 the cabinet to an individual dispenser. The cabinet shall establish acceptable 20 error tolerance rates for data. Dispensers shall ensure that reports fall within 21 these tolerances. Incomplete or inaccurate data shall be corrected upon 22 notification by the cabinet if the dispenser exceeds these error tolerance 23 rates ;[.] 24 (f)[(7)] The cabi net[ for Health and Family Services] shall only disclose data to 25 persons and entities authorized to receive that data under this 26 subsection [section] . Disclosure to any other person or entity, including 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 123 of 141 HB013630.100 - 50 - XXXX House Committee Substitute disclosure in the context of a civil action where the disclosure is sought either 1 for the purpose of discovery or for evidence, is prohibited unless specifically 2 authorized by this section. The cabinet [ for Health and Family Services] shall 3 be authorized to provide data to: 4 1.[(a)] A designated representative of a board responsible for the 5 licensure, regulation, or discipline of practitioners, pharmacists, or other 6 person who is authorized to prescribe, administer, or dispense controlled 7 substances and who is involved in a bona fide specific investigation 8 involving a designated person; 9 2.[(b)] Employees of the Office of the Inspector General of the cabinet [ 10 for Health and Family Services] who have successfully completed 11 training for the electronic system and who have been approved to use the 12 system, federal pro secutors, Kentucky Commonwealth's attorneys and 13 assistant Commonwealth's attorneys, county attorneys and assistant 14 county attorneys, a peace officer certified pursuant to KRS 15.380 to 15 15.404, a certified or full -time peace officer of another state, or a f ederal 16 agent whose duty is to enforce the laws of this Commonwealth, of 17 another state, or of the United States relating to drugs and who is 18 engaged in a bona fide specific investigation involving a designated 19 person; 20 3.[(c)] A state -operated Medicaid progr am in conformity with subsection 21 (8) of this section; 22 4.[(d)] A properly convened grand jury pursuant to a subpoena properly 23 issued for the records; 24 5.[(e)] A practitioner or pharmacist, or employee of the practitioner's or 25 pharmacist's practice acting und er the specific direction of the 26 practitioner or pharmacist, who certifies that the requested information 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 124 of 141 HB013630.100 - 50 - XXXX House Committee Substitute is for the purpose of: 1 a[1]. Providing medical or pharmaceutical treatment to a bona fide 2 current or prospective patient; 3 b[2]. Reviewing data on controlled substances that have been reported 4 for the birth mother of an infant who is currently being treated by 5 the practitioner for neonatal abstinence syndrome, or has 6 symptoms that suggest prenatal drug exposure; or 7 c[3]. Reviewing a nd assessing the individual prescribing or dispensing 8 patterns of the practitioner or pharmacist or to determine the 9 accuracy and completeness of information contained in the 10 monitoring system; 11 6.[(f)] The chief medical officer of a hospital or long -term-care facility, 12 an employee of the hospital or long -term-care facility as designated by 13 the chief medical officer and who is working under his or her specific 14 direction, or a physician designee if the hospital or facility has no chief 15 medical officer, if the officer, employee, or designee certifies that the 16 requested information is for the purpose of providing medical or 17 pharmaceutical treatment to a bona fide current or prospective patient or 18 resident in the hospital or facility; 19 7.[(g)] In addition to the p urposes authorized under subparagraph 1. of 20 this paragraph [ (a) of this subsection] , the Kentucky Board of Medical 21 Licensure, for any physician who is: 22 a[1]. Associated in a partnership or other business entity with a 23 physician who is already under investi gation by the Board of 24 Medical Licensure for improper prescribing or dispensing 25 practices; 26 b[2]. In a designated geographic area for which a trend report indicates a 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 125 of 141 HB013630.100 - 50 - XXXX House Committee Substitute substantial likelihood that inappropriate prescribing or dispensing 1 may be occurring; or 2 c[3]. In a designated geographic area for which a report on another 3 physician in that area indicates a substantial likelihood that 4 inappropriate prescribing or dispensing may be occurring in that 5 area; 6 8.[(h)] In addition to the purposes authorized under subparagraph 1. of 7 this paragraph [ (a) of this subsection] , the Kentucky Board of Nursing, 8 for any advanced practice registered nurse who is: 9 a[1]. Associated in a partnership or other business entity with a 10 physician who is already under investigation by th e Kentucky 11 Board of Medical Licensure for improper prescribing or dispensing 12 practices; 13 b[2]. Associated in a partnership or other business entity with an 14 advanced practice registered nurse who is already under 15 investigation by the Board of Nursing for imp roper prescribing 16 practices; 17 c[3]. In a designated geographic area for which a trend report indicates a 18 substantial likelihood that inappropriate prescribing or dispensing 19 may be occurring; or 20 d[4]. In a designated geographic area for which a report on a p hysician 21 or another advanced practice registered nurse in that area indicates 22 a substantial likelihood that inappropriate prescribing or 23 dispensing may be occurring in that area; 24 9.[(i)] A judge or a probation or parole officer administering a diversion 25 or probation program of a criminal defendant arising out of a violation 26 of this chapter or of a criminal defendant who is documented by the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 126 of 141 HB013630.100 - 50 - XXXX House Committee Substitute court as a substance abuser who is eligible to participate in a court - 1 ordered drug diversion or probation program; or 2 10.[(j)] A medical examiner engaged in a death investigation pursuant to 3 KRS 72.026 ;[.] 4 (g)[(8)] The Department for Medicaid Services shall use any data or reports from 5 the system for the purpose of identifying Medicaid providers or recipients 6 whose prescr ibing, dispensing, or usage of controlled substances may be: 7 1.[(a)] Appropriately managed by a single outpatient pharmacy or primary 8 care physician; or 9 2.[(b)] Indicative of improper, inappropriate, or illegal prescribing or 10 dispensing practices by a prac titioner or drug seeking by a Medicaid 11 recipient ;[.] 12 (h)[(9)] A person who receives data or any report of the system from the cabinet 13 shall not provide it to any other person or entity except as provided in this 14 subsection [section] , in another statute, or by order of a court of competent 15 jurisdiction and only to a person or entity authorized to receive the data or the 16 report under this section, except that: 17 1.[(a)] A person specified in paragraph (f)2. of this subsection [ (7)(b) of 18 this section] who is auth orized to receive data or a report may share that 19 information with any other persons specified in paragraph (f)2. of this 20 subsection [(7)(b) of this section ] authorized to receive data or a report if 21 the persons specified in paragraph (f)2. of this subsect ion[ (7)(b) of this 22 section] are working on a bona fide specific investigation involving a 23 designated person. Both the person providing and the person receiving 24 the data or report under this subparagraph [paragraph] shall document in 25 writing each person to whom the data or report has been given or 26 received and the day, month, and year that the data or report has been 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 127 of 141 HB013630.100 - 50 - XXXX House Committee Substitute given or received. This document shall be maintained in a file by each 1 agency engaged in the investigation; 2 2.[(b)] A representative of the Dep artment for Medicaid Services may 3 share data or reports regarding overutilization by Medicaid recipients 4 with a board designated in paragraph (f)1. of this subsection [ (7)(a) of 5 this section] , or with a law enforcement officer designated in paragraph 6 (f)2. of this subsection [ (7)(b) of this section] ; 7 3.[(c)] The Department for Medicaid Services may submit the data as 8 evidence in an administrative hearing held in accordance with KRS 9 Chapter 13B; 10 4.[(d)] If a state licensing board as defined in KRS 218A.205 i nitiates 11 formal disciplinary proceedings against a licensee, and data obtained by 12 the board is relevant to the charges, the board may provide the data to 13 the licensee and his or her counsel, as part of the notice process required 14 by KRS 13B.050, and admit the data as evidence in an administrative 15 hearing conducted pursuant to KRS Chapter 13B, with the board and 16 licensee taking all necessary steps to prevent further disclosure of the 17 data; and 18 5.[(e)] A practitioner, pharmacist, or employee who obtains data under 19 paragraph (f)5. of this subsection [ (7)(e) of this section] may share the 20 report with the patient or person authorized to act on the patient's behalf. 21 Any practitioner, pharmacist, or employee who obtains data under 22 paragraph (f)5. of this subsection [(7)(e) of this section ] may place the 23 report in the patient's medical record, in which case the individual report 24 shall then be deemed a medical record subject to disclosure on the same 25 terms and conditions as an ordinary medical record in lie u of the 26 disclosure restrictions otherwise imposed by this section ;[.] 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 128 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (i)[(10)] The cabinet [ for Health and Family Services] , all peace officers 1 specified in paragraph (f)2. of this subsection [ (7)(b) of this section] , all 2 officers of the court, and all r egulatory agencies and officers, in using the data 3 for investigative or prosecution purposes, shall consider the nature of the 4 prescriber's and dispenser's practice and the condition for which the patient is 5 being treated ;[.] 6 (j)[(11) The data and any repo rt obtained therefrom shall not be a public record, 7 except that the Department for Medicaid Services may submit the data as 8 evidence in an administrative hearing held in accordance with KRS Chapter 9 13B. 10 (12)] Intentional failure to comply with the reportin g requirements of this 11 subsection [section] shall be a Class B misdemeanor for the first offense and a 12 Class A misdemeanor for each subsequent offense ; and [.] 13 (k) If the cabinet becomes aware of a prescriber's or dispenser's failure to 14 comply with this sect ion, the cabinet shall notify the licensing board or 15 agency responsible for licensing the prescriber or dispenser. The licensing 16 board shall treat the notification as a complaint against the licensee. 17 (4) For the purpose of monitoring the cultivation, processing, production, 18 recommending, and dispensing of medical cannabis: 19 (a) Every medicinal cannabis practitioner who is authorized, pursuant to 20 Section 9 of this Act, to provide written certifications for t he use of 21 medicinal cannabis and every cannabis business licensed under Sections 22 16, 17, and 18 of this Act shall register with the cabinet to use the system 23 provided for in this section and shall maintain such registration 24 continuously during the medicina l practitioner's authorization to provide 25 written certifications or a cannabis business's term of licensure and shall 26 not have to pay a fee or tax specifically dedicated to the operation of the 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 129 of 141 HB013630.100 - 50 - XXXX House Committee Substitute system. 1 (b) No later than January 1, 2023, the cabinet shall e nsure that the system 2 provided for in this section allows: 3 1. Medicinal cannabis practitioners to record the issuance of written 4 certifications to a patient as required by Section 9 of this Act; 5 2. Pharmacists to record the completion of consultations with 6 cardholders as required by Section 10 of this Act; 7 3. The cabinet, law enforcement personnel, and dispensary agents to 8 verify the validity of registry identification cards issued by the 9 Department for Public Health. When verifying the validity of an 10 ident ification card, system shall only disclose whether the 11 identification card is valid and whether the cardholder is a registered 12 qualified patient, visiting qualified patient, or designated caregiver; 13 4. Dispensary agents to record the amount of medicinal ca nnabis that is 14 dispensed to a cardholder during each transaction, as required by 15 Section 22 of this Act; 16 5. Law enforcement personnel and dispensary agents to access medicinal 17 cannabis sales data recorded by dispensary agents pursuant to Section 18 22 of this Act; 19 6. The sharing of dispensing data recorded by dispensary agents, 20 pursuant to Section 22 of this Act, with all licensed dispensaries in 21 real time; 22 7. Licensed cannabis businesses to record data required by 23 administrative regulations promulgated pursua nt to with Section 28 of 24 this Act to facilitate the tracking of medicinal cannabis from the point 25 of cultivation to the point of sale to cardholders; and 26 8. The cabinet to track all medicinal cannabis in the state from the point 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 130 of 141 HB013630.100 - 50 - XXXX House Committee Substitute of cultivation to the point of sale to a cardholder. 1 (c) The cabinet shall only disclose data related to the cultivation, production, 2 recommending, and dispensing of medical cannabis to persons and entities 3 authorized to receive that data under this subsection. Disclosure to any 4 other person or entity, including disclosure in the context of a civil action 5 where the disclosure is sought either for the purpose of discovery or for 6 evidence, is prohibited unless specifically authorized by this subsection. The 7 cabinet shall be authorized to provide data to: 8 1. Any person or entity authorized to receive data pursuant to paragraph 9 (b) of this subsection; 10 2. A designated representative of a state licensing board responsible for 11 the licensure, regulation, or discipline of medicinal cannabis 12 practitioners and who is involved in a bona fide specific investigation 13 involving a designated person; 14 3. Employees of the Office of the Inspector General of the cabinet who 15 have successfully completed training for the electronic system and 16 who have been app roved to use the system, Kentucky Commonwealth's 17 attorneys and assistant Commonwealth's attorneys, and county 18 attorneys and assistant county attorneys who are engaged in a bona 19 fide specific investigation involving a designated person; 20 4. A properly conven ed grand jury pursuant to a subpoena properly 21 issued for the records; 22 5. A medicinal cannabis practitioner or an employee of a medicinal 23 cannabis practitioner's practice acting under the specific direction of 24 the medicinal cannabis practitioner, who certif ies that the request for 25 information is for the purpose of complying with subsection (4)(c) of 26 Section 9 of this Act; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 131 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 6. The chief medical officer of a hospital or long -term -care facility, an 1 employee of the hospital or long -term -care facility as designate d by the 2 chief medical officer and who is working under his or her specific 3 direction, or a physician designee if the hospital or facility has no 4 chief medical officer, if the officer, employee, or designee certifies that 5 the requested information is for t he purpose of providing medical or 6 pharmaceutical treatment to a bona fide current or prospective patient 7 or resident in the hospital or facility; 8 7. In addition to the purposes authorized under subparagraph 2. of this 9 paragraph, the Kentucky Board of Medi cal Licensure, for any 10 physician or physician assistant who is: 11 a. Associated in a partnership, other business entity, or supervision 12 agreement established pursuant to KRS 311.854 with a physician 13 or physician assistant who is already under investigation b y the 14 Board of Medical Licensure for improper issuance of written 15 certifications; 16 b. Associated in a partnership or other business entity with an 17 advanced practice registered nurse who is already under 18 investigation by the Board of Nursing for improper iss uance of 19 written certifications; 20 c. In a designated geographic area for which a trend report 21 indicates a substantial likelihood that inappropriate issuance of 22 written certifications may be occurring; or 23 d. In a designated geographic area for which a report on another 24 physician or physician assistant in that area indicates a 25 substantial likelihood that inappropriate issuance of written 26 certifications may be occurring in that area; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 132 of 141 HB013630.100 - 50 - XXXX House Committee Substitute 8. In addition to the purposes authorized under subparagraph 2. of this 1 paragr aph, the Kentucky Board of Nursing, for any advanced practice 2 registered nurse who is: 3 a. Associated in a partnership or other business entity with a 4 physician or physician assistant who is already under 5 investigation by the Kentucky Board of Medical Licen sure for 6 improper issuance of written certifications; 7 b. Associated in a partnership or other business entity with an 8 advanced practice registered nurse who is already under 9 investigation by the Board of Nursing for improper issuance of 10 written certificati ons; 11 c. In a designated geographic area for which a trend report 12 indicates a substantial likelihood that inappropriate issuance of 13 written certifications may be occurring; or 14 d. In a designated geographic area for which a report on a 15 physician, physician assistant, or another advanced practice 16 registered nurse in that area indicates a substantial likelihood 17 that inappropriate issuance of written certifications may be 18 occurring in that area; 19 9. A judge or a probation or parole officer ad ministering a diversion or 20 probation program of a criminal defendant arising out of a violation 21 of this chapter or of a criminal defendant who is documented by the 22 court as a substance abuser who is eligible to participate in a court - 23 ordered drug diversion or probation program; 24 10. A medical examiner engaged in a death investigation pursuant to KRS 25 72.026; or 26 11. The Legislative Research Commission or the University of Kentucky 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 133 of 141 HB013630.100 - 50 - XXXX House Committee Substitute College of Medicine if the cabinet determines that disclosing data 1 related to th e cultivation, production, recommending, and dispensing 2 of medical cannabis to the Legislative Research Commission or the 3 University of Kentucky College of Medicine is necessary to comply 4 with the reporting requirements established in subsection (8) of 5 Section 3 of this Act. 6 (d) A person who receives data or any report of the system from the cabinet 7 shall not provide it to any other person or entity except as provided in this 8 section, in another statute, or by order of a court of competent jurisdiction 9 and only to a person or entity authorized to receive the data or the report 10 under this section, except that: 11 1. A person specified in paragraph (c)3. of this subsection who is 12 authorized to receive data or a report may share that information with 13 any other per sons specified in paragraph (c)3. of this subsection 14 authorized to receive data or a report if the persons specified in 15 paragraph (c)3. of this subsection are working on a bona fide specific 16 investigation involving a designated person. Both the person prov iding 17 and the person receiving the data or report under this subparagraph 18 shall document in writing each person to whom the data or report has 19 been given or received and the day, month, and year that the data or 20 report has been given or received. This docu ment shall be maintained 21 in a file by each agency engaged in the investigation; 22 2. If a state licensing board initiates formal disciplinary proceedings 23 against a licensee, and data obtained by the board is relevant to the 24 charges, the board may provide the data to the licensee and his or her 25 counsel, as part of the notice process required by KRS 13B.050, and 26 admit the data as evidence in an administrative hearing conducted 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 134 of 141 HB013630.100 - 50 - XXXX House Committee Substitute pursuant to KRS Chapter 13B, with the board and licensee taking all 1 necessary steps t o prevent further disclosure of the data; and 2 3. A medicinal cannabis practitioner or an employee of a medicinal 3 cannabis practitioner's practice acting under the specific direction of 4 the medicinal cannabis practitioner who obtains data under 5 paragraph (c )5. of this subsection may share the report with the 6 patient or person authorized to act on the patient's behalf. Any 7 medicinal cannabis practitioner or employee who obtains data under 8 paragraph (c)5. of this subsection may place the report in the patient' s 9 medical record, in which case the individual report shall then be 10 deemed a medical record subject to disclosure on the same terms and 11 conditions as an ordinary medical record in lieu of the disclosure 12 restrictions otherwise imposed by this section. 13 (5) The data contained in, and any report obtained from, the electronic system for 14 monitoring established pursuant to this section shall not be a public record, 15 except that the Department for Medicaid Services may submit the data as 16 evidence in an administrativ e hearing held in accordance with KRS Chapter 13B. 17 (6)[(13)] Intentional disclosure of transmitted data to a person not authorized by 18 subsection (3)(f) to (h) or subsection (4)(c) and (d) [subsections (7) to (9) ] of this 19 section or authorized by KRS 315.12 1, or obtaining information under this section 20 not relating to a bona fide current or prospective patient or a bona fide specific 21 investigation, shall be a Class B misdemeanor for the first offense and a Class A 22 misdemeanor for each subsequent offense. 23 (7)[(14)] The cabinet [ for Health and Family Services] may, by promulgating an 24 administrative regulation, limit the length of time that data remain in the electronic 25 system. Any data removed from the system shall be archived and subject to retrieval 26 within a reasonable time after a request from a person authorized to review data 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 135 of 141 HB013630.100 - 50 - XXXX House Committee Substitute under this section. 1 (8)[(15)] (a) The cabinet [ for Health and Family Services] shall work with each board 2 responsible for the licensure, regulation, or discipline of practitioners, 3 pharmacists, or other persons who are authorized to prescribe, administer, or 4 dispense controlled substances for the development of a continuing education 5 program about the purposes and uses of the electronic system for monitoring 6 established in this section. 7 (b) The cabinet shall work with each board responsible for the licensure, 8 regulation, or discipline of medicinal cannabis practitioners, as defined in 9 Section 1 of this Act, who are authorized to provider written certifications 10 for the use of medicinal ca nnabis for the development of a continuing 11 education program about the purposes and uses of the electronic system for 12 monitoring established in this section. 13 (c)[(b)] The cabinet shall work with the Kentucky Bar Association for the 14 development of a continu ing education program for attorneys about the 15 purposes and uses of the electronic system for monitoring established in this 16 section. 17 (d)[(c)] The cabinet shall work with the Justice and Public Safety Cabinet for the 18 development of a continuing education pr ogram for law enforcement officers 19 about the purposes and uses of the electronic system for monitoring 20 established in this section. 21 (e) The cabinet shall work with the Department for Public Health for the 22 development of a training program for cannabis busi ness agents about the 23 purposes and uses of the electronic system for monitoring established in this 24 section. 25 [(16) If the cabinet becomes aware of a prescriber's or dispenser's failure to comply with 26 this section, the cabinet shall notify the licensing boa rd or agency responsible for 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 136 of 141 HB013630.100 - 50 - XXXX House Committee Substitute licensing the prescriber or dispenser. The licensing board shall treat the notification 1 as a complaint against the licensee.] 2 (9)[(17)] The cabinet [ for Health and Family Services] , Office of Inspector General, 3 shall conduct qu arterly reviews to identify patterns of potential improper, 4 inappropriate, or illegal prescribing or dispensing of a controlled substance , 5 issuance of written certifications, or cultivation, processing, or dispensing of 6 medical cannabis . The Office of Insp ector General may independently investigate 7 and submit findings and recommendations to the appropriate boards of licensure or 8 other reporting agencies. 9 (10)[(18)] The cabinet shall promulgate administrative regulations to implement the 10 provisions of this s ection. Included in these administrative regulations shall be: 11 (a) An error resolution process allowing a patient to whom a report had been 12 disclosed under subsections (3) and (4) [subsection (9)] of this section to 13 request the correction of inaccurate info rmation contained in the system 14 relating to that patient; and 15 (b) A requirement that data be reported to the system under subsection (3) (b) of 16 this section within one (1) day of dispensing. 17 (11)[(19)] (a) Before July 1, 2018, the Administrative Office of t he Courts shall 18 forward data regarding any felony or Class A misdemeanor conviction that 19 involves the trafficking or possession of a controlled substance or other 20 prohibited acts under KRS Chapter 218A for the previous five (5) calendar 21 years to the cabine t for inclusion in the electronic monitoring system 22 established under this section. On or after July 1, 2018 , such data shall be 23 forwarded by the Administrative Office of the Courts to the cabinet on a 24 continuing basis. The cabinet shall incorporate the da ta received into the 25 system so that a query by patient name indicates any prior drug conviction . 26 (b) Before January 1, 2023, the Administrative Office of the Courts shall 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 137 of 141 HB013630.100 - 50 - XXXX House Committee Substitute forward data regarding any disqualifying felony offense for the previous 1 five (5) cal endar years to the cabinet for inclusion in the electronic 2 monitoring system established under this section. On or after January 1, 3 2023, such data shall be forwarded by the Administrative Office of the 4 Courts to the cabinet on a continuing basis. The cabi net shall incorporate 5 the data received into the system so that a query by patient name indicates 6 any prior disqualifying felony conviction . 7 Section 42. KRS 218A.500 is amended to read as follows: 8 As used in this section and KRS 218A.510: 9 (1) \"Drug paraphernalia\" means all equipment, products and materials of any kind 10 which are used, intended for use, or designed for use in planting, propagating, 11 cultivating, growing, harvesting, manufacturing, comp ounding, converting, 12 producing, processing, preparing, testing, analyzing, packaging, repackaging, 13 storing, containing, concealing, injecting, ingesting, inhaling, or otherwise 14 introducing into the human body a controlled substance in violation of this cha pter. 15 The term \"drug paraphernalia\" does not include medicinal cannabis accessories 16 as defined in Section 1 of this Act. It includes but is not limited to: 17 (a) Kits used, intended for use, or designed for use in planting, propagating, 18 cultivating, growing, or harvesting of any species of plant which is a 19 controlled substance or from which a controlled substance can be derived; 20 (b) Kits used, intended for use, or designed for use in manufacturing, 21 compounding, converting, producing, processing, or preparing controlled 22 substances; 23 (c) Isomerization devices used, intended for use, or designed for use in increasing 24 the potency of any species of plant which is a controlled substance; 25 (d) Testing equipment used, intended for use, or designed for use in identifying , 26 or in analyzing the strength, effectiveness or purity of controlled substances; 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 138 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (e) Scales and balances used, intended for use, or designed for use in weighing or 1 measuring controlled substances; 2 (f) Diluents and adulterants, such as quinine hydrochlorid e, mannitol, mannite, 3 dextrose and lactose, used, intended for use, or designed for use in cutting 4 controlled substances; 5 (g) Separation gins and sifters used, intended for use, or designed for use in 6 removing twigs and seeds from, or in otherwise cleaning or refining 7 marijuana; 8 (h) Blenders, bowls, containers, spoons, and mixing devices used, intended for 9 use, or designed for use in compounding controlled substances; 10 (i) Capsules, balloons, envelopes, and other containers used, intended for use, or 11 designe d for use in packaging small quantities of controlled substances; 12 (j) Containers and other objects used, intended for use, or designed for use in 13 storing or concealing controlled substances; 14 (k) Hypodermic syringes, needles, and other objects used, intende d for use, or 15 designed for use in parenterally injecting controlled substances into the human 16 body; and 17 (l) Objects used, intended for use, or designed for use in ingesting, inhaling, or 18 otherwise introducing marijuana, cocaine, hashish, or hashish oil int o the 19 human body, such as: metal, wooden, acrylic, glass, stone, plastic, or ceramic 20 pipes with or without screens, permanent screens, hashish heads, or punctured 21 metal bowls; water pipes; carburetion tubes and devices; smoking and 22 carburetion masks; roach clips which mean objects used to hold burning 23 material, such as marijuana cigarettes, that have become too small or too short 24 to be held in the hand; miniature cocaine spoons, and cocaine vials; chamber 25 pipes; electric pipes; chillums; bongs; ice 26 pipes or chillers. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 139 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (2) It is unlawful for any person to use, or to possess with intent to use, drug 1 paraphernalia for the purpose of planting, propagating, cultivating, growing, 2 harvesting, manufacturing, compounding, converting , producing, processing, 3 preparing, testing, analyzing, packing, repacking, storing, containing, concealing, 4 injecting, ingesting, inhaling, or otherwise introducing into the human body a 5 controlled substance in violation of this chapter. 6 (3) It is unlawfu l for any person to deliver, possess with intent to deliver, or 7 manufacture with intent to deliver, drug paraphernalia, knowing, or under 8 circumstances where one reasonably should know, that it will be used to plant, 9 propagate, cultivate, grow, harvest, ma nufacture, compound, convert, produce, 10 process, prepare, test, analyze, pack, repack, store, contain, conceal, inject, ingest, 11 inhale, or otherwise introduce into the human body a controlled substance in 12 violation of this chapter. 13 (4) It is unlawful for an y person to place in any newspaper, magazine, handbill, or other 14 publication any advertisement, knowing, or under circumstances where one 15 reasonably should know, that the purpose of the advertisement, in whole or in part, 16 is to promote the sale of objects designed or intended for use as drug paraphernalia. 17 (5) (a) This section shall not prohibit a local health department from operating a 18 substance abuse treatment outreach program which allows participants to 19 exchange hypodermic needles and syringes. 20 (b) To operate a substance abuse treatment outreach program under this 21 subsection, the local health department shall have the consent, which may be 22 revoked at any time, of the local board of health and: 23 1. The legislative body of the first or home rule class city in which the 24 program would operate if located in such a city; and 25 2. The legislative body of the county, urban -county government, or 26 consolidated local government in which the program would operate. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 140 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (c) Items exchanged at the program shall not be deemed d rug paraphernalia under 1 this section while located at the program. 2 (6) (a) Prior to searching a person, a person's premises, or a person's vehicle, a peace 3 officer may inquire as to the presence of needles or other sharp objects in the 4 areas to be searched that may cut or puncture the officer and offer to not 5 charge a person with possession of drug paraphernalia if the person declares to 6 the officer the presence of the needle or other sharp object. If, in response to 7 the offer, the person admits to the pres ence of the needle or other sharp object 8 prior to the search, the person shall not be charged with or prosecuted for 9 possession of drug paraphernalia for the needle or sharp object or for 10 possession of a controlled substance for residual or trace drug amou nts present 11 on the needle or sharp object. 12 (b) The exemption under this subsection shall not apply to any other drug 13 paraphernalia that may be present and found during the search or to controlled 14 substances present in other than residual or trace amounts. 15 (7) (a) This section shall not prohibit the retail sale of hypodermic syringes and 16 needles without a prescription in pharmacies. 17 (b) Hypodermic syringe and needle inventory of a pharmacy shall not be deemed 18 drug paraphernalia under this section. 19 (8) Any person who violates any provision of this section shall be guilty of a Class A 20 misdemeanor. 21 Section 43. KRS 342.815 is amended to read as follows: 22 (1) The authority may provide coverage for insurance, authorized in K RS 342.803, to 23 any employer in the Commonwealth, and who tenders the required premium for 24 coverage and comply with other conditions and qualifications for obtaining and 25 maintaining coverage adopted by the authority to protect and ensure its actuarial 26 sound ness and solvency. 27 UNOFFICIAL COPY 22 RS HB 136/HCS 1 Page 141 of 141 HB013630.100 - 50 - XXXX House Committee Substitute (2) The authority shall provide coverage to any employer who is unable to secure 1 coverage in the voluntary market unless : 2 (a) The employer owes undisputed premiums to a previous workers' 3 compensation carrier or to a workers' compensation residual market 4 mechanism ; or 5 (b) Providing coverage to the employer would subject the authority or its 6 employees to a violation of federal or state law . 7 Section 44. Section 2, Sections 4 to 8, Section 11, Sections 13 t o 15, Sections 8 18 to 25, Section 30, and Sections 37 to 43 of this Act take effect July 1, 2023. 9 "}